Postreplicative repair is an integral component of lagging strand DNA replication and a suppressor of replication stress by Becker, Jordan
  
 
 
 
 
Postreplicative repair is an integral component of lagging strand DNA replication 
and a suppressor of replication stress 
 
 
 
 
A DISSERTATION 
SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL  
OF THE UNIVERSITY OF MINNESOTA 
BY 
 
 
 
 
Jordan Robert Becker 
 
 
 
 
 
 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF  
DOCTOR OF PHILOSOPHY 
 
 
 
Dr. Anja-Katrin Bielinsky 
 
 
 
 
April 2016 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Jordan Robert Becker 2016 
 
  i 
Acknowledgements 
 
I want to begin by thanking all of the current and former members of the 
Bielinsky lab that I’ve had the pleasure to meet and work with over the past 5.5 
years. I would be lucky to work with any scientists of your caliber but am particularly 
fortunate in that you are also my close friends.  
I must also give a deep thanks to my adviser, Anja. Not only have you taught 
me to hold myself to a high standard, but you have daily demonstrated the drive 
and work ethic necessary to be successful in this profession. I can never thank you 
enough for the time (and undoubtedly frustration) that you have expended in 
teaching me how to do science the right way. Thank you. 
I am so incredibly lucky to have a family that is such an unyielding source 
of love and support. My brothers, Alex, Kyle and Aaron, and my sister Ellen. I love 
you all and even though many of us live far away from one another, when we all 
get together it’s as if we never missed a beat. To my extended family, Janet and 
Dale, and my “in-laws” Andy, Sheila, and Paul who have all been so supportive 
through this process. In particular I would like to thank my parents, Brian and Jill. 
Mom and Dad, I love you so much and will never be able to thank you enough for 
everything that you’ve done for me. Thank you. 
Finally and most importantly, my wife Abbey. We met in the first week of 
grad school and have shared this journey together from the beginning. I love you 
more than anything and cannot wait to share the rest of our lives adventures 
together. 
  ii 
Dedication 
 
This thesis is dedicated to my family and friends for their unwavering love 
and support. 
  iii 
Abstract 
Cell division is a basic requirement for the propagation of all organisms. 
This process begins with a parental cell which divides, leaving two daughter cells. 
Prior to division, it is necessary for the parental cell to generate a precise duplicate 
of its genetic material via the process of DNA replication, so that each resulting 
daughter segregates with a full genetic complement. Errors that occur during this 
process are thus inherited as mutations by the daughter cells and perpetuated in 
each subsequent generation along that lineage. Because an estimated 10,000 
trillion cell divisions occur in the average lifetime of a human being, it is imperative 
that this process occurs with a minimum of errors [Quammen 2008]. In the event 
of difficulty or error, a network of repair and checkpoint pathways has arisen to 
facilitate the completion of replication with a minimum of inherited mutations 
[Myung et al. 2001]. The high level of conservation in these replication, repair and 
checkpoint pathways has allowed us to utilize relatively simple model organisms, 
such as S. cerevisiae (budding yeast), to better understand how these processes 
are carried out in more complex metazoan systems. My research has focused on 
one such group of pathways collectively referred to as postreplicative repair or 
“PRR” [Chen et al. 2011]. PRR is activated in response to a variety of stressors, 
which cause difficulty for the replication program and mitigates their impact on 
genome integrity. The findings included in this dissertation expand our knowledge 
of stressors, which impact the usage of PRR pathways and moreover describe 
PRR as an integral component of lagging strand DNA replication.  
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Cell cycle regulation 
 The cell cycle has historically been divided into 4 phases: 1) G1 or “gap 1” 
phase in which the cell prepares by ensuring that it contains the necessary 
components to transit the cell cycle, 2) S or “synthesis” phase when the genome 
is replicated, 3) G2 or “gap 2” to ensure that replication is completed sufficiently 
for cell division, and finally 4) M or “mitosis” phase in which the chromosomes are 
separated and the cell divides.  
 The phases of this cycle are defined by the specific events outlined above, 
but are also defined and regulated by the interaction of cyclin dependent kinase 1 
(Cdk1) with a cohort of nine different cyclins which regulate its activity [Hartwell et 
al. 1974, Reed et al. 1985]. These related proteins can be sub-classified and 
include three G1 cyclins (Cln) and six B-type cyclins (Clb) [Mendenhall and Hodge 
1998]. Different cyclins are present at distinct stages of the cell cycle and their 
binding to Cdk1 specifies its activity to the correct substrates at the correct time 
[Reed et al. 1985, Mendenhall and Hodge 1998]. Being that the majority of my 
research has been carried out using the yeast model system, the nomenclature 
used herein is derived from S. cerevisiae.  
 In G1 phase, Cdk1 is bound by the G1 cyclins Cln1-3. There is no individual 
G1 cyclin that is essential, but at least one must be present to proceed from G1 
phase past the restriction point or “Start” in yeast, into S phase [Richardson et al. 
1989]. Despite this, Cln1-3 each have some unique molecular functions. The Cln3-
Cdk1 complex plays a critical role by phosphorylating the transcriptional repressor 
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whiskey 5 (Whi5), enabling derepression of transcription of a massive cohort of 
genes involved in the upcoming cell cycle including Cln1/2 and Clb5/6 [Simon et 
al. 2001, Costanzo et al. 2004]. Following transcriptional derepression, Cln1 and 
Cln2 levels rise and when bound to Cdk1 they promote spindle pole body 
duplication, bud formation, and phosphorylation of substrate/subunit inhibitor of 
cyclin-dependent protein kinase 1 (Sic1) [Lew and Reed 1993, Dirick et al. 1995, 
Lew and Reed 1995, Schneider et al. 1996]. Phosphorylation of Sic1 results in its 
degradation, relieving the inhibition of Cdk1-Clb5 and Cdk1-Clb6 complexes and 
allowing entry into S phase [Hereford and Hartwell 1974, Tyers 1996, Feldman et 
al. 1997]. 
 Progression through S, G2, and M phases sees a handoff from the G1 
specific A-type (Cln1-3) to the early B-type (Clb5/6) cyclins. Clb5/6 are present in 
the beginning of S phase and are directly involved in assembling factors involved 
in the initiation of DNA replication [Tanaka et al. 2007]. Clb3/4 accumulate in mid-
S phase and persist until the completion of mitosis, during which time they are 
partially redundant for Clb5/6 and support proper spindle assembly [Fitch et al. 
1992, Schwob and Nasmyth 1993, Haase et al. 2001]. After the bulk of replication 
is completed, Clb1 and Clb2 accumulate during G2 phase where they promote the 
transition into and through M phase [Fitch et al. 1992, Seufert et al. 1995]. In M 
phase, Clb1/2-Cdk1 activates the anaphase promoting complex (APC), an E3 
ubiquitin ligase which targets precocious dissociation of sisters 1 (Pds1) or 
“securin” for degradation [Cohen-Fix et al. 1996]. Pds1 degradation relieves its 
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inhibition of extra spindle pole bodies 1 (Esp1) or “separase”, which is then free to 
cleave cohesin and thereby allow separation of the chromosomes [Ciosk et al. 
1998, Uhlmann et al. 1999]. APC then goes on to target the majority of the Clb 
cyclins for degradation by the 26S proteasome enabling exit from mitosis [Morgan 
1999].  
 
Mechanism of DNA replication 
Origin licensing and activation  
Origins of replication in budding yeast are located throughout the genome 
and are defined by related autonomous replicating sequences (ARSs) 
[Stinchcomb et al. 1979]. These ARS sequences are bound by a multiprotein origin 
recognition complex (ORC) in late M/G1 phase of the cell cycle which identifies 
them as potential origins of replication [Bell and Dutta 2002]. During G1 phase, 
ORC recruits cell division cycle 6 (Cdc6) and chromatin licensing and DNA 
replication factor 1 (Cdt1) before loading minichromosome maintenance 2-7 
(Mcm2-7) helicase hexamers in a head-to-head fashion (Figure 1.1) [Liang et al. 
1995, Coleman et al. 1996, Maiorano et al. 2000, Nishitani et al. 2000, Whittaker 
et al. 2000, Remus et al. 2009]. Loading of Mcm2-7 completes assembly of the 
pre-replication complex (pre-RC) and at this juncture the origins are inactive but 
considered to be “licensed” [Evrin et al. 2009, Remus et al. 2009].  
With the transition from G1 to S phase and the initiation of DNA replication, 
the pre-RC is sequentially targeted by two S-phase specific kinases, Dbf4-
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dependent kinase (DDK) and S-cyclin-dependent kinase (S-CDK), stimulating 
formation of the pre-initiation complex (pre-IC) (Figure 1.1) [Heller et al. 2011]. This 
is marked by the recruitment of a series of additional replication factors including 
GINS (Go, Ichi, Nii, and San) and Cdc45 which together with Mcm2-7 forms the 
Cdc45-Mcm2-7-GINS (CMG) holoenzyme [Zou and Stillman 2000, Moyer et al. 
2006]. After activation, CMG will translocate along the chromosome unwinding 
DNA [Moyer et al. 2006]. In the first event of activation, DDK phosphorylates Mcm4 
and Mcm6 stimulating the recruitment of synthetically lethal with dpb11-1 (Sld3) 
and Cdc45 [Randell et al. 2006, Sheu and Stillman 2010]. Then, Clb5/6-Cdk1 or 
“S-CDK” phosphorylates Sld3 and Sld2, enabling their interaction with Dpb11 
[Zegerman and Diffley 2007]. Dpb11 recruits Pol-ε and GINS, which along with 
Sld2 forms the pre-loading complex (pre-LC) and delivers Pol-ε and GINS to 
origins (Figure 1.1) [Muramatsu et al. 2010]. However, before the helicase can 
become fully activated the Mcm2-7 helicase ring, which loads encircling double-
stranded (ds)DNA, must melt the two strands, extruding one from the inner pore 
of the ring [Costa et al. 2011]. Mcm2-7 is then positioned encircling the leading 
strand template and unwinds the two strands for replication as it travels along the 
chromosome [Fu et al. 2011]. The precise mechanism by which melting and strand 
extrusion occurs is not yet entirely understood but is an active area of study [Gai 
et al. 2010].  
One of the final steps in origin activation is the recruitment of Mcm10 to the 
pre-IC. This serves two proposed roles: 1) binding and stabilization of single-
 6 
 
stranded (ss)DNA upon melting of the two DNA strands, allowing replication 
protein A (RPA) recruitment, and 2) recruitment of polymerase (Pol-) α primase in 
concert with chromosome transmission fidelity 4 (Ctf4) [Ricke and Bielinsky 2004, 
Ricke and Bielinsky 2006, Warren et al. 2008, Gambus et al. 2009, Warren et al. 
2009, Baxley et al. 2016]. Pol-α primase is necessary to generate primers with a 
3’-OH end that can be extended by the replicative polymerases Pol-ε and Pol-δ 
[Bell and Dutta 2002]. Mcm10 then travels with the replication fork in association 
with proliferating cell nuclear antigen (PCNA), moving away from the origin as a 
component of the DNA elongation machinery (Figure 1.1) [Ricke and Bielinsky 
2004, Das-Bradoo et al. 2006]. In a recent and exciting development, the Diffley 
laboratory at the Francis Crick Institute in London has reconstituted origin 
assembly and activation completely in vitro using only purified yeast protein 
components [Yeeles et al. 2015]. This has for the first time undisputedly 
established the minimum number and identity of essential components necessary 
for origin assembly and replication start [Yeeles et al. 2015]. 
 
DNA synthesis and Okazaki fragment maturation 
 Replication proceeds bidirectionally from the sites of origin activation with 
complete CMG complexes moving away in both directions (Figure 1.2) [Bell and 
Dutta 2002, Fu et al. 2011]. Synthesis of the DNA is primed by Pol-α primase, 
generating short (20-30 nucleotide) RNA-DNA fragments de novo on a ssDNA 
template [Arezi and Kuchta 2000]. The 3’-OH end of the primer plays 2 crucial roles 
 7 
 
in enabling bulk DNA synthesis: 1) unlike Pol-α primase, the replicative 
polymerases Pol-ε and Pol-δ are unable to polymerize DNA on unprimed ssDNA 
and require a starting 3’-OH for nucleotide addition which the primer provides, and 
2) the 3’ end is recognized by the replication factor C (RFC) clamp loader complex 
which loads the homotrimeric replication clamp and polymerase processivity factor 
PCNA [Majka and Burgers 2004]. Because replicative polymerases only 
synthesize DNA in one direction (5’ to 3’), one strand is replicated continuously 
following in the same direction as the helicase. This is referred to as the leading 
strand and is thought to be synthesized primarily by Pol-ε [Pursell et al. 2007]. In 
contrast, the lagging strand is replicated by Pol-δ in the opposite direction and is 
carried out in short bursts called Okazaki fragments (Figure 1.2) [Sakabe and 
Okazaki 1966, McElhinny et al. 2007]. Each Okazaki fragment requires the 
synthesis of a short RNA-DNA primer by Pol-α primase, DNA synthesis by Pol-δ, 
and processing by the combined efforts of a number of enzymes, which act to join 
the newly synthesized Okazaki fragment with the 5’ end of the preceding fragment 
(Figure 1.2) [Burgers 2009].  
The joining of Okazaki fragments is a regulated multistep process 
collectively referred to as Okazaki fragment maturation [Hubscher and Seo 2001]. 
It begins when DNA synthesis by Pol-δ collides with the 5’ end of the previous 
Okazaki fragment and displaces it into a 5’ flap [Burgers 2009]. PCNA then 
coordinates the processing of this flap in a manner that is dependent on a 
conserved interaction between the PCNA interacting peptide (PIP) box of the flap 
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endonuclease radiation sensitive 27 (Rad27) and the interdomain connector loop 
of PCNA [Gary et al. 1999, Chapados et al. 2004, Tsutakawa et al. 2011].  Flaps 
that escape processing by Rad27 are degraded by the endonuclease/helicase 
Dna2 in a reaction that depends on RPA binding to the flap [Bae and Seo 2000, 
Bae et al. 2001]. Successful flap cleavage results in a ligatable nick, which is joined 
by DNA ligase I [Pascal et al. 2004, Tomkinson et al. 2006]. After ligation, PCNA 
is unloaded in an enhanced level of genomic instability (Elg1)-dependent reaction, 
completing Okazaki fragment maturation [Kubota et al. 2013, Kubota et al. 2015]. 
Because of their relatively small size (100-200 nucleotides), one round of 
replication of the yeast genome includes the priming, synthesis, and processing of 
~100,000 Okazaki fragments [Jin et al. 2003]. This fact underlines the importance 
to genome stability of reliably completing maturation with a minimum of errors. In 
human cells with a much larger genome, the lagging strand is synthesized in an 
estimated 26,000,000 Okazaki fragments [Hubscher and Seo 2001]. If even a 
small percentage of these fail to efficiently join and result in mutations or breaks in 
the DNA, the effect on genome stability is profoundly disastrous. In the next 
section, I will focus on the cellular response to such DNA damage and more 
generally stress on the replication machinery. This will be described with particular 
emphasis on PRR as it pertains to my own research. 
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Cellular response to DNA damage/replication stress 
 “Replication stress” is a complex condition that can be generally 
characterized as a cellular environment in which replication is impaired by any 
exogenous or endogenous factors that impinge on its normal regulation or 
successful completion. The primary signal for replication stress is unreplicated 
ssDNA which becomes coated with the ssDNA binding protein complex RPA 
[Branzei and Foiani 2010]. As discussed in the previous section, ssDNA is an 
important and natural intermediate in many of the DNA/protein transactions that 
occur during unperturbed replication. However, in the presence of replication 
stressors, either in the form of chemical damage to the DNA that impedes 
polymerase progress, or inherent defects within the replication machinery, ssDNA 
gaps can persist for an inordinate amount of time [Lopes et al. 2006]. These ssDNA 
gaps act as a marker for replication stress or DNA damage that – if unaddressed 
– can lead to unintended breakage or recombination events, translocation, 
mutation, or loss of genetic material [Zou and Elledge 2003, Branzei and Foiani 
2010, Flynn and Zou 2011]. RPA binds ssDNA with high affinity and acts as a 
platform to initiate checkpoint and rescue pathways to mitigate the effects of 
replication stress [Zou and Elledge 2003].  
 
The S-phase checkpoint is activated by replication stress 
 The S phase checkpoint acts as a sort of pause button when DNA 
replication encounters any of a variety of obstacles and promotes its completion 
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with a minimum of heritable mutations. Activation of the checkpoint begins with the 
binding of mitotic entry checkpoint 1 (Mec1) kinase and its partner DNA damage 
checkpoint 2 (Ddc2) to RPA-coated ssDNA [Rouse and Jackson 2000, Zou and 
Elledge 2003]. Mec1 and Ddc2 are homologs of the mammalian ATR kinase and 
ATR interacting protein (ATRIP), respectively [Zou and Elledge 2003]. Mec1 then 
acts through two independently operating mediator proteins, mediator of the 
replication checkpoint 1 (Mrc1) and Rad9 which when phosphorylated are capable 
of activating the checkpoint kinase Rad53 (homolog of the human kinase CHK2) 
(Figure 1.3) [Sanchez et al. 1996, Sun et al. 1996, Vialard et al. 1998, Alcasabas 
et al. 2001]. Activation of Rad53 serves several important roles in response to 
replication stress. First, it inhibits origins that have not yet fired [Santocanale and 
Diffley 1998]. Rad53 targets the initiation factors Sld3 and DDK, inactivating them 
and preventing the creation of additional replication forks until the source of 
replication stress has been addressed [Lopez-Mosqueda et al. 2010, Zegerman 
and Diffley 2010]. Second, it upregulates cellular dNTP pools, promoting efficient 
replication under conditions of replication stress [Chabes et al. 2003]. Finally, and 
perhaps most importantly, Rad53 activation stabilizes stressed replication forks, 
preventing their collapse and preserving them for resumption of replication when 
the checkpoint signal subsides [Tercero and Diffley 2001]. 
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Postreplicative repair 
 In parallel to the S phase checkpoint and activated through the same RPA-
ssDNA stimulus are the so-called postreplicative repair or “PRR” pathways. The 
role of PRR in facilitating replication under various adverse conditions has been 
the primary focus of my thesis research and as such I will devote extended space 
to the details underlying PRR and related pathways along with a historical 
perspective.  
 PRR, which is also referred to as DNA damage tolerance, can be divided 
into two general pathways: 1) Error-prone, which relies on low fidelity translesion 
polymerases to bypass lesions on the template strand DNA, completing replication 
and avoiding ssDNA persistence at the cost of an increased mutation load, and 2) 
Error-free, whereby the template strand for replication is switched from the 
damaged strand to the nascent strand of its newly replicated sister chromatid in a 
recombination-like process (Figure 1.4) [Prakash et al. 2005, Branzei 2011]. The 
importance of completing replication in a timely manner is underlined by the 
observation that cells will knowingly take on additional mutations by utilizing the 
error-prone branch of PRR to fill ssDNA gaps. The “DNA damage tolerance” 
terminology which is often used to describe PRR is literally accurate in the sense 
that both pathways enable the tolerance of DNA damage and promote bypass by 
the replication machinery [Branzei and Foiani 2010]. Neither pathway is directly 
involved in the repair of DNA damage, which is carried out afterward by 
independent repair pathways [Ganesan 1974]. The “postreplicative” moniker is 
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derived from early studies in which it was erroneously assumed that these 
pathways are active exclusively after the bulk of replication had taken place [Rupp 
and Howard-Flanders 1968]. However, more recent work has demonstrated that 
while PRR can be functional after S phase, it is also at work in the context of active 
replication forks [Branzei and Foiani 2010, Daigaku et al. 2010, Karras and Jentsch 
2010]. Despite the literal accuracy of “DNA damage tolerance”, PRR is the 
preferred terminology in the field and will thus be the primary term in this 
dissertation. 
PRR was first described in E. coli by Rupp and Howard-Flanders in a 1968 
study in which they provided evidence for the exchange of genetic information 
between sister chromatids after UV irradiation [Rupp and Howard-Flanders 1968]. 
Such a model is consistent with what we now know about error-free PRR and the 
use of undamaged sister chromatid DNA as a replication template (Figure 1.4) 
[Branzei 2011]. The authors observed that the chromosomes of UV irradiated cells 
incorporated less [3H]thymidine than non-irradiated cells and inferred that UV-
induced lesions impaired the completion of replication, leaving unreplicated gaps. 
However, if the cells were incubated for a longer time after radiation they were able 
to fully incorporate [3H]thymidine and complete replication. Rupp and Howard-
Flanders named the process by which this occurs “postreplication repair”.  It is 
remarkable that these early researchers were able to devise such an accurate 
model based solely on the pattern of [3H]thymidine incorporation into the DNA of 
excision repair deficient cells following UV irradiation. 
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As indicated earlier, the error-prone branch of PRR gains its name from a 
reliance on low fidelity translesion polymerases [Prakash et al. 2005]. These were 
first identified in a 1971 study in which the translesion polymerase genes 
reversionless 1 and 3 (REV1 and REV3) (although they were not known to be 
polymerases at the time) were found to be responsible for the majority of mutations 
in S. cerevisiae after UV treatment [Lemontt 1971, Quah et al. 1980]. We now know 
that Rev1 is a highly conserved translesion polymerase present throughout 
evolution and Rev3 is the catalytic subunit of another highly conserved translesion 
polymerase, Pol-ζ [Prakash et al. 2005]. The study by J.F. Lemontt that identified 
these genes turned out to be seminal, as many of the additional translesion 
polymerases in yeast, mammalian, and E. coli systems were later identified by 
their homology to REV1 [Kenyon and Walker 1980, McDonald et al. 1997, 
McDonald et al. 1999]. A subsequent genetic screen for alleles, which confer 
sensitivity to UV radiation in yeast confirmed for the first time that genes involved 
in error-prone PRR belong to an epistasis group downstream of RAD6 [Lawrence 
and Christensen 1976]. This so-called RAD6 epistasis group, which originally 
included REV1, REV3, and RAD18, was later connected to error-free PRR by the 
inclusion of RAD5 [Johnson et al. 1992]. Rad5 acts downstream of Rad6 and 
regulates the initiation of error-free PRR [Branzei 2011]. Thus, error-prone and 
error-free PRR are co-regulated by Rad6, but at the time the basis for this 
regulation was not clear. 
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Mechanistically, the regulation of PRR by Rad6 remained something of a 
mystery until 1986 when it was demonstrated to be a ubiquitin conjugating enzyme 
[Jentsch et al. 1986]. Several studies at the time described Rad6 ubiquitination of 
histones H2A and H2B, although these did not turn out to be the key targets for 
PRR regulation [Jentsch et al. 1986, Sung et al. 1988]. It was not until 2002 that 
the critical target of Rad6 was identified as PCNA by Hoege and colleagues in the 
laboratory of Stefan Jentsch (Figure 1.3) [Hoege et al. 2002]. Interestingly, it was 
Dr. Jentsch who had first described the enzymatic activity of Rad6 as a 
postodoctoral researcher 15 years earlier [Jentsch et al. 1986]. In a proteomic 
screen for small ubiquitin-like modifier (SUMO) conjugates in response to DNA 
damage induced by the base alkylating agent methylmethane sulfonate (MMS), 
PCNA was identified as a target for both ubiquitination and sumoylation at the 
same residue of lysine (K)164. Further analysis confirmed that this conserved 
residue was indeed the crucial elusive target of Rad6 which regulates PRR. It 
emerged that the ubiquitin conjugating enzyme Rad6 in conjunction with the E3 
ubiquitin ligase Rad18 targets PCNA-K164 for mono-ubiquitination in response to 
DNA damage that cannot be replicated by Pol-δ or -ε and leads to their stalling 
[Hoege et al. 2002]. This results in a loss of coordination between the unwinding 
activity of the CMG helicase and the DNA synthesis activity of the polymerases 
[Byun et al. 2005]. Loss of coordination promotes the formation of ssDNA regions, 
which rapidly become coated with RPA, and recruits Rad6-Rad18 to mono-
ubiquitinate PCNA [Byun et al. 2005, Lopes et al. 2006, Davies et al. 2008]. This 
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mono-ubiquitin moiety can then be extended to a K63-linked poly-ubiquitin chain 
by the Rad5-Mms2-Ubc13 complex [Hoege et al. 2002]. The length of this ubiquitin 
chain plays a crucial role in determining which of the two PRR pathways is 
activated. Mono-ubiquitin facilitates the error-prone pathway for lesion bypass 
dependent on translesion polymerase activity [Hoege et al. 2002, Stelter and Ulrich 
2003, Garg and Burgers 2005, Freudenthal et al. 2010]. Alternatively, poly-
ubiquitin chains enable the error-free template switching pathway [Branzei 2011]. 
This extremely satisfying result finally put into place the activities of the various 
genes, which had for a quarter of a century been implicated in the RAD6 epistasis 
group and PRR without a clear mechanistic understanding of how they functioned.  
As mentioned earlier, K164 was identified as the attachment site for both 
ubiquitin and SUMO.  This added a layer of complexity to our understanding of 
PRR regulation [Hoege et al. 2002]. Unlike ubiquitination, sumoylation occurs in 
the absence of DNA damage and inhibits illegitimate recombination between 
nascent sister chromatids. This is executed by recruiting the helicase/anti-
recombinase suppressor of rad six 2 (Srs2) [Papouli et al. 2005, Pfander et al. 
2005]. Srs2 inhibits recombination at replication forks by disrupting the formation 
of Rad51 nucleoprotein filaments that are necessary for strand invasion, a key step 
in homologous recombination (HR). The default suppression of HR during normal 
replication ultimately prevents formation of undesirable recombination 
intermediates between the two nascent strands [Krejci et al. 2003, Veaute et al. 
2003].  
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The identification of PCNA ubiquitination as a mediator of PRR also offered 
a second physical marker (besides RPA-ssDNA) for replication stress. Until this 
point, I have described PRR exclusively as a mechanism for the tolerance of 
physical damage to the DNA in the form of UV-induced lesions or chemically-
induced alkyl adducts. However, it became apparent that certain mutations in 
replication factors, which impair their function, cause constitutive PRR activation 
in the absence of exogenous DNA damage [Northam et al. 2006, Becker et al. 
2014, Becker et al. 2015]. This was first described by the Shcherbakova laboratory, 
which reported hypomorphic mutants for Pol-α, Pol-ε, and Pol-δ triggering 
constitutive ubiquitination of PCNA and activation of PRR [Northam et al. 2006].  
Later work in other laboratories and work contained in this dissertation reported 
similar results in additional polymerase and non-polymerase replication mutants 
[Karras and Jentsch 2010, Becker et al. 2014, Becker et al. 2015].  
Ubiquitination at residues different from K164 has also been reported in 
response to specific forms of replication stress, initially by our laboratory and later 
by other groups [Das-Bradoo et al. 2010, Das-Bradoo et al. 2010, Povlsen et al. 
2012, Nguyen et al. 2013, Elia et al. 2015]. There is some indication that alternate 
sites of ubiquitination coordinate non-PRR pathways, but the details are poorly 
understood  [Das-Bradoo et al. 2010]. In particular, yeast cells deficient for DNA 
ligase I exhibit ubiquitination of PCNA at K107 [Das-Bradoo et al. 2010]. This 
modification is essential for the viability of ligase mutants and appears to 
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coordinate a Rad59-dependent rescue pathway independently of PRR [Nguyen et 
al. 2013, Lee et al. 2014]. 
  
Genome stability and cancer 
 In the second edition of their comprehensive “Hallmarks of Cancer” review, 
Hanahan and Weinberg included genome instability and mutation as the most 
prominent enabling characteristics of cancer [Hanahan and Weinberg 2011]. In 
general, this refers to the acquisition of mutations and genomic rearrangements, 
which impair the function of checkpoint and repair pathways, inactivate tumor 
suppressors, or activate oncogenes. We now know that the vast majority of 
mutations and genomic rearrangements occurs during S phase and results from 
defects in replication, repair, or checkpoint activation [Myung et al. 2001, Kolodner 
et al. 2002]. As such, the integrity of these pathways is imperative for the 
maintenance of genome stability and acts a critical anti-cancer barrier.  
 This point is best illustrated by the clinical predisposition to cancer in 
patients with germline mutations that impair the function of replication or repair 
genes [Jackson and Bartek 2009, Zeman and Cimprich 2014]. These include 
components of PRR, such as the translesion polymerase Pol-η. Pol-η specializes 
in the bypass of thymidine dimers resulting from UV damage to DNA. Bulky lesions 
cannot be replicated by Pol-ε and Pol-δ [Prakash et al. 2005], leading to the 
formation of RPA-ssDNA structures and subsequent ubiquitination of PCNA 
[Lopes et al. 2006, Davies et al. 2008]. This facilitates the recruitment of Pol-η to 
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bypass the UV lesion [Watanabe et al. 2004]. Patients with inherited mutations that 
inactivate Pol-η suffer from a disorder known as Xeroderma Pigmentosum (XP) 
that renders them highly sensitive to UV light [Masutani et al. 1999]. When the skin 
of XP patients is exposed to sunlight it results in painful sores and a dramatic 
increase in the incidence of skin cancers [Cleaver 2005]. 
 In addition to inherited mutations, early tumorigenic events are also thought 
to put stress on DNA replication and repair pathways, thereby promoting cancer 
progression [Bartkova et al. 2005]. In these cases, it is more difficult to assess 
whether a specific mutation played a role as a “driver” in cancer development. Due 
to the prominence of genome instability and mutation in carcinogenesis, such 
clinical specimens typically have a high mutation load and determining the stage 
at which each occurred is often not possible after the fact [Kolodner et al. 2002]. 
However, recapitulating mutations of interest in model organisms can be 
informative in learning whether they have the potential to drive tumorigenesis. One 
such example is FEN1, the human homolog of the yeast gene RAD27 which, as 
described earlier, cleaves 5’ flaps that are generated during lagging strand 
replication [Hubscher and Seo 2001]. Mutations that impair the catalytic function 
of FEN1 were observed in a wide variety of cancers, and subsequently 
recapitulated in mouse models to establish their potential to promote cancer 
formation [Zheng et al. 2007, Larsen et al. 2008].  
 We now appreciate genome instability to be a unifying characteristic of most 
human cancers [Hanahan and Weinberg 2011]. The high level of evolutionary 
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conservation in replication and checkpoint pathway components has made S. 
cerevisiae particularly useful in characterizing this relationship [Kolodner et al. 
2002]. While recent advances in genome engineering with the CRISPR-Cas9 
system have drastically reduced the time requirement and complexity of 
addressing targeted genetic questions in human cells, the genetic malleability and 
speed of yeast research remains unparalleled [Ran et al. 2013].  
 
Rationale 
 Replication stress is a prominent contributor to genome instability and 
mutation, both enabling characteristics of cancer. Over the past half-century we 
have come to understand PRR as a crucial mechanism by which cells minimize 
the negative impact of replication stress and promote the timely completion of S 
phase. The subject of this dissertation has been to better understand the cellular 
conditions that lead to a requirement for PRR in the absence of exogenous DNA 
damage. A clearer picture for the genetic conditions under which PRR is required 
holds the potential to identify unique cancer vulnerabilities that could be explored 
as novel targets for cancer therapy. The studies presented herein have served to 
build a better understanding of PRR as a potential therapeutic target as well as an 
anti-cancer barrier. 
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Figure 1.1  
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Figure 1.1. Origin licensing and activation. ORC binds origins and recruits Cdt1, 
Cdc6 and Mcm2-7, forming the pre-RC and “licensing” the origin (top panel). DDK 
phosphorylation of Mcm4 and Mcm6 recruits Cdc45 and Sld3. This is followed by 
the formation and recruitment of the pre-LC, composed of Dpb11, Pol-ε, Sld2, and 
GINS in an S-CDK dependent manner. This completes pre-IC formation (middle 
panel). Recruitment of Mcm10, Pol-α, and RPA then enables DNA unwinding and 
origin firing, beginning DNA synthesis (bottom panel). This figure was adapted 
from Thu and Bielinksy, 2014 [Thu and Bielinsky 2014]. 
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Figure 1.2  
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Figure 1.2. The eukaryotic replication fork.  The mechanism of DNA replication 
is semiconservative and antiparallel in nature. The leading strand (top) is replicated 
in the same direction as helicase unwinding and occurs in a more or less 
continuous manner. Lagging strand replication (bottom) moves in the opposite 
direction of helicase unwinding and therefore must be constantly re-primed 
(Mcm10, Ctf4, and Pol-α) as the helicase unspools new regions of template strand. 
These discontinuous segments are referred to as Okazaki fragments and are 
synthesized by Pol-δ. Following synthesis, each fragment is processed and ligated 
to the adjacent fragment by the combined activities of Pol-δ, Rad27 and DNA 
ligase I (LigI). Adapted from Thu and Bielinsky, 2014 [Thu and Bielinsky 2014].  
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Figure 1.3  
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Figure 1.3. The eukaryotic replication stress response.  In response to DNA 
damage or replication stress (symbolized by the red triangle) that leads to the 
formation of RPA-coated ssDNA there are two critical responses that act in 
parallel. One is activation of the checkpoint kinase Rad53 by the ATR homolog 
Mec1, which serves to initiate the S phase checkpoint. The other is recruitment of 
the Rad6-Rad18 ubiquitination complex to ubiquitinate (orange diamond) PCNA 
at K164 and trigger activation of PRR (see Figure 1.1). Adapted from Thu and 
Bielinsky, 2014 [Thu and Bielinsky 2014].
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Figure 1.4 
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Figure 1.4. Postreplicative repair pathways. Lesions in template strand DNA 
(red triangle) lead to PCNA-K164 ubiquitination and activation of PRR pathways 
to facilitate damage bypass. Error-prone PRR (top) utilizes mutagenic translesion 
polymerases to replicate past lesions, incurring mutations to avoid the greater risk 
that is replication stalling and fork breakage. In error-free PRR (bottom) the 
nascent strand of the undamaged sister chromatid is used as a template to 
replicate past the lesion before re-annealing to the original damaged template. 
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CHAPTER 2   
 
Mcm10 deficiency causes defective-replisome-induced 
mutagenesis and a dependency on error-free postreplicative 
repair 
 
(The work in this chapter was published in Becker, J.R., Nguyen, H.D., Wang X., 
and Bielinsky, A.K. (2014) Cell Cycle 1;13(11):1737-48. PMID: 24674891) 
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Mcm10 is a multifunctional replication factor with reported roles in origin 
activation, polymerase loading, and replication fork progression. The literature 
supporting these variable roles is controversial and it has been debated whether 
Mcm10 has an active role in elongation. Here, we provide evidence that the 
mcm10-1 allele confers alterations in DNA synthesis that lead to defective-
replisome-induced mutagenesis (DRIM). Specifically, we observed that mcm10-1 
cells exhibited elevated levels of PCNA ubiquitination and activation of the 
translesion polymerase, pol-. Whereas translesion synthesis had no measurable 
impact on viability, mcm10-1 mutants also engaged in error-free PRR, and this 
pathway promoted survival at semi-permissive conditions. Replication gaps in 
mcm10-1 were likely caused by elongation defects, as dbf4-1 mutants, which are 
compromised for origin activation did not display any hallmarks of replication 
stress. Furthermore, we demonstrate that deficiencies in priming, induced by a 
pol1-1 mutation, also resulted in DRIM, but not in error-free PRR. Similar to 
mcm10-1 mutants, DRIM did not rescue the replication defect in pol1-1 cells. Thus, 
it appears that DRIM is not proficient to fill replication gaps in pol1-1 and mcm10-
1 mutants. Moreover, the ability to correctly prime nascent DNA may be a crucial 
prerequisite to initiate error-free PRR.  
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INTRODUCTION 
 Timely and accurate replication of the genome is critical for the long-term 
health and viability of eukaryotic organisms and their offspring. Accomplishing this 
task requires the precise orchestration of a multitude of enzymatic and non-
enzymatic factors. Errors in this process can cause mutations and genomic 
rearrangements, which are both hallmarks of cancer [Hanahan and Weinberg 
2011]. In particular, defects in replication genes are a contributing source of errors 
that can engender genome instability [Myung et al. 2001]. A detailed mechanistic 
knowledge of how DNA replication is regulated and how cells counteract 
replication stress is thus intimately linked to our understanding of carcinogenesis. 
 At the center of both normal DNA replication and the response to replication 
stress is the homotrimeric clamp, proliferating cell nuclear antigen (PCNA). PCNA 
is loaded onto primed template DNA and – spatially and temporally – coordinates 
the action of a multitude of proteins involved in DNA polymerization and nascent 
DNA processing [Moldovan et al. 2007]. During normal replication, PCNA binds 
the replicative polymerases, pol-andpol- to facilitate leading and lagging strand 
synthesis, respectively, acting as a processivity factor to promote efficient 
replication [Burgers 2009]. When these processive DNA polymerases encounter 
bulky lesions in the template strand that they are unable to bypass, they will stall, 
leaving regions of unreplicated single-stranded (ss)DNA [Lopes et al. 2006]. This 
ssDNA rapidly becomes coated with replication protein A (RPA), which facilitates 
the recruitment of the E2-E3 ubiquitination complex Rad6-Rad18 to catalyze the 
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transfer of mono-ubiquitin onto lysine (K)164 of PCNA [Hoege et al. 2002, Davies 
et al. 2008]. Mono-ubiquitination at K164 can subsequently be extended to a K63-
linked poly-ubiquitin chain by Mms2-Ubc13-Rad5. Mono- versus poly-
ubiquitination of PCNA-K164 plays a crucial role in determining the downstream 
pathway that will be activated to bypass the lesion. Poly-ubiquitination promotes 
error-free postreplication repair (PRR) by template switching, whereas mono-
ubiquitination is necessary for the activation of specialized translesion synthesis 
(TLS) polymerases that temporarily replace the processive replicative 
polymerases, albeit at the cost of an elevated intrinsic error rate [Branzei and 
Foiani 2010, Branzei 2011]. Higher eukaryotes possess a wide variety of TLS 
polymerases, however, yeast expresses only Rev1, pol- (composed of Rev3 and 
Rev7)and pol-(Rad30) [Prakash et al. 2005]. Pol- is responsible for nearly all 
subsequent replication-generated mutations induced by treatment with DNA-
damaging agents in vivo [Prakash et al. 2005]. Pol- works in conjunction with pol-
to bypass UV light-induced pyrimidine dimers and has a structural requirement 
for Rev1 in TLS [Waters et al. 2009]. Thus, loss of pol-leads to an almost 
complete reduction in the mutational load accrued in response to DNA damage 
[Prakash et al. 2005]. Although originally described as a response to obstructive 
template strand lesions, PCNA ubiquitination and TLS by pol-have more recently 
been implicated in the response to non-template-altering sources of replication 
stress [Northam et al. 2006, Northam et al. 2010]. In an elegant set of genetic 
experiments, Northam and co-workers showed that replication impediments, 
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including hydroxyurea (HU), as well as defective copies of pol-, - and -induce 
pol-synthesis independently of DNA damage [Northam et al. 2006, Northam et 
al. 2010].This phenomenon, termed defective-replisome-induced mutagenesis 
(DRIM), occurs on undamaged template DNA, but nonetheless results in PCNA-
K164 ubiquitination and a pol-dependent elevation of the mutation rate. 
 PCNA ubiquitination and DRIM occur in a pol1 mutant that exhibits 
abnormal priming [Suzuki et al. 2009]. It is notable that priming must take place 
every 100-200 base pairs along the lagging strand template to initiate the synthesis 
of a new Okazaki fragment, making its accuracy and regulation critical to 
successful replication [Burgers 2009]. Unlike Pol1, Mcm10 is a non-catalytic 
scaffold protein that has been implicated in multiple steps during DNA replication 
[Thu and Bielinsky 2013]. Early work analyzing Mcm10 in Xenopus egg extract 
indicated that it was recruited to replication origins after licensing and required for 
DNA unwinding [Wohlschlegel et al. 2002]. Additional reports in yeast have shed 
light on the mechanistic role of Mcm10 in replication complex assembly and 
helicase activation [Heller et al. 2011, Kanke et al. 2012, van Deursen et al. 2012, 
Watase et al. 2012]. These studies came to the conclusion that Mcm10 is essential 
to activate the unwinding of DNA duplexes at origins by the Cdc45-Mcm2-7-GINS 
(CMG) helicase complex. It remains unclear whether Mcm10 acts as a bona fide 
helicase activator or is simply needed by its virtue of stabilizing ssDNA. 
 In addition to origin unwinding, multiple laboratories in various model 
systems have demonstrated that Mcm10 binds the catalytic subunit of pol-Pol1, 
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and facilitates its chromatin association [Fien et al. 2004, Ricke and Bielinsky 2004, 
Yang et al. 2005, Ricke and Bielinsky 2006, Chattopadhyay and Bielinsky 2007, 
Zhu et al. 2007, Warren et al. 2009, Haworth et al. 2010, Lee et al. 2010, Robertson 
et al. 2010]. Moreover, Mcm10 is post-transcriptionally modified during G1 and S 
phase, resulting in non-proteolytic ubiquitination at two distinct lysines. This 
modification is a prerequisite for Mcm10’s interaction with PCNA, which is essential 
for cell proliferation [Das-Bradoo et al. 2006]. In addition, Mcm10 travels with the 
replication fork, pointing to a function in DNA elongation [Ricke and Bielinsky 2004, 
Pacek et al. 2006, Raveendranathan et al. 2006, Taylor et al. 2011]. Although roles 
for Mcm10 in origin unwinding, elongation and pol-regulation are not mutually 
exclusive, the notion that Mcm10 is part of the eukaryotic replisome is a matter of 
ongoing debate in the field [Kanke et al. 2012, van Deursen et al. 2012, Watase et 
al. 2012, Thu and Bielinsky 2013].  
 Here, we exploited the fact that PCNA ubiquitination and DRIM can be 
utilized as a sensitive biological readout for the accumulation of ssDNA gaps. 
Consistent with a previous report, we detected both ubiquitination of PCNA and 
DRIM in pol1-1 cells [Northam et al. 2006]. In support of a role for Mcm10 in DNA 
synthesis, we also detected these two diagnostic markers in mcm10-1, but not 
dbf4-1 mutants known to be compromised in origin firing similarly to mcm10-1 cells 
[Zou and Stillman 2000, Varrin et al. 2005]. Interestingly, mcm10-1 – but not pol1-
1 – engaged in error-free PRR to promote completion of DNA replication and cell 
survival. Together, these results argue that reduced origin activation is unlikely to 
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trigger gap formation in the genome of budding yeast. We propose that defective 
priming in pol1-1 and mcm10-1 leads to ubiquitination of PCNA and DRIM. 
Moreover, wild-type priming activity appears to be required to initiate template 
switch events. 
 
RESULTS  
Mutants defective in Mcm10 exhibit PCNA ubiquitination 
Translesion polymerases are not only required to bypass DNA lesions, but 
also act in response to intrinsic defects of the replicative polymerases, pol-, - 
and -[Northam et al. 2006, Northam et al. 2010]  Specifically, the pol1-L868F 
mutant, which has a higher rate of nucleotide misincorporation than the wild-type 
enzyme and therefore produces mismatched primers that are unsuitable for 
extension by pol-, displays constitutive PCNA ubiquitination [Suzuki et al. 2009]. 
We addressed whether other types of defects in pol-or pol--associated 
proteins, such as Mcm10, have a similar effect. We examined two different 
temperature-sensitive mutations, pol1-1 and mcm10-1. The former is a G493R 
substitution in the N-terminus that does not alter the active site nor the expression 
level of Pol1 [Lucchini et al. 1988, Pizzagalli et al. 1988, Lucchini et al. 1990]. 
However, the mutated protein no longer assembles into a stable pol-primase 
complex, which almost certainly affects the catalytic rate of RNA/DNA primer 
synthesis [Lucchini et al. 1988]. In addition, it has been proposed that the positive 
charge interferes with chromatin association, and independent evidence supports 
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that the enzyme is prone to replication slippage [Schweitzer and Livingston 1998, 
Gutiérrez and Wang 2003]. All of these effects are more pronounced at non-
permissive conditions, under which cells arrest in mid-to-late S phase (Figure 2.1). 
The P269L mutation in mcm10-1, on the other hand, confers lower steady-state 
protein levels than wild-type under permissive conditions and these further 
diminish at elevated temperatures [Merchant et al. 1997, Sawyer et al. 2004]. We 
monitored the status of PCNA ubiquitination in pol1-1, mcm10-1, and their 
respective parental wild-type strains at permissive and various elevated 
temperatures (Figure 2.2). Whereas pol1-1 mutants exhibited constitutive PCNA 
ubiquitination (Figure 2.2A), the modification was first induced at semi-permissive 
conditions in mcm10-1 cells (Figure 2.2B). To ascertain that PCNA ubiquitination 
was triggered by the loss of Mcm10, we complemented the mcm10-1 strain with a 
wild-type MCM10 transgene under the control of its endogenous promoter. 
Expression of the transgene alleviated PCNA ubiquitination at 35C (Figure 2.2C) 
and complemented the temperature-sensitive growth of the mutant (Figure 2.2D). 
Since ubiquitination of PCNA is diagnostic for replication stress that interferes with 
normal elongation, these results suggest that both the pol1-1 and mcm10-1 
mutations result in aberrant DNA synthesis and ssDNA gaps.  
To further corroborate this notion, we determined whether ubiquitin was 
attached to K164. To this end, we generated double mutants that expressed His6-
tagged PCNA that was either wild-type or carried a K164R substitution. 
Asynchronous cell cultures were shifted to 35C for 3h and PCNA was purified 
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under denaturing conditions on Ni-NTA agarose [Ulrich 2009]. The eluates were 
then analyzed for ubiquitin and small ubiquitin-like modifier (SUMO). Sumoylation 
of PCNA occurs constitutively during S phase at K127 and K164 [Hoege et al. 
2002]. Both pol1-1 and mcm10-1 mutants displayed mono- and poly-ubiquitination 
as well as mono- and poly-sumoylation (Figure 2.3A and B). The K164R 
substitution in PCNA eliminated most of these modifications, except for mono-
sumoylation at K127, a known alternate sumoylation site to K164 [Hoege et al. 
2002]. To ensure that the mutants used in these experiments behaved in a manner 
consistent with previous reports, we treated mcm10-1 and mcm10-1 pol30-K164 
mutants with methyl methanesulfonate (MMS) at room temperature, 
demonstrating that K164-specific ubiquitin attachment can be observed in these 
strains (Figure 2.3B) [Hoege et al. 2002]. When we shifted mcm10-1 pol30-K164R 
double mutants to 35°C, ubiquitination was slightly reduced, but we consistently 
observed measurable mono- and poly-ubiquitination, raising the possibility that 
alternate lysine residues are targeted for ubiquitin conjugation in this mutant 
(Figure 2.3B) [Das-Bradoo et al. 2010, Das-Bradoo et al. 2010, Nguyen et al. 
2013]. To verify that the pol30 mutations conferred the expected DNA damage 
sensitivity in the mcm10-1 background, we exposed mcm10-1 pol30 double and 
triple mutants to UV light. Consistent with previous reports, the pol30-K164R 
mutation rendered cells UV-sensitive. This sensitivity was partially alleviated in the 
pol30-KK127/164RR mutant (Figure 2.4) [Hoege et al. 2002, Stelter and Ulrich 
2003]. In summary, these pull down experiments unequivocally identify PCNA-
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K164 as the target site for ubiquitination in pol1-1 mutants. Furthermore, they 
independently confirm the presence of ubiquitinated PCNA in mcm10-1 cells, albeit 
ubiquitin conjugation does not occur exclusively at K164. 
 
Spontaneous mutations in mcm10-1 cells are dependent on K164 of PCNA 
and the translesion polymerase genes REV1 and REV3 
Since the biochemical data for mcm10-1 remained ambiguous with respect 
to the site of ubiquitin attachment on PCNA, we explored this issue genetically. To 
validate that PCNA-K164 played a functional role in both pol1-1 and mcm10-1 
strains, we determined whether it had any effect on their respective spontaneous 
mutation rates. To this end, we quantified the frequency of canavanine resistance 
by a standard fluctuation analysis at semi-permissive growth conditions. For pol1-
1, the mutation rate was elevated ~15-fold over wild-type controls (Figure 2.5A). 
Interestingly, a K164R substitution in PCNA reduced this mutation rate 
approximately 4-fold, but did not decrease it to wild-type levels. This is consistent 
with a previous report that suggested that the replication fidelity of Pol1-1-
containing pol-/primase complexes is lower than that of its wild-type counterpart 
[Gutiérrez and Wang 2003, Northam et al. 2006]. This would result in mutations 
that are independent of K164, due to an intrinsic catalytic dysfunction as observed 
in Figure 2.5A. In contrast, spontaneous mutations in mcm10-1 cells were 
exclusively dependent on K164 of PCNA (Figure 2.5B). Furthermore, the K164-
dependent mutation rate was very similar between the pol1-1 and mcm10-1 
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strains. These results strongly suggested that mcm10-1 mutants ubiquitinated 
PCNA at K164, and that DRIM was the primary source of the measured mutagenic 
events. To address this issue experimentally, we deleted REV1, REV3 and 
RAD30, respectively, in both pol1-1 and mcm10-1 cells. Loss of either Rev1 or 
Rev3 had a comparable effect to that caused by the K164R substitution in PCNA 
(compare Figure 2.5A to Figure 2.6A, and 2.5B to 2.6B), whereas ablation of 
RAD30 triggered no significant alterations. These results are in agreement with the 
fact that Rev3 and its accessory subunit Rev7 are exchanged with the catalytic 
subunit of pol- to form a chimeric translesion polymerase complex known as pol-
 which works in conjunction with Rev1 [Prakash et al. 2005, Baranovskiy et al. 
2012, Makarova et al. 2012]. Unlike pol-, Rad30 specifically promotes UV-
induced DNA damage tolerance (DDT), but has not been implicated in DRIM 
[Northam et al. 2010]. To exclude the possibility that Rad30 was not active in the 
pol1-1 and mcm10-1 strains, we exposed cells to UV light and measured the 
resulting mutation frequencies. Both strains showed a significant increase in UV-
induced mutations (Figure 2.7). Consistent with the results shown in Figures 3 and 
4, pol1-1 cells displayed a higher frequency of mutagenesis than mcm10-1 
mutants relative to their corresponding wild-type strains (Figure 2.7A). mcm10-1 
cells exhibited the same relative increase in UV-induced mutagenesis as wild-type 
controls (Figure 2.7B), whereas this was not the case for pol1-1 mutants (Figure 
2.7A). The underlying reason is unknown. Nevertheless, these findings argue that 
neither the pol1-1 nor the mcm10-1 mutation compromises TLS in response to UV 
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irradiation. This suggests that despite not being involved in spontaneous 
mutagenesis (Figures 2.6A and 2.6B), Rad30 is not otherwise disabled, confirming 
that only Rev1 and pol- are participating in DRIM. 
 
RAD5 and POL30-K164 but not REV3 suppress mcm10-1 temperature 
sensitivity 
Our finding that PCNA is ubiquitinated at K164 in pol1-1 and mcm10-1 and 
facilitates pol- dependent DRIM led us to examine the importance of PCNA-K164 
for cell viability. Interestingly, we found that mcm10-1 pol30-K164R double mutants 
showed an approximately 10-fold growth defect at 33°C in comparison to the 
mcm10-1 single mutant (Figure 2.8A). In contrast, pol1-1 pol30-K164R double 
mutants exhibited no enhanced growth defect at any of the temperatures analyzed 
(Figure 2.8A). As previously indicated, mono- and poly-ubiquitination of PCNA at 
K164 are known to facilitate distinct PRR pathways, and thus we dissected the 
relative contribution of each of these pathways in promoting survival of mcm10-1 
cells [Branzei and Foiani 2010]. Because we had previously observed that deletion 
of REV3 was sufficient to abrogate DRIM (Figure 2.6B), we generated a mcm10-1 
rev3doublemutant. To disable the error-free branch of PRR we combined 
mcm10-1 with rad5. Finally, to inhibit both pathways, we created mcm10-1 
rad5rev3 triple mutants. Whereas deletion of REV3 did not have any effect at 
the temperatures examined, deletion of RAD5 alone or in combination with REV3 
caused a 10-fold reduction in viability at 33°C (Figure 2.8B). This is consistent with 
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the 10-fold growth defect observed in mcm10-1 pol30-K164 mutants (Figure 2.8A) 
and suggests that the RAD5-dependent error-free branch of PRR suppresses the 
temperature sensitivity of the mcm10-1 strain. Importantly, the growth defects in 
mcm10-1 pol30-K164R and mcm10-1 rad5mutants were rescued by expression 
of a wild-type MCM10-2HA transgene (Figure 2.8C). Similar to pol1-1 pol30-
K164R cells (Figure 2.8A), neither pol1-1 rev3double-, pol1-1 rad5double-
,nor pol1-1 rad5rev3triple mutants exhibited any growth alterations compared 
to the pol1-1 parental strain (Figure 2.8B). These findings suggest that DRIM is not 
proficient to promote survival of pol1-1 or mcm10-1 strains. Additionally, there must 
be an intrinsic difference between these mutants in their ability to engage into 
RAD5-dependent PRR. Despite the fact that both pol1-1 and mcm10-1 exhibit 
poly-ubiquitin chains (Figure 2.3), the former do not efficiently utilize error-free 
PRR to complete replication.  
 
PCNA ubiquitination in mcm10-1 mutants is not the result of a defect in 
origin activation  
Mcm10 has been implicated in the activation of the replicative helicase and 
its role in elongation has been disputed [Kanke et al. 2012, van Deursen et al. 
2012, Watase et al. 2012, Thu and Bielinsky 2013]. Theoretically, it was therefore 
possible that defects in origin unwinding triggered PCNA ubiquitination in mcm10-
1 mutants in an indirect manner by increasing inter-origin distances and thus 
raising the overall probability of spontaneous fork arrest. To address this issue, we 
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analyzed the well-defined dbf4-1 mutant [Zou and Stillman 2000]. Dbf4 is required 
for Cdc7-dependent phosphorylation of the Mcm 2, 4 and 6 subunits which enables 
the subsequent formation of the pre-initiation complex [Lei et al. 1997, Sheu and 
Stillman 2006, Sheu and Stillman 2010, Heller et al. 2011]. In addition it has been 
reported that Dbf4 may play a direct or indirect role in PRR [Pessoa-Brandão and 
Sclafani 2004, Harkins et al. 2009]. To ensure that disruption of Dbf4 did not inhibit 
ubiquitination of PCNA, we grew asynchronous cultures of dbf4-1 cells for 3 h in 
the presence and absence of MMS, a known inducer of replication stress. When 
treated with MMS at 25°C or the semi-permissive temperature of 35°C, dbf4-1 cells 
were able to efficiently ubiquitinate PCNA (Figure 2.9B). Importantly, this 
modification was not observed at 35°C in the absence of MMS despite a significant 
accumulation of cells in mid-to-late S phase (Figure 2.9A). Consistent with these 
findings, introduction of a pol30-K164R mutation had no effect on the temperature 
sensitivity of dbf4-1 cells (Figure 2.9C). The level of MMS-induced PCNA 
ubiquitination in dbf4-1 cells at 35°C was slightly lower than that observed in wild-
type (Figure 2.9B), likely because dbf4-1 mutants arrested significantly earlier in S 
phase and therefore had fewer active replication forks (Figure 2.9A). In contrast, 
MMS-treated mcm10-1 and wild-type cells exhibited similar levels of PCNA 
ubiquitination (Figure 2.9B). When shifted to 35°C in the absence of MMS, PCNA 
ubiquitination in mcm10-1 was elevated to similar levels as those induced by MMS 
treatment (Figure 2.9B). Together, these data suggest that despite significant 
disruptions to cell cycle progression, and a severe S phase delay, defects in origin 
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activation do not lead to the formation of ssDNA gaps. This is further corroborated 
by the finding that dbf4-1 cells grown at 35°C did not exhibit activation of the Rad53 
checkpoint kinase, nor did they exhibit elevated levels of histone H2A 
phosphorylation at S129, both known Mec1 targets and markers of replication 
stress and DNA damage, respectively (Figure 2.9D) [Downs et al. 2000, Osborn 
and Elledge 2003]. In contrast, the mcm10-1 mutation caused Rad53 
hyperphosphorylation at 35°C. We did not detect any significant phosphorylation 
of histone H2A-S129 3h after temperature shift, arguing that Rad53 activation was 
not primarily due to double-strand breaks, but rather ssDNA regions. However, we 
detected histone H2A phosphorylation after prolonged exposure to semi-
permissive conditions (Figure 2.10). These results support the conclusion that 
mcm10-1 mutants form extended regions of ssDNA, whereas dbf4-1 cells do not. 
Because it has been reported that Cdc7/Dbf4 acts upstream of Rad53, we included 
MMS treatment as a positive control to ascertain that dbf4-1 mutants are capable 
of activating the intra-S-phase checkpoint (Figure 2.9D) [Zhong et al. 2013]. Lastly, 
the lack of PCNA ubiquitination in dbf4-1 cells was also confirmed in experiments 
in which we arrested cells in G1 and released them synchronously into S phase at 
35C  (Figure 2.11). In summary, we conclude that a defect in origin activation is 
unlikely to be the crucial trigger of PCNA ubiquitination in mcm10-1 mutants. 
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DISCUSSION 
Hypomorphic mutations in the DNA replication genes POL1 and MCM10 
cause replication stress, which activates ubiquitination of PCNA at K164 and pol-
-dependent DRIM. Although DRIM has been described for strains defective in all 
three replicative polymerases, it has not been reported in the context of 
dysregulating scaffold proteins, such as Mcm10 [Northam et al. 2006, Northam et 
al. 2010]. Moreover, the biological impact of DRIM on cell viability had not been 
explored. Despite the fact that TLS is error-prone, it has a clear role in DNA 
damage resistance and contributes to cell growth under conditions of nucleotide 
shortage [Hoege et al. 2002, Lazzaro et al. 2012]. However, DRIM had no 
beneficial effect on cell survival in the pol1-1 or mcm10-1 strains, suggesting that 
it is not proficient to fill gaps, at least in these two mutants. This result is also 
consistent with the observation that half of the pol1-1 population arrested in mid S 
phase and did not reach G2 (Figure 2.1). In contrast, mcm10-1 mutants were able 
to engage in error-free PRR and arrested uniformly in G2 (Figure 2.9A). Our 
findings are in line with reports that argued that TLS is most active in late S/G2 
phase, due to the cell cycle-specific upregulation of Rev1 and that error-free PRR 
has a predominant role earlier in S phase to facilitate completion of genome 
duplication [Branzei et al. 2004, Waters and Walker 2006, Hishida et al. 2009, 
Huang et al. 2013, Karras et al. 2013]. 
 Our results further suggest that replication defects in pol1-1 and mcm10-1 
mutants are leading to persistent regions of unreplicated ssDNA, which recruit the 
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E2-E3 ligase complexes, Rad6-Rad18 and Mms2-Ubc13-Rad5, to modify PCNA 
at K164 [Hoege et al. 2002, Davies et al. 2008]. How are these gaps generated?  
We envision that the two mutants are deficient in proper initiation of nascent DNA, 
leading to similar but not identical types of replication stress. The G493R missense 
mutation in pol1-1 impairs pol-/primase complex assembly [Pizzagalli et al. 1988]. 
This increases the probability for larger gaps, especially along the lagging strand 
template (Figure 2.12), and these activate the RAD6 pathway, even in the absence 
of any DNA damaging agents [Karras and Jentsch 2010]. Moreover, the structural 
alterations caused by the pol1-1 mutation negatively affect the fidelity of pol-, 
resulting in increased levels of nucleotide misincorporation during primer 
synthesis. This was revealed by the finding that neither the K164R substitution in 
PCNA nor the deletion of REV1 or REV3 reduced the pol1-1-dependent mutation 
rate completely to wild-type levels (Figs. 2.5A and 2.6A). As a result, pol1-1 
mutants likely initiate Okazaki fragments much more infrequently than wild-type 
cells and with a higher propensity for mismatches. In fact, these mismatches might 
contribute to the formation of ssDNA gaps, as they are poor substrates for pol- 
[Haracska et al. 2001, Acharya et al. 2006]. It is tempting to speculate that pol- is 
required in conjunction with Rev1 to extend synthesis from mismatched primers in 
pol1-1, especially since there is precedence for such a scenario from the study of 
a different pol1 mutant (L868F) that has elevated levels of nucleotide 
misincorporation [Suzuki et al. 2009]. Therefore, DRIM might in fact be necessary 
for primer extension, but it may not work at a sufficiently high level during S phase 
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to rescue viability, which would explain why we did not detect any genetic 
interaction between pol1-1 and REV3 (Figure 2.8B). 
Unlike Pol1, Mcm10 is a non-catalytic, multifunctional replication factor 
active at various steps of DNA replication [Thu and Bielinsky 2013]. The 
ubiquitination of PCNA (Figures 2.2 and 2.3) and activation of Rad53 (Figure 2.9D 
and Figure 2.10B) indicate the presence of persistent regions of ssDNA in mcm10-
1 cells that can be rescued by complementation with the wild-type gene. Mcm10 
interacts with Pol1 and acts as a chromatin recruitment factor [Fien et al. 2004, 
Ricke and Bielinsky 2004, Yang et al. 2005, Das-Bradoo et al. 2006, Ricke and 
Bielinsky 2006, Chattopadhyay and Bielinsky 2007, Zhu et al. 2007, Warren et al. 
2009, Haworth et al. 2010, Robertson et al. 2010]. Therefore, our data is consistent 
with the notion that inefficient chromatin assembly of pol-/primase complexes in 
both pol1-1 and mcm10-1 mutants may be responsible for the impairment of DNA 
synthesis, which triggers DRIM. However, we cannot exclude that Mcm10 
depletion interferes with DNA synthesis in a manner unrelated to priming. 
Nevertheless, in mcm10-1 mutants, all pol-/primase complexes that are brought 
to chromatin have wild-type function. In our view, this is a critical difference 
between the two mutants and provides a rationale for the finding that mcm10-1 
cells were able to engage in error-free PRR, whereas pol1-1 cells did not appear 
to utilize this pathway efficiently (Figure 2.8A and B). Primer elongation in mcm10-
1 should not require pol-, but could simply be carried out by pol- (Figure 2.12). 
We propose that longer nascent DNA strands in mcm10-1 mutants are proficient 
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for Rad5-dependent template switching, which facilitates gap filling. It is not 
immediately obvious why gap filling requires Rad5 in the absence of DNA damage, 
and not just pol-It is possible that error-free PRR is necessary in specific regions 
of the genome or at particularly large gaps. Moreover, we cannot exclude the 
possibility that Mcm10 may have a role during replication fork restart and that this 
function leads to an increase in the half-life of ssDNA at stalled forks. Although we 
consider this scenario unlikely, we cannot formally exclude it.  
Lastly, Mcm10’s proposed role in stimulating origin unwinding led us to 
consider the possibility that PCNA ubiquitination in pol1-1 and mcm10-1 cells may 
not be the result of a common defect in priming [Kanke et al. 2012, van Deursen 
et al. 2012, Watase et al. 2012, Thu and Bielinsky 2013]. Less efficient origin firing 
in mcm10-1 mutants may increase the likelihood of incomplete replication. To 
address this issue, we compared the level of PCNA ubiquitination in mcm10-1 and 
dbf4-1 mutants. Our finding that dbf4-1 mutants did not exhibit any sign of 
replication stress (Figures 2.9, 2.10 and 2.11), argues that defects in origin firing 
are probably not the trigger of PCNA ubiquitination in mcm10-1. However, the 
study of additional origin activation mutants is required to further substantiate this 
conclusion. 
Taken together, our observations support a role for Mcm10 in the synthesis 
of nascent DNA fragments, possibly by regulating the turnover and/or chromatin 
association of Pol1 [Ricke and Bielinsky 2004, Zhu et al. 2007, Haworth et al. 2010, 
Lee et al. 2010]. Importantly, we also demonstrate that disruption of Mcm10 
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function leads to pol--dependent DRIM. This is particularly relevant to cancer 
biology because dysregulation of translesion polymerases is strongly associated 
with tumor formation [Jiyang et al. 2001, Lee et al. 2003, Yang et al. 2004, 
Albertella et al. 2005, Lee and Matsushita 2005, Sakiyama et al. 2005] and 
negative clinical outcomes [Lemée et al. 2010]. 
 
MATERIALS AND METHODS 
Strains and plasmids 
All strains are derived from W303-1a or SSL204 parental strains (Table 2.1). 
All mcm10-1 strains are isogenic derivatives of W303-1a, whereas all pol1-1 
strains are isogenic derivatives of SSL204. Strains carrying gene deletions 
(including REV1, REV3, RAD30, RAD5, BAR1, and POL30) were constructed by 
PCR-based gene disruption [Lorenz et al. 1995]. The deletions were subsequently 
confirmed by PCR and sequencing. 
The expression vector pRS316-MCM10-2HA used for mcm10-1 
complementation was generated by insertion of MCM10 and its endogenous 
promoter into the pRS316 backbone. 
PCNA lysine mutants for the canavanine assays were generated using 
pCH1572 (a gift from L. Prakash, UTMB, USA). Fragments composed of PCNA, 
its endogenous promoter and a LEU2 marker were amplified by PCR and 
integrated at the endogenous PCNA locus. Integration and clonal homogeneity 
were confirmed by PCR. PCNA mutations were confirmed by sequencing. 
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His6-tagged PCNA strains were constructed using YIp128-P30-POL30wt (a 
gift from H.D. Ulrich, IMB Mainz, Germany). Lysine mutations were introduced 
using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent 
Technologies). The plasmid was linearized by AflII  (NEB) and integrated at the 
LEU2 locus. Expression of His6-tagged PCNA was confirmed by western blot 
analysis. Endogenous PCNA was knocked out by PCR-mediated gene disruption. 
The can1-100::CAN1(HIS1) allele was generated by two-step gene 
replacement.76 Briefly, DNA fragments containing wild-type CAN1 and HIS1 with 
complementary linker sequences were generated by PCR. Equal molar amounts 
of the two fragments were mixed, denatured at 95°C for 5 min and allowed to re-
anneal at room temperature. The resulting mixture was transformed into yeast and 
integration was confirmed by PCR and sequencing. 
 
Yeast culture conditions 
All temperature shift experiments were carried out in yeast peptone 
dextrose (YPD). Asynchronous cultures were grown to OD600=0.6 at 25°C before 
shifting to various temperatures. MMS was added immediately before the 
temperature shift where indicated. Strains carrying pRS316 or pRS316-MCM10-
2HA were grown to OD600 = 0.6 in medium lacking uracil at 25°C and shifted to 
35°C in pre-warmed YPD. 
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Ni-Purification of His6-tagged PCNA 
Cultures were grown to OD600 = 0.6 at 25°C and shifted to 35°C for 3 h 
before harvesting. His6-tagged PCNA was purified from whole cell extracts 
prepared under denaturing conditions as described [Ulrich 2009]. Briefly, extracts 
were incubated overnight with Ni-NTA agarose beads (Qiagen) also under 
denaturing conditions. After binding, the His6-tagged PCNA conjugated beads 
were washed with buffers of increasing stringency before elution into EDTA-
containing loading buffer. Eluted proteins were fractionated by SDS-PAGE and 
analyzed by western blot. 
 
Protein preparation and western blotting 
Total protein extracts were obtained by trichloroacetic acid (TCA) 
precipitation and analyzed by western blot analysis [Ricke and Bielinsky 2006]. In 
all experiments, PCNA was detected using an anti-PCNA antibody (clone S871, a 
gift from B. Stillman, CSHL, NY). In pull-down experiments, His6-tagged PCNA-
ubiquitin conjugates were detected with an anti-ubiquitin antibody (P4D1, 
Covance) and His6-tagged PCNA-SUMO conjugates were detected with an anti-
SUMO antibody (a gift from X. Zhao, MSKCC, NY). Rad53 was detected using an 
anti-Rad53 antibody (a gift from JFX Diffley, LRI, UK). Phospho-histone H2A was 
detected using a phospho-S129 specific anti-histone H2A antibody (ab15083, 
Abcam). Tubulin served as loading control (MMS-407R, Covance). 
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Measurement of mutation rate and frequency 
Measurement of the rate of forward mutations in CAN1 was determined 
from at least 12 independent yeast cultures for each strain. Cultures were 
inoculated from single colonies and grown to stationary phase in YPD for 4 days 
at semi-permissive temperatures (30°C for pol1-1 and 33°C for mcm10-1). Cells 
were then treated with 10 J/m2 of UV before plating where indicated. After 
appropriate dilution, cells were plated on solid medium lacking arginine, but 
containing 60 mg/L canavanine to select for mutants and on YPD to obtain a viable 
cell count. Colonies were counted after 3-4 days of growth. Mutation rates and 
frequencies were calculated as described [Drake 1991, Foster 2006]. Significance 
was determined using the Mann-Whitney U test [Mann and Whitney 1947]. 
 
Cell cycle arrest and flow cytometry 
 For G1 arrest, cultures were grown to OD600 = 0.2 to 0.3 and -factor was 
added to a final concentration of 150 ng/ml. Cultures were incubated with shaking 
for 2 h at 25°C and then shifted to 35°C for 1 h. To release cells from the G1 arrest, 
cultures were washed once in water and re-suspended in medium pre-warmed to 
35°C with 0.1 mg/ml pronase (Sigma-Aldrich). DNA was stained for flow cytometry 
analysis with sytox green (Invitrogen). Cell cycle progression was monitored as 
described [Das-Bradoo et al. 2010]. All samples were analyzed using a Becton 
Dickinson FACSCalibur. 
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Figure 2.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2.1. pol1-1 mutants arrest in mid-to-late S phase at 35°C. Asynchronous 
cultures of pol1-1 and wild-type parental cells were grown to OD600=0.6 at 25°C. 
They were then split and incubated for 3 h at 25°C or 35°C as indicated. 
 
 52 
 
Figure 2.2 
 
 
 
 
 
 
 53 
 
 
  
Figure 2.2. pol1-1 and mcm10-1 mutations stimulate mono-ubiquitination of 
PCNA. (A, B) Cultures of mcm10-1, pol1-1 and the corresponding parental strains 
were grown to mid-log phase at 25°C and shifted to varying temperatures as 
indicated for 3 h. Total protein was precipitated with TCA and fractionated by SDS-
PAGE for western blot analysis with an anti-PCNA antibody. The asterisk indicates 
a PCNA form with a low molecular weight post-translational modification (or a non-
specific band) visible in darker exposures. (C) mcm10-1 and wild-type parental 
strains containing no vector DNA (-), empty vector (pEV), or a wild-type MCM10 
transgene expressed from the endogenous MCM10 promoter (pMCM10) were 
cultured to mid-log phase at 25°C. Cultures were then split and shifted to 25°C or 
35°C as indicated for 3 h before harvesting. Unmodified and ubiquitinated PCNA 
were monitored as mentioned above. (D) 10-fold serial dilutions of strains from C 
were grown on synthetic complete medium lacking uracil for 3 days at the indicated 
temperatures. 
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Figure 2.3 
 
  
 
 
Figure 2.3. Ubiquitination and sumoylation patterns of PCNA in pol1-1 and 
mcm10-1 mutants. (A, B) mcm10-1, pol1-1, and the corresponding parental 
strains expressing His6-tagged PCNA were grown to mid-log phase at 25°C and 
shifted to 35°C for 3 h. Cultures were treated with MMS immediately prior to 
temperature shift where indicated. PCNA was purified under denaturing conditions 
and the eluates fractionated by SDS-PAGE for western blot analysis with anti-
PCNA, anti-ubiquitin, and anti-SUMO antibodies as indicated. Ubiquitinated forms 
of PCNA are denoted as Ub1 and Ub2 for mono- and di-ubiquitin, respectively. 
SUMO attachment is indicated as SK164 for K164 and SK127 for K127. Poly-
sumoylated species are represented by Spoly. 
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Figure 2.4 
 
  
Figure 2.4. mcm10-1 his-pol30-K164R mutants are UV sensitive. The indicated 
strains were grown for two days in liquid culture at 25°C until they had reached 
saturation. Serial 10-fold dilutions were plated on YPD and immediately exposed 
to UV light. Images were taken after 2 days.  
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Figure 2.5  
 
 
 
 
 
 
 
 
  
Figure 2.5. Elevated mutation rates in pol1-1 and mcm10-1 mutants are 
PCNA-K164 dependent. Bars indicate the mutation rates in pol1-1 (A), mcm10-1 
(B), and the corresponding parental strains expressing either wild-type PCNA 
(POL30) or PCNA carrying a substitution in K164R (K164R). Each mutation rate 
represents the median of at least 12 independent measurements. Significance was 
determined by the Mann-Whitney U test and is indicated by an asterisk. 
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Figure 2.6  
 
 
 
 
  
Figure 2.6. Elevated mutation rates in pol1-1 and mcm10-1 are dependent on 
Rev1 and Rev3. Bars indicate the mutation rates in pol1-1 (A), mcm10-1 (B), and 
the corresponding parental strains, carrying deletions of REV1, REV3, or RAD30 
as indicated. Each mutation rate represents the median of at least 12 independent 
measurements. Significance was determined by the Mann-Whitney U test and is 
indicated by an asterisk. 
 
 58 
 
Figure 2.7  
 
 
 
 
  
Figure 2.7. pol1-1 and mcm10-1 mutations do not impact the normal TLS 
response to UV damage. Bars indicate the mutation frequencies in pol1-1 (A), 
mcm10-1 (B), and the corresponding parental strains in the presence or absence 
of UV light (10 J/m2) treatment. Each bar represents the median of at least 12 
independent measurements. Significance was determined by the Mann-Whitney 
U test and is indicated by an asterisk. 
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Figure 2.8  
Figure 2.8. Error-free PRR but not TLS suppresses the temperature 
sensitivity of mcm10-1. (A) (B) Serial 10-fold dilutions of the indicated strains 
were grown on YPD plates for 2 days at the indicated temperatures. (C) Serial 10-
fold dilutions of the indicated strains were grown on SC plates lacking uracil for 3 
days at the indicated temperatures. 
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Figure 2.9   
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Figure 2.9. Origin activation defects do not trigger PCNA ubiquitination in 
asynchronous cultures. (A) Asynchronous cultures of wild-type, mcm10-1 and 
dbf4-1 cells were grown to mid-log phase and then shifted to either 25°C or 35°C 
for 3 h in the absence or presence of 0.02% MMS. Cells were then harvested and 
analyzed for DNA content. (B) Protein extracts were prepared from cells treated 
as described in panel A. Modified and unmodified forms of PCNA were detected 
using an anti-PCNA antibody. (C) Serial 10-fold dilutions of the indicated strains 
were grown on YPD plates for 2 days at various temperatures as marked. (D) Wild-
type, mcm10-1, and dbf4-1 cells were harvested from the cultures analyzed in 
panel A and protein extracts were prepared. Modified and unmodified forms of 
Rad53 were detected with an anti-Rad53 antibody. Phosphorylated histone H2A 
was detected using a phospho-S129 specific anti-histone H2A antibody. Tubulin 
served as a loading control. 
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Figure 2.10  
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Figure 2.10. dbf4-1 mutants do not trigger checkpoint activation in 
asynchronous cultures. (A) Asynchronous cultures of wild-type, mcm10-1 
and dbf4-1 cells were grown to OD600=0.6 and then shifted to either 25°C or 
35°C for 5 h in the presence or absence of 0.02% MMS. Cells were harvested 
and analyzed for DNA content. (B) Wild-type, mcm10-1, and dbf4-1 cells were 
harvested from the cultures analyzed in panel A and protein extracts were 
prepared. Modified and unmodified forms of Rad53 were detected with an 
anti-Rad53 antibody. Phosphorylated histone H2A was detected using a 
phospho-S129 specific anti- -tubulin served as a 
loading control. 
 
 64 
 
Figure 2.11 
Figure 2.11. dbf-1 mutants do not trigger PCNA ubiquitination in S-phase. (A) 
Asynchronous cultures of mcm10-1 and dbf4-1 strains were arrested in G1 phase 
-factor for 3 h. Cultures were released at 35°C and analyzed for 
cell cycle progression (A) and PCNA ubiquitination (B) at the indicated time points. 
The asterisks and triangles indicate bands of unknown origin. 
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Figure 2.12 
 
 
.
Figure 2.12. Primer quality affects PRR pathway choice. The cartoon depicts 
the inherent differences between pol1-1 and mcm10-1 mutants in PRR pathway 
dynamics. (Left) In pol1-1, intrinsically inaccurate primer synthesis by the Pol1-1 
enzyme leads to mismatches unsuitable for pol-
likely extended, at least initially, by pol-ζ, which is efficient in adding to terminal 
mismatche [Prakash et al. 2005]. It is possible that mismatched primers are also 
unsuitable to initiate template switching, explaining why the Rad5-dependent error-
free pathway is not efficiently utilized in these mutants. (Right) Primers in mcm10-
1 are synthesized by a wild-type Pol1 enzyme, allowing for engagement in 
template switching, which promotes cell survival. The dashed line denotes the 
actual switch from the lagging strand template to the nascent leading strand. 
*Although the translesion polymerase pol- ζ is activated in both pol1-1 and mcm10-
1 mutants, it does not impact survival of either strain. 
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Table 2.1 
Table 2.1. Yeast Strains used in Chapter 2. 
Strain Name Relevant Genotype Source 
 W303-1a-derived strains  
W303-1a MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-52 [Thomas and Rothstein 1989] 
BTY100 mcm10-1 [Homesley et al. 2000] 
ABy1702 can1-100::CAN1 (HIS1), bar1::TRP1 This Study 
ABy1703 mcm10-1, can1-100::CAN1 (HIS1), bar1::TRP1 This Study 
ABy1704 mcm10-1, rev1::URA3, can1-100::CAN1 (HIS1) 
 
This Study 
ABy1705 mcm10-1, rev3::URA3, can1-100::CAN1 (HIS1) 
 
This Study 
ABy1706 mcm10-1, rad30::URA3, can1-100::CAN1 (HIS1) 
 
This Study 
ABy1737 pol30::POL30 (LEU2), can1-100::CAN1 (HIS1) 
 
This Study 
ABy1740 mcm10-1, pol30::POL30 (LEU2), can1-100::CAN1 (HIS1) This Study 
ABy1742 mcm10-1, pol30::pol30-K164R (LEU2), can1-100::CAN1 (HIS1) This Study 
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Strain Name Relevant Genotype Source 
ABy1900 leu2::his-POL30 (LEU2), pol30::URA3 This Study 
ABy1901 mcm10-1, leu2::his-POL30 (LEU2), pol30::URA3 This Study 
ABy1903 mcm10-1, leu2::his-pol30-K164R (LEU2), pol30::URA3 This Study 
ABy1937 pRS316 This Study 
ABy1938 pRS316-MCM10-2HA This Study 
ABy1898 mcm10-1, pRS316 Cl. 1 This Study 
ABy1939 mcm10-1, pRS316 Cl. 2 This Study 
ABy1899 mcm10-1, pRS316-MCM10-2HA Cl. 1 This Study 
ABy1940 mcm10-1, pRS316-MCM10-2HA Cl. 2 This Study 
ABy1885 dbf4-1, bar1::TRP1 [Zou and Stillman 2000] 
ABy2009 rev3::URA3 This Study 
ABy2012 rad5::LEU2 This Study 
ABy2013 mcm10-1, rad5::LEU2 This Study 
ABy2021 mcm10-1, rev3::URA3, rad5::LEU2 This Study 
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Strain Name Relevant Genotype Source 
ABy2025 
 
rev3::URA3, rad5::LEU2 This Study 
ABy2026 mcm10-1, pol30::pol30-K164R (LEU2), pRS316 This Study 
ABy2028 mcm10-1, pol30::pol30-K164R (LEU2), pRS316-MCM10-2HA This Study 
ABy2030 mcm10-1, rad5::LEU2, pRS316 This Study 
ABy2032 mcm10-1, rad5::LEU2, pRS316-MCM10-2HA This Study 
ABy2035 mcm10-1, leu2::his-pol30-K127R (LEU2), pol30::URA3 This Study 
ABy2036 mcm10-1, leu2::his-pol30-K127/164R (LEU2), pol30::URA3 This Study 
ABy2044 dbf4-1, pol30::POL30 (LEU2) 
 
This Study 
ABy2045 dbf4-1, pol30::pol30-K164R (LEU2) This Study 
 SSL204-derived strains  
SSL240 MATa, ade2, his3D200, trp1, leu2, ura3-52 [Dornfeld and Livingston 1991] 
SSL530 SSL240, pol1-1 [Schweitzer and Livingston 
1999] 
ABy1589 SSL240, bar1::TRP1 This Study 
ABy1590 pol1-1, bar1::TRP1 This Study 
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Strain Name Relevant Genotype Source 
ABy1533 pol1-1, pol30::POL30 (LEU2) This Study 
ABy400 pol30::POL30 (LEU2) This Study 
ABy1426 pol30::pol30-K164R (LEU2) This Study 
ABy1412 rev1::URA3 This Study 
ABy1414 rev3::URA3 This Study 
ABy1443 rad30::URA3 This Study 
ABy1409 pol1-1, rev1::URA3 This Study 
ABy1410 pol1-1, rev3::URA3 This Study 
ABy1445 pol1-1, rad30::URA3 This Study 
ABy1591 pol1-1, leu2::his-POL30 (LEU2), pol30::URA3 This Study 
ABy1592 pol1-1, leu2::hispol30-K164R (LEU2), pol30::URA3 This Study 
ABy1600 leu2::his-POL30 (LEU2), pol30::URA3 This Study 
ABy2010 rad5::LEU2 This Study 
ABy2015 pol1-1, rev3::URA3, rad5::LEU2 This Study 
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Strain Name Relevant Genotype Source 
ABy2020 pol1-1, rad5::LEU2 This Study 
ABy2023 rev3::URA3, rad5::LEU2 This Study 
ABy2037 pol1-1, leu2::his-pol30-K127R (LEU2), pol30::URA3 This Study 
ABy2038 pol1-1, leu2::his-pol30-K127/164R (LEU2), pol30::URA3 This Study 
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CHAPTER 3   
Genetic interactions implicating postreplicative repair in 
Okazaki fragment processing  
 
(The work in this chapter was published in Becker, J.R., Pons, C., Nguyen, H.D., 
Costanzo, M., Boone, C., Myers, C.L., and Bielinsky, A.K. (2015) PLOS Genetics 
6;11(11) PMID: 26545110) 
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were interpreted and prepared for publication by J.R.B., C.P. and A.K.B.  
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Ubiquitination of the replication clamp PCNA at the conserved residue 
lysine K164 triggers PRR to fill single-stranded gaps that result from stalled DNA 
polymerases. However, it has remained elusive as to whether cells engage PRR 
in response to replication defects that do not directly impair DNA synthesis. To 
experimentally address this question, we performed synthetic genetic array (SGA) 
analysis with a ubiquitination-deficient K164 to arginine (K164R) mutant of PCNA 
against a library of S. cerevisiae temperature-sensitive alleles. The SGA signature 
of the K164R allele showed a striking correlation with profiles of mutants deficient 
in various aspects of lagging strand replication, including rad27Δ and elg1Δ. 
Rad27 is the primary flap endonuclease that processes 5’ flaps generated during 
lagging strand replication, whereas Elg1 has been implicated in unloading PCNA 
from chromatin. We observed chronic ubiquitination of PCNA at K164 in both 
rad27Δ and elg1Δ mutants. Notably, only rad27Δ cells exhibited a decline in cell 
viability upon elimination of PRR pathways, whereas elg1Δ mutants were not 
affected. We further provide evidence that K164 ubiquitination suppresses 
replication stress resulting from defective flap processing during Okazaki fragment 
maturation. Accordingly, ablation of PCNA ubiquitination increased S phase 
checkpoint activation, indicated by hyperphosphorylation of the Rad53 kinase. 
Furthermore, we demonstrate that alternative flap processing by overexpression 
of catalytically active exonuclease 1 eliminates PCNA ubiquitination. This suggests 
a model in which unprocessed flaps may directly participate in PRR signaling. Our 
findings demonstrate that PCNA ubiquitination at K164 in response to replication 
 73 
 
stress is not limited to DNA synthesis defects but extends to DNA processing 
during lagging strand replication. 
 
INTRODUCTION 
The accurate copying of a cellular genome and subsequent transmission of 
genetic material to two daughter cells occurs on a microscopic scale, but is 
nonetheless a prodigious task. Considering the difficulty of accomplishing this 
fundamental process for living cells, it is hardly surprising that evolution has 
selected for a complex and multi-layered system of checkpoints and redundancies 
that promote its completion under sub-optimal conditions [Myung et al. 2001, 
Cremona et al. 2012]. Many of these processes are regulated by post-translational 
modification of proteins that act as molecular switches to regulate downstream 
responses.  
The replication clamp, proliferating cell nuclear antigen (PCNA), is one such 
target for a variety of post-translational modifications that trigger an array of 
downstream effects. Known modifications include the covalent attachment of 
ubiquitin and the small ubiquitin-like modifier (SUMO) to specific lysine (K) 
residues [Hoege et al. 2002]. SUMO modification of chromatin-bound PCNA, or 
sumoylation, occurs during an unperturbed S phase at K164 and – to a lesser 
extent – at K127 [Hoege et al. 2002]. Sumoylation acts primarily to recruit the 
helicase/anti-recombinase suppressor of rad six 2 (Srs2), which prevents 
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illegitimate recombination at replication forks [Haracska et al. 2004, Papouli et al. 
2005, Pfander et al. 2005].  
Ubiquitination of PCNA occurs predominately at K164, however, alternative 
attachment sites have been mapped in yeast and human cells [Das-Bradoo et al. 
2010, Xu et al. 2010, Povlsen et al. 2012, Nguyen et al. 2013, Elia et al. 2015]. In 
contrast to sumoylation, ubiquitination is induced by replication stress [Hoege et 
al. 2002]. PCNA-K164 ubiquitination was initially identified as a response to 
template strand lesions, which stall the highly selective processive polymerases 
(Pol-) δ and Pol-ε [Hoege et al. 2002]. Polymerase stalling leads to the 
accumulation of single-stranded (ss) DNA, which quickly becomes coated with 
replication protein A (RPA) [Lopes et al. 2006]. This allows for the recruitment of 
the E2-E3 ubiquitin ligase complex radiation sensitive-6 and -18 (Rad6-Rad18) to 
mono-ubiquitinate PCNA-K164 [Davies et al. 2008]. Mono-ubiquitin can be 
subsequently extended to K63-linked poly-ubiquitin chains by methyl 
methanesulfonate sensitive 2-ubiquitin conjugating 13-radiation sensitive 5 
(Mms2-Ubc13-Rad5) [Hoege et al. 2002]. The length of the ubiquitin chain plays a 
crucial role in determining which of two PRR pathways is activated. Mono-ubiquitin 
facilitates an error-prone pathway for lesion bypass dependent on translesion 
polymerase activity [Hoege et al. 2002, Stelter and Ulrich 2003, Garg and Burgers 
2005, Freudenthal et al. 2010]. Recent data indicates that replication past lesions 
by the mutagenic translesion polymerase Pol-ζ may continue for up to 1 kilobase 
beyond the lesion [Kochenova et al. 2015]. Alternatively, poly-ubiquitin chains 
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enable a template switching pathway in which the nascent DNA of the sister 
chromatid acts as a template, allowing for lesion bypass and filling of ssDNA gaps 
[Branzei 2011]. This process is considered to be “error-free”, because it does not 
rely on the intrinsically mutagenic translesion polymerases of the error-prone 
pathway [Vanoli et al. 2010]. The precise mechanism of this branch is not yet well 
understood.  
In addition to the originally described function of PRR in DNA damage 
tolerance and lesion bypass, recent work has suggested that mutants with 
impaired replisome function also activate these pathways for replication of 
undamaged template strands [Northam et al. 2006, Karras and Jentsch 2010, 
Northam et al. 2010, Becker et al. 2014]. We have previously demonstrated that 
PRR promotes the viability of mcm10 mutants in the absence of DNA damage 
[Becker et al. 2014]. To systematically explore the role of PCNA-K164 in response 
to intrinsic cellular dysfunction, we performed SGA analysis of a PCNA-K164 to 
arginine (PCNA-K164R) mutant. Interestingly, we found that the genetic interaction 
profile of the PCNA-K164R mutant closely resembled that of many alleles of 
lagging strand replication factors, including those involved in Okazaki fragment 
processing. This observation was particularly intriguing, as PRR has not been 
implicated in tolerating Okazaki fragment processing defects. As a result, we 
further investigated the activity of PCNA-K164-dependent pathways in mutants 
disrupting normal lagging strand replication. Specifically, we focused on the role of 
PCNA-K164 in cells deficient for the flap endonuclease radiation sensitive 27 
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(Rad27) or enhanced level of genomic instability 1 (Elg1), a homolog of replication 
factor C (RFC) subunit Rfc1 [Bellaoui et al. 2003].  
Rad27 processes 5’ flaps generated during lagging strand replication when 
DNA synthesis by Pol-δ collides with the 5’ end of the RNA-DNA primer of the 
previous Okazaki fragment, displacing it into a small <10-nucleotide (nt) flap 
[Ayyagari et al. 2003, Jin et al. 2003]. If the 5’ flap escapes processing by Rad27 
and grows long enough to bind replication protein A (RPA), it is then cleaved by 
Dna2 [Bae et al. 2001, Jin et al. 2003, Levikova and Cejka 2015]. RPA binding of 
the flap serves both to inhibit Rad27, and to recruit Dna2 [Bae et al. 2001]. Dna2 
cleaves the long ~30-nt flap to a short flap (5-10 nt), which can then be further 
processed by Dna2 or Rad27 into a ligatable nick [Bae and Seo 2000, Bae et al. 
2001, Ayyagari et al. 2003, Levikova and Cejka 2015]. Although processing of long 
flaps must be relatively efficient under normal conditions, rad27Δ mutants exhibit 
a temperature dependent slow-growth phenotype [Reagan et al. 1995]. This is best 
explained by an increased rate in DNA replication and concomitant increase in the 
formation of long flaps [Reagan et al. 1995, Tishkoff et al. 1997]. At the restrictive 
temperature of 37°C, rad27Δ mutants are unable to meet flap processing 
demands, resulting in lethality, whereas at the semi-permissive temperature of 
35°C growth is merely impaired [Reagan et al. 1995, Symington 1998]. In the 
absence of complete flap removal – even at lower temperatures – Pol δ-
exonuclease (exo) activity can resect the nascent 3’ end allowing the small 5’ flap 
to re-anneal and form a ligatable nick [Jin et al. 2001, Jin et al. 2003]. After ligation 
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of the nick by DNA ligase I (Cdc9), PCNA is unloaded from chromatin by the 
Elg1:Rfc2-5 complex [Parnas et al. 2010, Kubota et al. 2013, Kubota et al. 2015]. 
In the present study, we report that PCNA is ubiquitinated in rad27Δ and elg1Δ 
mutants. Whereas ablation of PRR is inconsequential in the elg1Δ strain, both 
translesion synthesis (TLS) and template switching promote rad27Δ viability, 
possibly by enabling alternative flap processing. Furthermore, the long RPA-
coated flaps generated in the absence of Rad27 play an active role in promoting 
the ubiquitination of PCNA at K164 and initiating PRR.  
 
RESULTS 
PCNA-K164R mutants resemble lagging strand replication mutants 
To examine the global role of PCNA-K164 in the absence of exogenous 
DNA replication stressors, we performed SGA analysis of two independently 
isolated PCNA-K164R mutant clones (identified as PCNA-K164R clone 1 and 
PCNA-K164R clone 2, respectively) against a library of temperature-sensitive (TS) 
alleles and a full genome (FG) array as previously described (Tables 3.1 and 3.2) 
[Baryshnikova et al. 2010, Li et al. 2011]. Parallel analyses were performed against 
the TS array using a decreased abundance by mRNA perturbation (DAmP) allele 
of PCNA or a wild type (WT) allele as the query strain [Schuldiner et al. 2005, 
Beltrao et al. 2010]. Since ubiquitination or sumoylation of K164 facilitates only a 
subset of PCNA functions, we anticipated that interactions identified in the PCNA-
K164R SGA screens should represent a small part of those identified in the PCNA-
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DAmP analysis. Indeed the vast majority of hits identified in the K164R mutant 
screen with the TS array were also identified with the PCNA-DAmP allele (for 
PCNA-K164R clone 1: 18/26 hits overlapped with PCNA-DAmP with p-value < 10-
11, and for PCNA-K164R clone 2: 11/14 hits overlapped with p-value < 10-8 as 
determined by Fisher’s test) (Table 3.1 and Figure 3.1A). Furthermore, the 
negative genetic interactions were largely consistent with previous reports, 
including a requirement for PRR when thiol-specific antioxidant 1 (TSA1) is 
deficient [Huang and Kolodner 2005]. Mutants of TSA1 have reduced ability to 
neutralize reactive oxygen species, leading to increased DNA damage and 
synthetic sickness with PRR mutation [Huang and Kolodner 2005]. We also 
observed a modest requirement for homologous recombination (HR) components 
in K164R mutants (Figure 3.1A) [Motegi et al. 2006]. This gave us confidence that 
genes identified in the PCNA-K164R screens represented bona fide genetic 
interactions. 
The most informative results were revealed when examining the similarity 
of the PCNA-K164R SGA profiles with the interaction signatures of other mutants. 
Strong Pearson correlation coefficient (PCC) values between PCNA-K164R 
clones and rad5Δ and rad6Δ mutants were consistent with the known functions of 
K164 in facilitating PRR (Figure 3.1B and Table 3.3). Strikingly, PCNA-K164R also 
exhibited strong correlation with many mutant alleles of genes involved in lagging 
strand replication, suggesting that those mutants have replication defects similar 
to those in the PCNA-K164R mutants (Figure 3.1B and Table 3.3). To validate this 
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observation in an unbiased manner, we performed a Gene Ontology (GO) 
enrichment analysis (http://www.ebi.ac.uk/QuickGO/). Alleles with SGA profiles similar to 
that of PCNA-K164R against the FG array (PCC > 0.15) were significantly 
associated with leading and lagging strand replication GO terms (Figure 3.1C). 
Interestingly, the list of enriched GO terms included “Okazaki fragment 
processing”, which has not been associated with PCNA-K164-dependent 
pathways (Fig 1C). GO enrichment of SGA profiles similar to PCNA-K164R against 
the TS array (PCC > 0.2) also showed nearly 25-fold enrichment with the “Okazaki 
fragment processing” term (Table 3.5). Because this initial analysis relied on 
existing GO annotations, we manually compiled an informed list of genes 
associated with leading and lagging strand replication for further analysis (Table 
3.6). We found that PCNA-DAmP and PCNA-K164R profiles against the TS array 
were highly similar (PCC > 0.2) to profiles of genes implicated in leading and 
lagging strand replication (Figure 3.2A-D). We confirmed these results when we 
compared the profile of a second PCNA-K164R query strain (Table 3.3 and Figure 
3.3). The PCNA-WT profile did not show any significant similarities (Table 3.3 and 
Figure 3.3). 
Altogether, these findings suggested that PCNA-K164 may have an active 
role in lagging strand replication, even in the absence of exogenous DNA damage. 
Strong correlations with PCNA-K164R included pol1 mutants, which we previously 
described to activate PRR pathways, and pol3 mutants (deficient in Pol-δ) which 
have also been described to elicit PCNA ubiquitination and TLS (Table 3.3) 
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[Northam et al. 2006, Becker et al. 2014]. Additional strong correlations were 
observed for rfc5, pol31, rad27, and elg1 mutants (Figure 3.1B and Table 3.3). 
These genes have been implicated in different steps of Okazaki fragment 
synthesis and processing, suggesting that PCNA-K164 is required at multiple 
junctions when lagging strand replication is impaired. This was surprising, as K164 
ubiquitination of PCNA is dependent on the formation of ssDNA and is typically 
associated with DNA synthesis defects only [Davies et al. 2008]. The source of 
ssDNA – particularly in Okazaki fragment processing mutants, such as rad27Δ – 
was thus not immediately obvious. Nonetheless, these results led us to 
hypothesize that PCNA-K164-dependent pathways may be required to tolerate 
defects in lagging strand maturation. Because the function of K164 in PRR is 
dependent on its modification by ubiquitin, we hypothesized that lagging strand 
defects would result in chronic PCNA ubiquitination and activation of PRR 
pathways. To experimentally address this question, we assayed PCNA 
ubiquitination in rad27Δ and elg1Δ mutants, both of which had interaction profiles 
that correlated strongly with the PCNA-K164R alleles (Figure 3.1B and Table 3.3).  
 
rad27Δ and elg1Δ mutants constitutively ubiquitinate PCNA at K164 
rad27Δ is a temperature-sensitive allele, and for all subsequent 
experiments we shifted these mutants to 37°C for 3 h prior to analysis. To 
determine whether PCNA is ubiquitinated at K164 in rad27Δ and elg1Δ mutants, 
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we purified histidine tagged PCNA (His6-PCNA) on Ni-NTA agarose and analyzed 
the eluates with PCNA-, ubiquitin- and SUMO-specific antibodies by western blot 
(Figure 3.4A and 3B). PCNA was indeed ubiquitinated in both mutants and 
ubiquitin attachment was completely ablated when PCNA carried a K164R 
substitution (Figure 3.4A and 3B), indicating that alternative attachment sites were 
not targeted. PCNA-K164R mutants also exhibited loss of K164-dependent 
sumoylation, consistent with previous reports [Hoege et al. 2002, Windecker and 
Ulrich 2008]. Interestingly, when we introduced the PCNA-K164R mutation in 
elg1Δ cells, we reproducibly observed a minor PCNA-SUMO species of a slightly 
lower molecular weight than K164-SUMO (marked by an asterisk), consistent with 
an earlier study that revealed an alternative sumoylation site (Figure 3.4B) 
[Windecker and Ulrich 2008]. As shown previously, K127-SUMO migrated 
markedly slower than K164-SUMO. Moreover, levels of K127-SUMO were 
elevated in PCNA-K164R mutants [Hoege et al. 2002]. Both rad27Δ and elg1Δ 
exhibited increased PCNA sumoylation at K127 and K164 compared to wild type 
(Figure 3.4A and 3B). 
Next we asked whether PCNA-K164 modifications were important for 
viability of these two strains. Spotting analysis revealed that rad27Δ mutants had 
a significant reduction in growth at the semi-permissive temperature of 35°C when 
combined with the PCNA-K164R (pol30-K164R) mutation, whereas elg1Δ cells 
exhibited no such sensitivity at any temperature tested (Figure 3.4C), nor when 
they were exposed to UV light (Figure 3.4D). In contrast, rad27Δ pol30-K164R 
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double mutants were acutely sensitive even to low doses of UV, showing a severe 
reduction in growth after exposure to 1J/m2 (Figure 3.4D). Together, these results 
suggested that K164-dependent pathways are important for the growth of rad27Δ, 
but not elg1Δ cells.  
 
TLS and template switching play redundant roles in rad27Δ mutants 
Because ubiquitination of PCNA at K164 is necessary for both TLS and 
template switching, we sought to determine which of these pathways are active in 
rad27Δ cells. Spotting analysis revealed that pol30-K164R and rad18Δ mutations 
each significantly reduced the viability of rad27Δ cells at 35°C (Figure 3.5A). The 
rad27Δ rad18Δ double mutant reproducibly appeared to have a slightly more 
severe growth defect than the rad27Δ pol30-K164R strain (Figure 3.5A). We 
attribute this finding to the known fact that PCNA-K164 sumoylation suppresses 
HR, and therefore substitution of K164 upregulates HR [Papouli et al. 2005, 
Pfander et al. 2005]. To address whether sumoylation of PCNA-K164 affected the 
viability of rad27Δ mutants, we deleted SIZ1, which encodes the SUMO E3 ligase 
that catalyzes this reaction. Consistent with published reports, rad27Δ siz1Δ 
double mutants did not exhibit any increased temperature sensitivity [Motegi et al. 
2006, Chen et al. 2007]. These results strongly suggest that the PCNA-K164 
dependent phenotype is solely due to the loss of ubiquitination. 
To estimate the relative contribution of TLS and template switching to 
rad27Δ viability, we generated rad27Δ strains with rev3Δ or rad5Δ mutations 
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rendering them deficient in TLS and template switching, respectively. In addition, 
we analyzed a rad27Δ rev3Δ rad5Δ triple mutant, defective in both branches. We 
found that rad27Δ rev3Δ double mutants did not display any significant growth 
defects, whereas the rad27Δ rad5Δ cells exhibited a mild but noticeable growth 
delay, suggesting that the template switching pathway is the more prominent of 
the two (Figure 3.5B). However, loss of both pathways in the rad27Δ rev3Δ rad5Δ 
triple mutant resulted in a synergistic effect, resembling that of the rad27Δ 
rad18Δdouble mutant (Figure 3.5A and 3.5B). These results argue that the two 
branches of PRR are both active in rad27Δ cells and have partially redundant roles 
in promoting viability. 
The finding that REV3 affected the survival of rad27Δ mutants in the 
absence of RAD5 encouraged us to further examine the activity of the TLS branch 
of PRR. To accomplish this, we took advantage of the fact that TLS employs 
intrinsically mutagenic polymerases, which have a higher rate of nucleotide 
misincorporation combined with a lack of proofreading activity [Waters et al. 2009]. 
We predicted that TLS induced mutations would be dependent on K164. Mutation 
of K164 to arginine disables DNA synthesis by pol-ζ and its binding partner Rev1, 
which are responsible for the vast majority of TLS induced mutations [Nelson et al. 
1996]. Consistent with previous reports, fluctuation analysis revealed that rad27Δ 
mutants have a drastically increased rate of mutation (Figure 3.5C) [Tishkoff et al. 
1997, Serero et al. 2014]. Addition of the pol30-K164R allele led to a significant 
decrease in the mutation rate that accounted for 20-25% of total alterations, 
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confirming that TLS was active in these cells (Figure 3.5C). Because the pol30-
K164R mutation also removes the suppressive effect of PCNA-SUMO on HR, an 
increase in gross chromosomal rearrangements may mask the decrease in 
mutation rate due to the loss of TLS. Therefore, the K164-dependent reduction is 
likely an underestimation of the contribution by TLS [Haracska et al. 2004, Papouli 
et al. 2005, Pfander et al. 2005]. In agreement with this notion, deletion of the pol-
ζ catalytic subunit REV3 results in a more severe reduction in the mutation rate 
than the pol30-K164R mutation (Figure 3.5C). Nonetheless, our observations are 
consistent with a recent report that had estimated point mutations in rad27Δ 
mutants to account for ~40% of all genomic aberrations [Serero et al. 2014]. Our 
results support the idea that the majority of these single nucleotide variations are 
a result of translesion polymerase activity. 
 
PCNA-K164 suppresses rad27Δ replication defects   
 To further explore how PCNA-K164 aids in cell survival, we analyzed 
activation of the Rad53 kinase, a downstream target of the mitotic entry checkpoint 
kinase 1 (Mec1), the homolog of human ATR (ataxia telangiectasia mutated- and 
Rad3-related) [Osborn and Elledge 2003]. rad27Δ pol30-K164R double mutants 
showed increased phosphorylation of Rad53 relative to rad27Δ cells after they 
were shifted to the restrictive temperature of 37°C for 3 and 4 h. This was indicative 
of enhanced replication stress (Figure 3.6A). Consistently, the double mutants also 
displayed a robust late S/G2 phase arrest at those time points (Figure 3.6B). Since 
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rad27Δ cells passed more proficiently through mitosis (indicated by the higher G1 
peak marked with a red arrow at 3 and 4 h in Figure 3.6B), we concluded that PRR 
pathways likely facilitated the completion of S phase and ultimately allowed for 
entry into mitosis. Therefore, without PRR cells have a reduced ability to tolerate 
Rad27 deficiency. Altogether, our findings support a role for PRR pathways in 
suppressing replication defects when Rad27 is absent. In contrast, elg1Δ pol30-
K164R double mutants did not display any Rad53 activation or observable 
alterations in cell cycle distribution relative to elg1Δ (Figure 3.7). 
 
Overexpression of EXO1 eliminated PCNA ubiquitination in rad27Δ  
Previous work demonstrated that ubiquitination of PCNA at K164 by Rad6-
Rad18 requires persistent regions of RPA-coated ssDNA [Davies et al. 2008]. 
These normally accumulate if the replicative polymerases are impeded [Lopes et 
al. 2006]. However, in the context of Rad27 deficiency, the source of ssDNA was 
not readily apparent. Earlier studies established that in the absence of Rad27, 
Okazaki fragment flaps are processed through a “long flap” pathway by the 
combined activities of Dna2 and Pol3-exo [Jin et al. 2001, Ayyagari et al. 2003, Jin 
et al. 2003, Garg et al. 2004, Burgers 2009]. In this pathway short flaps become 
longer through enhanced strand displacement until they are sufficiently large to be 
bound by RPA [Budd et al. 2006, Rossi et al. 2008]. Binding by RPA serves to 
recruit Dna2 and stimulate its nuclease activity, reducing the flap to approximately 
5 nt [Bae et al. 2001, Levikova and Cejka 2015]. Although Dna2 has been shown 
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to be competent to subsequently cleave the remaining short flap in vitro [Levikova 
and Cejka 2015], Pol3-exo activity is clearly essential in rad27Δ mutants at all 
temperatures [Jin et al. 2001]. Pol3-exo is thought to resect the 3’ end of the 
preceding Okazaki fragment, allowing the remaining 5’ flap to re-anneal and form 
a ligatable nick [Jin et al. 2001, Jin et al. 2003]. It is conceivable that both Dna2 
and Pol3-exo contribute to the resolution of short flaps in rad27Δ cells. The binding 
of RPA to long flap intermediates prior to processing by Dna2 led us to consider 
that long ssDNA flaps themselves could provide the stimulus for PCNA 
ubiquitination. We inferred that the close proximity of these RPA-bound structures 
to PCNA should allow for recruitment of the Rad6-Rad18 complex and subsequent 
PCNA ubiquitination. To test this hypothesis, we sought to modulate flap 
processing by overexpression of DNA2 [Bae and Seo 2000]. Because the current 
model for Dna2 processing of 5’ flaps proposes that RPA binding occurs prior to 
cleavage, we expected that recruitment of Rad6 and Rad18 may not be 
significantly reduced upon DNA2 overexpression (Figure 3.8A) [Bae et al. 2001, 
Stewart et al. 2008], unless it would directly compete with the E2-E3 complex. 
Notably, overexpression of DNA2 did not reduce PCNA ubiquitination in rad27Δ 
(Figure 3.8B). We also considered the possibility that Pol3-exo activity during long 
flap processing could generate ssDNA regions sufficiently large to bind RPA 
(Figure 3.9A). However, overexpression of an exonuclease-dead allele of POL3 
(pol3-01) failed to reduce PCNA ubiquitination in rad27Δ (Figure 3.9B). Consistent 
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with previous reports, pol3-01 expression was lethal in combination with rad27Δ 
(Figure 3.9C) [Gary et al. 1999]. 
We next sought to modulate flap processing in a manner that reduced the 
formation of long RPA-bound flaps. Multiple studies have demonstrated that 
overexpression of exonuclease 1 (EXO1) rescues the DNA damage sensitivity of 
rad27Δ mutants [Tishkoff et al. 1997, Moreau et al. 2001, Lewis et al. 2002, Sun 
et al. 2003]. Exo1 and Rad27 are both Rad2 family nucleases and crystal 
structures of their human homologs, FEN1 and EXO1, reveal highly conserved 
mechanisms of substrate binding and cleavage [Orans et al. 2011, Tsutakawa et 
al. 2011, Miętus et al. 2014]. Thus, we hypothesized that Exo1, like Rad27, may 
cleave flaps before RPA can bind to them. If this were true, Exo1 overexpression 
should reduce PCNA ubiquitination in rad27Δ cells (Figure 3.8C). Indeed, 
overexpression of EXO1 from a galactose inducible promoter eliminated PCNA 
ubiquitination in rad27Δ mutants (Figure 3.8D). Furthermore, this phenotype was 
dependent on the catalytic activity of EXO1, as overexpression of a nuclease-dead 
exo1-D173A allele had no impact on PCNA ubiquitination (Figure 3.8D) [Moreau 
et al. 2001, Tran et al. 2002]. Furthermore, EXO1 overexpression did not rescue 
the temperature sensitivity of rad27Δ (Figure 3.10). In summary, our results 
suggest that the majority of PCNA ubiquitination in rad27Δ is dependent on RPA-
coated ssDNA intermediates, which recruit the Rad6-Rad18 complex and are 
degraded by Exo1.  
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PCNA ubiquitination caused by ssDNA gaps is not impacted by EXO1 
overexpression   
To examine whether the effect of EXO1 overexpression on PCNA 
ubiquitination in rad27Δ mutants could be due to indirect suppression of ssDNA 
gap formation, we exposed EXO1 overexpressing cells to 50 J/m2 of UV light, 
which has been proven to cause ssDNA gaps (Figure 3.11A) [Lopes et al. 2006]. 
Overexpression of EXO1 had no impact on the level of PCNA ubiquitination under 
these conditions (Figure 3.11B). Moreover, we did not observe any differences in 
ubiquitination when cells were treated with 100 J/m2 of UV light, arguing that Exo1 
did not act directly or indirectly to eliminate ssDNA regions (Figure 3.11B). In 
support of this conclusion, overexpression of EXO1 had no impact on PCNA 
ubiquitination in cells harboring the temperature sensitive pol1-1 allele (Figure 
3.11C and 7D). This allele is thought to generate ssDNA regions as a result of 
reduced efficiency in the priming of Okazaki fragments (Figure 3.11C) [Gutiérrez 
and Wang 2003, Fumasoni et al. 2015], and causes ubiquitination of PCNA at 
K164 at the non-permissive temperature of 35°C [Becker et al. 2014]. Taken 
together, these findings indicate that Exo1 does not suppress the formation of 
ssDNA gaps.  
 
DISCUSSION 
 The power of SGA analysis to identify networks of genetic interactors has 
greatly increased our knowledge of cellular pathway control and carries the 
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considerable advantage of being an unbiased systems-level approach to complex 
biological questions [Tong et al. 2001]. However, such screens are useful not only 
for identifying direct genetic interactors, but also in revealing functional 
relationships between genes through comparison of their SGA signatures [Nagai 
et al. 2008, Baryshnikova et al. 2010, Li et al. 2011]. Using this type of comparative 
analysis we identified a pattern of correlation between the profiles of PCNA-K164R 
mutants and the profiles of several lagging strand replication and Okazaki fragment 
processing mutants, including rad27Δ (Figure 3.1B and Table 3.3). The high 
degree of similarity between the rad27Δ and PCNA-K164R profiles suggested to 
us that PCNA-K164-mediated pathways may counteract replication defects in 
rad27Δ. Proof of PCNA ubiquitination in rad27Δ cells and synthetic sickness in 
rad27Δ pol30-K164R and rad27Δ rad18Δ, but not rad27Δ siz1Δ double mutants 
further substantiated this notion and led us to focus on the role of K164 
ubiquitination-dependent pathways in the absence of flap endonuclease (Figures. 
3.4A and 3.5A).  
 
Long ssDNA flaps are a platform for PRR activation 
The primary replication defect in rad27Δ cells is caused by impaired 
processing of 5’ flaps generated during Okazaki fragment processing [Tishkoff et 
al. 1997]. At elevated temperatures, DNA replication proceeds more rapidly, likely 
leading to an increase in the formation of long flap intermediates, which must bind 
RPA before they can be efficiently processed [Bae et al. 2001]. We speculated that 
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these long RPA-coated flaps may serve as a platform to promote PCNA 
ubiquitination. To examine this hypothesis, we modulated flap length by 
overexpression of EXO1, a close relative of RAD27 with a highly conserved 
mechanism of substrate binding and cleavage [Orans et al. 2011, Tsutakawa et al. 
2011]. A number of prior studies have demonstrated that overexpression of EXO1 
suppresses the intrinsic mutagenicity of the rad27Δ allele [Tishkoff et al. 1997, Sun 
et al. 2003]. In particular, EXO1 overexpression suppresses the duplication of short 
direct repeats that have been hypothesized to result from longer flap structures 
generated in rad27Δ, which is consistent with Exo1 activity preventing long RPA-
coated flap formation [Tishkoff et al. 1997, Sun et al. 2003]. Thus, our finding that 
catalytically active Exo1 counteracts PCNA ubiquitination in rad27Δ, but has no 
effect on ubiquitination in pol1-1 cells or after UV treatment, argues that the DNA 
structures mediating ubiquitination in flap endonuclease deficient cells are different 
from ssDNA gaps (Figs. 6 and 7). 
It has been speculated that long unprocessed flaps could participate in the 
replication stress response [Budd et al. 2006, Budd et al. 2011, Nguyen et al. 
2013]. Campbell and colleagues found that constitutive Mec1 activation is 
responsible for dna2Δ lethality [Budd et al. 2011]. They hypothesized that Mec1 
activation originated from long RPA-coated flaps that accumulate in these mutants 
[Budd et al. 2011]. Interestingly, EXO1 overexpression partially rescues the 
temperature sensitivity of a viable dna2-1 mutant, consistent with the notion that 
Exo1 acts upstream of long flap formation [Budd et al. 2005]. 
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Another well-documented hallmark of Okazaki fragment processing 
mutants is profound instability of trinucleotide repeat (TNR) regions [Freudenreich 
et al. 1998, Callahan et al. 2003]. This raises the question as to whether a 
requirement for PCNA-K164 in rad27Δ mutants is specific to the replication of TNR 
regions. A previous study had linked error-free PRR to the suppression of TNR 
expansion in rad27Δ cells [Daee et al. 2007]. However, error-prone TLS did not 
appear to regulate TNR expansion at all [Collins et al. 2007, Daee et al. 2007]. Our 
finding that both TLS and error-free PRR are active in rad27Δ cells therefore leads 
us to conclude that the role of PCNA-K164 in these mutants is not restricted to 
genomic regions that encompass TNRs (Figure 3.5B). 
 
PCNA ubiquitination is a sensor of Okazaki fragment processing defects 
Historically, PCNA ubiquitination and PRR were considered rescue 
pathways for template strand lesions that impair polymerase progression and 
require TLS or template switching for bypass [Hoege et al. 2002]. Later work from 
the Shcherbakova group demonstrated that intrinsic replisome deficiencies in 
hypomorphic alleles of the replicative polymerases POL2 and POL3 also lead to 
PCNA ubiquitination and activation of TLS on undamaged DNA templates 
[Northam et al. 2006]. This important finding described ubiquitination of PCNA and 
activation of PRR in the absence of replication stressors that damage DNA. 
Nevertheless, the essential effect of DNA damaging agents and hypomorphic 
polymerases on replication is a disruption of DNA synthesis. Both therefore 
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intuitively lead to ssDNA gaps, triggering PCNA ubiquitination and subsequent 
gap-filling by PRR.  
In contrast, our study describes PCNA ubiquitination under conditions in 
which DNA synthesis is not impaired. Rad27 catalyzes Okazaki fragment flap 
cleavage, which does not occur until after Okazaki fragment synthesis, yet we see 
a requirement for PRR to support the viability of Rad27 deficient cells. This 
distinction suggests that PCNA-K164 is active in mediating DNA processing 
defects that are unlinked to problems in DNA synthesis. It is tempting to speculate 
that PRR pathways are promoting processing of Okazaki fragments by Dna2 or 
potentially an alternative mechanism. Error-free template switching could allow for 
synthesis past multiple Okazaki fragments using the sister chromatid as a template 
and reducing the overall requirement for flap endonuclease. A role for PRR in 
promoting flap processing and thereby reducing the half-life of long flaps is 
consistent with our observation of elevated Rad53 phosphorylation in rad27Δ 
pol30-K164R double mutants (Figure 3.6A). The mechanism by which PRR 
promotes flap processing or bypass is currently unclear. 
 
PRR does not sustain survival of elg1Δ mutants 
Similar to RAD27, ELG1 has been described as an important protector of 
genome stability [Bellaoui et al. 2003, Ben-Aroya et al. 2003, Kanellis et al. 2003, 
Smith et al. 2004, Davidson et al. 2012]. Recent reports have identified Elg1 as a 
crucial component of an alternative RFC complex that unloads PCNA from double-
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stranded DNA [Parnas et al. 2010, Kubota et al. 2013]. Our SGA screen revealed 
that the genetic interaction profile of elg1Δ correlates strongly with the PCNA-
K164R and PCNA-DAmP profiles, leading us to investigate ubiquitination of PCNA 
at K164 in this mutant (Figures. 3.1B, 3.4B and Table 3.3). Unlike rad27Δ, elg1Δ 
cells did not exhibit synthetic sickness with the K164R mutation and displayed no 
acute requirement for PRR pathways to tolerate intrinsic replication stress or mild 
UV treatment (Figure 3.4C and 3D). We speculate that replication defects in elg1Δ 
are mimicking those present in PCNA-DAmP mutants in that both are limiting the 
amount of free PCNA in the nucleus that is available to load onto chromatin and 
engage in replication. In the case of the PCNA-DAmP allele this is simply the result 
of lower steady-state levels of PCNA protein, whereas in elg1Δ, PCNA is likely 
sequestered on DNA due to diminished unloading [Parnas et al. 2010, Kubota et 
al. 2013, Yu et al. 2014].  
In summary, our results suggest that during the processing of Okazaki 
fragments via the long flap pathway, the flap itself is likely not an inert DNA 
processing intermediate, but may play an active role in signaling replication stress 
through PCNA. It is conceivable that under normal conditions a division of labor 
between long and short flap processing is required for efficient Okazaki fragment 
maturation [Bae et al. 2001, Kao et al. 2004, Rossi and Bambara 2006, 
Balakrishnan et al. 2010]. In rad27Δ cells, the balance is pushed severely to the 
long flap pathway, leading to the accumulation of RPA bound ssDNA structures 
that can be eliminated by Exo1. This becomes particularly problematic at elevated 
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temperatures when the kinetics of DNA replication are increased and flaps are 
produced at a higher rate. The mechanism by which PRR is suppressing 
replication stress under these conditions is not clear at this time, but we speculate 
that it is helping to circumvent flap processing. 
These findings are salient in light of the relationship between the regulation 
of flap processing and cancer. Homozygous deletion of the RAD27 homolog FEN1 
in mice is lethal, but heterozygous deletion in combination with mutation of the 
adenomatous polyposis coli (Apc) gene results in increased numbers of 
adenocarcinomas, enhanced tumor progression and decreased survival 
[Kucherlapati et al. 2002]. Mutations which reduce FEN1 activity have also been 
demonstrated to vastly increase cancer incidence in mouse models [Zheng et al. 
2007]. This study provides molecular evidence for the pathways contributing to 
mutagenesis when flap endonuclease function is compromised and gives insight 
into how cells sustain viability under these conditions. 
  
MATERIALS AND METHODS 
Strains and plasmids 
All yeast strains used in this study are isogenic derivatives of wild type E133 
cells, which were derived from CG379 [Tran et al. 1997], with the exception of pol1-
1 strains which are derived from SSL204 [Becker et al. 2014]. Strains with gene 
deletions were generated by PCR mediated gene disruption [Lorenz et al. 1995]. 
All clones were verified by PCR and sequencing of the modified locus. Strains 
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carrying pol30-K164R mutations were generated by PCR mediated gene 
disruption as follows: continuous PCR fragments consisting of PCNA, its 
endogenous promoter and a LEU2 marker were amplified from pCH1654 (a gift 
from L Prakash, UTMB) and integrated at the endogenous PCNA locus. Integration 
and clonal homogeneity were verified by PCR and sequencing. All strains 
generated in this study are listed in Table 3.7. 
His6-tagged PCNA strains were constructed using Yip128-P30-POL30wt 
(gift from HD Ulrich, IMB Mainz). Plasmid variants with lysine mutations were 
constructed using the QuikChange Lightning (Agilent Technologies) site-directed 
mutagenesis kit. Briefly, the plasmid was linearized at an AflII restriction site in the 
LEU2 coding sequence and transformed. Clones were screened by PCNA western 
blot to ensure that His6-PCNA expression was equivalent to endogenous 
(untagged) expression levels. The endogenous copy of PCNA was then knocked 
out via PCR mediated gene disruption.  
In experiments using galactose inducible gene expression, liquid cultures 
were grown to OD600=0.600 at 25°C in raffinose containing medium. Galactose 
was then added to a final concentration of 2% and the cultures were shifted to 
37°C for 3 h before collecting. Overexpression of POL3 and pol3-01 was induced 
by adding galactose to cells carrying the plasmids pBL336 and pBL336-01, 
respectively (gifts from D. Gordenin, NIEHS, originally constructed in P.M.J. 
Burgers laboratory, Washington University in St. Louis) [Jin et al. 2003]. 
Expression of DNA2 was induced with galactose in cells carrying pgal-DNA2 (a 
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gift from R. Wellinger, Université de Sherbrooke, Québec) [Parenteau and 
Wellinger 1999]. EXO1 overexpression was induced by adding galactose to cells 
carrying pcDNA50.1, a derivative of pRS316 that was referred to as gal-EXO1 (a 
gift from K. Lewis, Texas State University) [Lewis et al. 2002]. The exo1-D173A 
variant was generated using the QuikChange Lightning (Agilent Technologies) 
site-directed mutagenesis kit. 
UV treatment (254nm) of liquid cultures was applied using a UV crosslinker 
(CL-1000, UVP). Cultures were transferred to a sterile tray and treated in the 
crosslinker before being returned to flasks and cultured an additional 40 min before 
harvesting. 
 
Synthetic Genetic Array (SGA) screen 
A genome-wide screen for genetic interactions with four POL30 alleles as 
query strains (PCNA-DAmP, PCNA-WT, PCNA-K164R Cl.1, and PCNA-K164R 
Cl.2) was conducted at 30°C as previously described [Baryshnikova et al. 2010]. 
Because the screens are performed at 30°C they did not uncover a synthetic 
interaction between PCNA-K164R and rad27Δ. Briefly, the query strains, marked 
with a nourseothricin (NatMX4) resistance cassette and harboring the SGA haploid 
specific markers and reporter [Baryshnikova et al. 2010], were mated to an array 
of 786 temperature-sensitive and 175 viable deletion mutants (TS array: 
manuscript in preparation) (Table 3.1). Additionally, PCNA-K164R Cl.1 and Cl.2 
were mated to an array of 3827 viable deletion mutants (FG array). Nourseothricin- 
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and geneticin-resistant heterozygous diploid mutants were selected and 
sporulated with MATa pol30 double mutants as described [Baryshnikova et al. 
2010] (Table 3.2). Different PCC cutoffs were applied to the FG and TS array data 
(0.15 and 0.2, respectively) in order to enrich for the top 2% of all profile 
correlations. 
 
His6-PCNA purification 
 Cultures were grown to OD600=0.600 at 25°C and then shifted to 37°C for 3 
h before harvesting (with the exception of elg1Δ strains which remained at 25°C 
for 3 h after reaching OD600=0.600). Cell pellets were frozen at -80°C. Briefly, cells 
were lysed under denaturing conditions and protein extracts were prepared as 
previously described [Ulrich 2009]. Extracts were incubated rotating overnight at 
room temperature with Ni-NTA conjugated agarose (Qiagen) to bind His6PCNA. 
After incubation, His6PCNA-bound beads were washed with buffers of decreasing 
pH to increase stringency with successive washes. His6-PCNA was eluted from 
the beads with an EDTA-containing buffer and eluates were fractionated by SDS-
PAGE. Purified PCNA and modified forms were then analyzed by western blot 
using specific antibodies against PCNA, ubiquitin, and SUMO. 
 
Protein extraction and western blotting 
Whole cell protein extraction was accomplished by TCA precipitation as 
previously described and fractionated by SDS-PAGE [Ricke and Bielinsky 2006]. 
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Western blots were probed using the following antibodies; anti-PCNA at 1:4000 
dilution (S871, a gift from B. Stillman, CSHL), anti-SUMO at 1:3000 dilution (A gift 
from X. Zhao, MSKCC), anti-ubiquitin at 1:1000 dilution(P4D1, Covance), anti-
Rad53 at 1:1000 dilution (A gift from JFX Diffley, LRI, UK), anti-phospho-S129 H2A 
at 1:1000 dilution (ab15083, Abcam), and anti-tubulin at 1:5000 dilution (MMS-
407R, Covance).  
 
Mutation rate analysis 
Mutation rates were estimated by measuring the forward rate of mutations 
at the CAN1 locus that confer resistance to canavanine [Whelan et al. 1979]. 
Determinations were made from the median of at least 14 independent cultures for 
each strain. Cultures were inoculated from single colonies in 5 ml of YPD medium 
and grown to saturation for 5 days at 30°C. Cells were then washed and diluted to 
appropriate concentrations before plating on medium lacking arginine and 
containing canavanine (60 mg/L). Dilutions were also plated on non-selective YPD 
to obtain a viable cell count. Mutation rates were calculated using Drake’s formula 
as previously described [Drake 1991, Foster 2006]. Significance was determined 
by the Mann Whitney U test as previously described [Mann and Whitney 1947].  
 
Cell viability analysis 
Relative cell viability was measured using an assay referred to as the 
“spotting assay”. In this assay, 10 ml cultures were grown to saturation for 4 days 
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at 25°C. Cells were then harvested, washed with water, quantified, and diluted to 
equal volumes containing 2x107 cells. 10-fold serial dilutions were made from 
these 2x107 cells in a 96-well plate and then “spotted” on rich medium using a 
multi-pronged spotting manifold. Replicates were generated for incubation at 
various temperatures. UV treatment (254nm) was applied where indicated after 
plating using a UV crosslinker (CL-1000, UVP). Plates were imaged after 1.5 days 
of growth except where indicated.  
 
Cell Cycle Analysis 
Cell cycle progression was measured by flow cytometry as previously described 
[Das-Bradoo et al. 2010]. Briefly, 1 ml of liquid culture was pelleted and fixed in 
ice-cold 70% ethanol overnight. DNA was stained with Sytox Green (Invitrogen) 
and cells were analyzed using a BD Accuri C6 flow cytometer (BD Biosciences). 
Peaks were quantified using the quantification feature of the BD Accuri C6 
software. 
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Figure 3.1  
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Figure 3.1. The PCNA-K164R SGA profile exhibits a limited set of direct 
genetic interactions but correlates strongly with other replication mutants. 
(A) Heat map of selected significant negative genetic interactions identified by 
SGA against the TS array for 2 independently isolated PCNA-K164R mutants. 
PCNA-WT and PCNA-DAmP are shown for comparison. The scale indicates 
epsilon- (ε-) values for the reported genetic interactions with negative interactions 
in red and positive interactions in green. (B) Heat map denoting the strength of 
correlation (measured by PCC) between PCNA-WT, PCNA-DAmP, PCNA-K164R 
clone 1 (Cl. 1) and PCNA-K164R clone 2 (Cl. 2) signatures against the TS array 
with the SGA signatures of the indicated strains. The scale denotes the strength 
of correlation between the indicated profiles with green being positive correlation 
and red being negative (C) Top 15 GO terms (http://www.ebi.ac.uk/QuickGO/) for 
alleles with PCC > 0.15 with the PCNA-K164R Cl. 1 profile against the FG array. 
This list is derived from a representative allele randomization (complete results in 
Table 3.4). Nine other randomizations were performed with similar results. 
 
 102 
 
Figure 3.2  
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Figure 3.2. The PCNA-K164R SGA profile strongly resembles lagging strand 
replication mutant profiles. (A and B) The fraction of leading and lagging strand 
mutants with a similar profile (PCC > 0.2) to that of the PCNA-DAmP and PCNA-
K164R alleles, respectively. PCNA-K164R Cl.1 was used for this analysis. All 
mutants were queried against the TS array. Significance was determined using 
Fisher’s exact test. (C and D) The distribution of profile similarities (calculated 
using PCC) between PCNA-DAmP or PCNA-K164R, respectively, and leading or 
lagging strand replication terms. All mutants were queried against the TS array for 
this analysis. Horizontal lines within the boxes indicate the median PCC. Error bars 
encompass the middle quartiles of the PCC value distribution. Outliers are 
represented with circular dots. Significance was determined by the Wilcoxon rank 
sum test [Mann and Whitney 1947]. 
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Figure 3.3  
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Figure 3.3. The PCNA-K164R Cl. 2 SGA profile, but not that of PCNA-WT, 
strongly resembles the genetic interactions of lagging strand replication 
mutants. (A and B) The fraction of leading and lagging strand mutants with a 
similar profile (PCC > 0.2) to that of the PCNA-WT and PCNA-K164R alleles, 
respectively. PCNA-K164R Cl.2 was used for this analysis. All mutants were 
queried against the TS array. Significance was determined using Fisher’s exact 
test. (C and D) The distribution of profile similarities (calculated using PCC) 
between PCNA-WT or PCNA-K164R, respectively, and leading or lagging strand 
replication terms. PCNA-K164R Cl.2 was used for this analysis. All mutants were 
queried against the TS array. Horizontal lines within the boxes indicate the median 
PCC. Error bars encompass the middle quartiles of the PCC value distribution. 
Outliers are represented with circular dots. Significance was determined by the 
Wilcoxon rank sum test [Mann and Whitney 1947]. 
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Figure 3.4 
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Figure 3.4. rad27Δ and elg1Δ mutants ubiquitinate PCNA at K164. (A) 
Asynchronous cultures were grown to OD600=0.600 at 25°C and then shifted to 
37°C for 3 h before harvesting. His6-PCNA was purified under denaturing 
conditions and analyzed by western blot using specific antibodies against PCNA, 
ubiquitin, and SUMO as indicated. (B) Asynchronous cultures were grown to 
OD600=1.0 at 25°C before harvesting. PCNA was purified as in (A). The asterisk 
(*) indicates a minor PCNA-SUMO species observed in elg1Δ pol30-K164R 
mutants. (C) 10-fold serial dilutions of the indicated strains were incubated 1.5 or 
2.5 days on YPD plates at varying temperatures. (D) 10-fold serial dilutions of the 
indicated strains were spotted on YPD plates and subsequently treated with UV. 
Plates were imaged 1.5 days after spotting. 
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Figure 3.5   
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Figure 3.5. TLS and template switching are redundant in promoting rad27Δ 
viability. (A and B) 10-fold serial dilutions of the indicated strains were incubated 
1.5 or 2.5 days on YPD plates at varying temperatures. (C) Bars indicate the rate 
of mutation at the CAN1 locus for the indicated strains. Each measurement 
represents the median of at least 14 independent determinations. Significance was 
determined using the Mann-Whitney U test. 
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Figure 3.6   
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Figure 3.6. rad27Δ pol30-K164R double mutants exhibit increased 
checkpoint activation and cell cycle arrest. (A) The indicated strains were 
grown to OD600=0.600 at 25°C and then shifted to 37°C for 4 h. Samples were 
harvested immediately before the temperature shift and every hour for 4 h 
afterward. Protein was subsequently extracted by TCA precipitation. Extracts were 
fractionated by SDS-PAGE and analyzed by western blot with anti-Rad53 and anti-
tubulin antibodies. Tubulin served as a loading control. (B) Aliquots of the same 
cultures from (A) were analyzed for DNA content by flow cytometry. Red arrows 
indicate the G1 peaks of rad27Δ and rad27Δ pol30-K164R after 3 and 4 h at 37°C 
for comparison. Percentages indicate the percent of all cells analyzed that fall 
within the highlighted area. Green regions indicate G1 phase peaks while red 
regions mark late S and G2/M phases. 
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Figure 3.7  
 
  
Figure 3.7. elg1Δ pol30-K164R double mutants do not exhibit increased 
replication defects. (A) The indicated strains were grown to OD600=0.600 at 25°C 
and then split in half, either remaining at 25°C or being shifted to 37°C. Both 
cultures were harvested after 3 h growth and protein was extracted by TCA 
precipitation. Extracts were fractionated by SDS-PAGE and analyzed by western 
blot with antibodies specific to Rad53 and phospho-H2A-S129. Tubulin served as 
a loading control. (B) Aliquots of the same cultures from (A) were analyzed for 
DNA content by flow cytometry. 
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Figure 3.8   
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Figure 3.8. Overexpression of EXO1 suppresses PCNA ubiquitination in 
rad27Δ. (A) RPA binding to long ssDNA flaps occurs prior to processing by Dna2. 
Therefore overexpression of DNA2 is unlikely to interfere with RPA binding. (B) 
Wild type and rad27Δ cells carrying gal-EV or gal-DNA2 plasmids were grown to 
OD600=0.600 at 25°C in raffinose containing medium lacking uracil. Galactose was 
then added to a final concentration of 2% and the cultures we shifted to 37°C for 
3 h before harvesting. His6-PCNA was purified under denaturing conditions and 
analyzed by western blot with antibodies specific to PCNA, ubiquitin, and SUMO 
as indicated. (C) Cartoon depicting the effect of EXO1 overexpression in the 
absence of flap endonuclease. If long RPA-coated flaps are the stimulus for PCNA 
ubiquitination in rad27Δ, we hypothesize that EXO1 overexpression and 
processing of flaps before they are long enough to bind RPA will reduce 
ubiquitination. (D) Wild-type and rad27Δ cells carrying gal-EV, gal-EXO1, or gal-
exo1-D173A plasmids were treated as in (B) in medium lacking uracil and purified 
PCNA was analyzed by western blot with antibodies specific to PCNA, ubiquitin 
and SUMO as indicated. 
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Figure 3.9   
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Figure 3.9. Overexpression of pol3-01 does not suppress PCNA 
ubiquitination in rad27Δ. (A) Long flaps generated in the absence of Rad27 are 
processed into short flaps before Pol3-exo activity resects the 3’ end of the nascent 
DNA strand allowing for the short flap to re-anneal and form a ligatable nick. If 3’ 
resection is extensive enough to form a ssDNA region sufficient to bind RPA we 
considered that this could serve as the stimulus for PCNA ubiquitination in rad27Δ. 
(B) Wild type and rad27Δ cells carrying gal-EV, gal-POL3, or gal-pol3-01 plasmids 
were grown to OD600=0.600 at 25°C in raffinose containing medium lacking 
tryptophan. Galactose was then added to a final concentration of 2% and the 
cultures were shifted to 37°C for 3 h before harvesting. His6-PCNA was purified 
under denaturing conditions and analyzed by western blot with antibodies specific 
to PCNA, ubiquitin, and SUMO as indicated. (C) 10-fold serial dilutions of the 
indicated strains were incubated 3 days at 35°C on medium lacking tryptophan 
and containing either 2% glucose or 2% galactose. 
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Figure 3.10  
 
 
 
  
Figure 3.10. EXO1 overexpression does not rescue the temperature 
sensitivity of rad27Δ mutants. 10-fold serial dilutions of the indicated strains 
were incubated 3 days at 25°C or 35°C on medium lacking uracil and containing 
either 2% glucose or 2% galactose. 
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Figure 3.11  
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Figure 3.11. Overexpression of EXO1 does not alter PCNA ubiquitination 
under conditions that cause ssDNA gap formation. (A) UV treatment leads to 
the formation of ssDNA gaps in replicating cells [Lopes et al. 2006]. Overexpression 
of EXO1 has no impact on ssDNA gap formation. The red triangles indicate UV-
induced lesions. RPA-coated ssDNA is marked as RPA-ssDNA. (B) Cells carrying 
gal-EV or gal-EXO1 plasmids were grown to OD600=0.600 at 25°C in raffinose 
containing medium lacking uracil. Galactose was then added to a final 
concentration of 2% and the cells were grown an additional 2 h at 25°C. Each 
culture was then split into 3 parts and treated with either 0, 50, or 100 J/m2 UV and 
left to recover for 40 min at 25°C before harvesting. His6-PCNA was purified under 
denaturing conditions and analyzed by western blot with antibodies specific to 
PCNA, ubiquitin, and SUMO as indicated. (C) Inefficient priming along the lagging 
strand template leads to the formation of RPA-coated ssDNA gaps (RPA-ssDNA) 
in pol1 mutants [Gutiérrez and Wang 2003, Suzuki et al. 2009, Becker et al. 2014]. 
Overexpression of EXO1 has no impact on ssDNA gap formation. (D) Wild-type 
and pol1-1 cells carrying gal-EV or gal-EXO1 plasmids were grown to OD600=0.600 
at 25°C in raffinose containing medium lacking uracil. Galactose was then added 
to a final concentration of 2% and the cultures we shifted to 35°C for 3 h before 
harvesting. His6-PCNA was purified under denaturing conditions and analyzed by 
western blot with antibodies specific to PCNA, ubiquitin, and SUMO as indicated. 
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Table 3.1 
Table 3.1. SGA screen of PCNA DAmP, PCNA-WT, PCNA-K164R Cl. 1, and PCNA-K164R Cl. 2 against temperature 
sensitive array. Genetic interactions were scored as described in [Baryshnikova et al. 2010]. Only genetic interactions with 
epsilon scores ε<-0.09 or ε> 0.09 are included.  
Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
PCNA-DAmP      
YBR088C PCNA-DAmP YJL074C SMC3 -0.6853 0.00e+00 
YBR088C PCNA-DAmP YGL163C RAD54 -0.6681 8.40e-83 
YBR088C PCNA-DAmP YFR027W ECO1 -0.6374 3.41e-33 
YBR088C PCNA-DAmP YAR007C RFA1 -0.5941 5.39e-99 
YBR088C PCNA-DAmP YFL008W SMC1 -0.5894 0.00e+00 
YBR088C PCNA-DAmP YOL094C RFC4 -0.5412 0.00e+00 
YBR088C PCNA-DAmP YML032C RAD52 -0.5407 0.00e+00 
YBR088C PCNA-DAmP YJR043C POL32 -0.5395 1.41e-24 
YBR088C PCNA-DAmP YPR085C ASA1 -0.5196 0.00e+00 
YBR088C PCNA-DAmP YFR004W RPN11 -0.5158 0.00e+00 
YBR088C PCNA-DAmP YJL074C SMC3 -0.5127 3.26e-25 
YBR088C PCNA-DAmP YPR135W CTF4 -0.4709 9.70e-42 
YBR088C PCNA-DAmP YMR076C PDS5 -0.4588 4.07e-31 
YBR088C PCNA-DAmP YOR259C RPT4 -0.4526 1.56e-68 
YBR088C PCNA-DAmP YMR224C MRE11 -0.4476 9.07e-37 
YBR088C PCNA-DAmP YFR004W RPN11 -0.4173 6.43e-15 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-DAmP YDL102W POL3 -0.4111 5.26e-19 
YBR088C PCNA-DAmP YDR180W SCC2 -0.3927 1.85e-28 
YBR088C PCNA-DAmP YCL061C MRC1 -0.3659 8.19e-11 
YBR088C PCNA-DAmP YMR190C SGS1 -0.3483 1.56e-20 
YBR088C PCNA-DAmP YFL008W SMC1 -0.3351 2.04e-09 
YBR088C PCNA-DAmP YMR198W CIK1 -0.3332 4.62e-08 
YBR088C PCNA-DAmP YFR052W RPN12 -0.3317 0.00e+00 
YBR088C PCNA-DAmP YLL002W RTT109 -0.3298 0.00e+00 
YBR088C PCNA-DAmP YGR092W DBF2 -0.3246 2.72e-08 
YBR088C PCNA-DAmP YIR011C STS1 -0.3242 1.31e-15 
YBR088C PCNA-DAmP YDL126C CDC48 -0.316 3.06e-10 
YBR088C PCNA-DAmP YHR191C CTF8 -0.2988 3.70e-05 
YBR088C PCNA-DAmP YPL055C LGE1 -0.295 2.44e-04 
YBR088C PCNA-DAmP YOR362C PRE10 -0.2919 1.19e-07 
YBR088C PCNA-DAmP YDL003W MCD1 -0.2888 6.61e-09 
YBR088C PCNA-DAmP YHR164C DNA2 -0.2888 4.13e-21 
YBR088C PCNA-DAmP YDL008W APC11 -0.2883 3.46e-84 
YBR088C PCNA-DAmP YHR191C CTF8 -0.2755 4.29e-90 
YBR088C PCNA-DAmP YNR003C RPC34 -0.2726 9.44e-09 
YBR088C PCNA-DAmP YKL113C RAD27 -0.2688 1.25e-06 
YBR088C PCNA-DAmP YNL064C YDJ1 -0.2596 8.69e-04 
YBR088C PCNA-DAmP YJL047C RTT101 -0.2512 1.29e-05 
YBR088C PCNA-DAmP YDL003W MCD1 -0.2477 1.44e-06 
YBR088C PCNA-DAmP YDL097C RPN6 -0.2431 4.41e-05 
YBR088C PCNA-DAmP YJR093C FIP1 -0.2291 5.03e-08 
YBR088C PCNA-DAmP YDR311W TFB1 -0.2281 1.89e-05 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-DAmP YDR083W RRP8 -0.2277 6.55e-06 
YBR088C PCNA-DAmP YPR108W RPN7 -0.2277 8.00e-10 
YBR088C PCNA-DAmP YOR259C RPT4 -0.2269 7.91e-03 
YBR088C PCNA-DAmP YMR078C CTF18 -0.2195 8.41e-70 
YBR088C PCNA-DAmP YHR118C ORC6 -0.219 2.38e-03 
YBR088C PCNA-DAmP YML028W TSA1 -0.2186 1.63e-07 
YBR088C PCNA-DAmP YER157W COG3 -0.2172 6.79e-15 
YBR088C PCNA-DAmP YHR191C CTF8 -0.217 8.20e-06 
YBR088C PCNA-DAmP YDR113C PDS1 -0.2116 9.88e-06 
YBR088C PCNA-DAmP YJL115W ASF1 -0.2115 1.36e-04 
YBR088C PCNA-DAmP YMR043W MCM1 -0.2089 1.65e-20 
YBR088C PCNA-DAmP YOR181W LAS17 -0.2063 2.81e-
139 
YBR088C PCNA-DAmP YIL040W APQ12 -0.1977 9.03e-03 
YBR088C PCNA-DAmP YML065W ORC1 -0.1926 1.97e-05 
YBR088C PCNA-DAmP YLL004W ORC3 -0.1915 3.06e-06 
YBR088C PCNA-DAmP YLR452C SST2 -0.1892 3.57e-02 
YBR088C PCNA-DAmP YMR093W UTP15 -0.1892 8.59e-04 
YBR088C PCNA-DAmP YFR050C PRE4 -0.1858 1.20e-03 
YBR088C PCNA-DAmP YER147C SCC4 -0.1812 4.77e-03 
YBR088C PCNA-DAmP YLR078C BOS1 -0.1804 0.00e+00 
YBR088C PCNA-DAmP YER094C PUP3 -0.1754 6.69e-17 
YBR088C PCNA-DAmP YER147C SCC4 -0.1737 1.33e-06 
YBR088C PCNA-DAmP YCL016C DCC1 -0.1729 1.15e-02 
YBR088C PCNA-DAmP YML103C NUP188 -0.1718 3.58e-03 
YBR088C PCNA-DAmP YDR510W SMT3 -0.1711 1.38e-03 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-DAmP YLR007W NSE1 -0.1699 5.87e-23 
YBR088C PCNA-DAmP YDL102W POL3 -0.167 1.04e-04 
YBR088C PCNA-DAmP YDL105W NSE4 -0.1666 1.84e-04 
YBR088C PCNA-DAmP YHR196W UTP9 -0.1646 1.03e-04 
YBR088C PCNA-DAmP YNL153C GIM3 -0.163 4.76e-02 
YBR088C PCNA-DAmP YJR068W RFC2 -0.1599 1.34e-02 
YBR088C PCNA-DAmP YOR341W RPA190 -0.1558 1.74e-04 
YBR088C PCNA-DAmP YDR288W NSE3 -0.1488 5.22e-03 
YBR088C PCNA-DAmP YHR027C RPN1 -0.1451 2.44e-08 
YBR088C PCNA-DAmP YLR298C YHC1 -0.1421 4.84e-03 
YBR088C PCNA-DAmP YLR071C RGR1 -0.1393 7.65e-11 
YBR088C PCNA-DAmP YPR162C ORC4 -0.1374 2.01e-02 
YBR088C PCNA-DAmP YER125W RSP5 -0.1369 1.16e-03 
YBR088C PCNA-DAmP YML023C NSE5 -0.1353 8.26e-03 
YBR088C PCNA-DAmP YLR459W GAB1 -0.1345 7.53e-02 
YBR088C PCNA-DAmP YDR156W RPA14 -0.1338 3.34e-02 
YBR088C PCNA-DAmP YHR122W YHR122W -0.1299 5.73e-02 
YBR088C PCNA-DAmP YLR119W SRN2 -0.126 5.52e-02 
YBR088C PCNA-DAmP YGL048C RPT6 -0.1241 6.07e-02 
YBR088C PCNA-DAmP YOR157C PUP1 -0.1227 6.31e-02 
YBR088C PCNA-DAmP YDL077C VAM6 -0.1174 1.52e-03 
YBR088C PCNA-DAmP YKL069W YKL069W -0.1172 3.44e-03 
YBR088C PCNA-DAmP YMR281W GPI12 -0.1159 3.90e-02 
YBR088C PCNA-DAmP YOR260W GCD1 -0.1131 8.78e-06 
YBR088C PCNA-DAmP YDL105W NSE4 -0.1118 1.22e-04 
YBR088C PCNA-DAmP YGL022W STT3 -0.1079 6.57e-02 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-DAmP YKL035W UGP1 -0.1071 6.00e-02 
YBR088C PCNA-DAmP YGR264C MES1 -0.1067 2.14e-04 
YBR088C PCNA-DAmP YMR240C CUS1 -0.1051 1.11e-01 
YBR088C PCNA-DAmP YLR089C ALT1 -0.1044 1.31e-01 
YBR088C PCNA-DAmP YDL105W NSE4 -0.1027 6.12e-04 
YBR088C PCNA-DAmP YDR478W SNM1 -0.1012 1.22e-01 
YBR088C PCNA-DAmP YLR293C GSP1 -0.1012 6.96e-02 
YBR088C PCNA-DAmP YDL147W RPN5 -0.0993 2.73e-04 
YBR088C PCNA-DAmP YGL130W CEG1 -0.0987 4.64e-02 
YBR088C PCNA-DAmP YDR064W RPS13 -0.0978 3.14e-02 
YBR088C PCNA-DAmP YHR069C RRP4 -0.0977 1.72e-02 
YBR088C PCNA-DAmP YIL150C MCM10 -0.0956 3.33e-02 
YBR088C PCNA-DAmP YIR006C PAN1 -0.0952 1.28e-01 
YBR088C PCNA-DAmP YNL061W NOP2 -0.092 7.82e-02 
YBR088C PCNA-DAmP YGR158C MTR3 -0.0908 4.75e-02 
YBR088C PCNA-DAmP YFL038C YPT1 0.0906 8.57e-02 
YBR088C PCNA-DAmP YML102W CAC2 0.0918 2.40e-04 
YBR088C PCNA-DAmP YJL039C NUP192 0.092 1.29e-04 
YBR088C PCNA-DAmP YFL034C-B MOB2 0.0927 1.22e-01 
YBR088C PCNA-DAmP YKL045W PRI2 0.0952 4.24e-02 
YBR088C PCNA-DAmP YNL118C DCP2 0.0964 2.06e-09 
YBR088C PCNA-DAmP YNL041C COG6 0.098 1.47e-15 
YBR088C PCNA-DAmP YPL063W TIM50 0.0982 5.60e-06 
YBR088C PCNA-DAmP YDL217C TIM22 0.0987 1.13e-01 
YBR088C PCNA-DAmP YMR117C SPC24 0.0992 7.72e-04 
YBR088C PCNA-DAmP YGL213C SKI8 0.1009 8.87e-06 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-DAmP YDL002C NHP10 0.1016 2.31e-02 
YBR088C PCNA-DAmP YPL266W DIM1 0.1016 8.75e-04 
YBR088C PCNA-DAmP YGR270W YTA7 0.1026 9.12e-04 
YBR088C PCNA-DAmP YJL104W PAM16 0.1038 1.45e-02 
YBR088C PCNA-DAmP YLR305C STT4 0.1053 1.14e-25 
YBR088C PCNA-DAmP YOL001W PHO80 0.1056 2.47e-02 
YBR088C PCNA-DAmP YFL034C-B MOB2 0.1066 3.78e-06 
YBR088C PCNA-DAmP YDL030W PRP9 0.1068 9.85e-06 
YBR088C PCNA-DAmP YOR020C HSP10 0.1082 2.39e-03 
YBR088C PCNA-DAmP YDR182W CDC1 0.1085 2.08e-14 
YBR088C PCNA-DAmP YML069W POB3 0.1098 3.58e-04 
YBR088C PCNA-DAmP YIR010W DSN1 0.1119 2.63e-03 
YBR088C PCNA-DAmP YNL102W POL1 0.1128 3.29e-01 
YBR088C PCNA-DAmP YIL144W TID3 0.113 2.60e-02 
YBR088C PCNA-DAmP YOL081W IRA2 0.1132 2.74e-03 
YBR088C PCNA-DAmP YDR404C RPB7 0.1137 1.93e-02 
YBR088C PCNA-DAmP YHR024C MAS2 0.1152 2.83e-
148 
YBR088C PCNA-DAmP YLR393W ATP10 0.1157 1.61e-17 
YBR088C PCNA-DAmP YDR240C SNU56 0.1184 2.45e-03 
YBR088C PCNA-DAmP YKR068C BET3 0.1203 7.42e-03 
YBR088C PCNA-DAmP YJR076C CDC11 0.1217 2.42e-02 
YBR088C PCNA-DAmP YDR182W CDC1 0.1237 1.13e-01 
YBR088C PCNA-DAmP YPL174C NIP100 0.1247 1.35e-09 
YBR088C PCNA-DAmP YJL081C ARP4 0.1267 3.12e-04 
YBR088C PCNA-DAmP YOR057W SGT1 0.1273 4.66e-03 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-DAmP YOL123W HRP1 0.1349 2.76e-04 
YBR088C PCNA-DAmP YGR119C NUP57 0.1356 6.60e-06 
YBR088C PCNA-DAmP YGR006W PRP18 0.1378 3.56e-04 
YBR088C PCNA-DAmP YKL089W MIF2 0.1415 1.14e-08 
YBR088C PCNA-DAmP YJR065C ARP3 0.1473 1.61e-02 
YBR088C PCNA-DAmP YKL112W ABF1 0.1513 7.99e-24 
YBR088C PCNA-DAmP YDR172W SUP35 0.1561 1.23e-14 
YBR088C PCNA-DAmP YPL190C NAB3 0.165 4.47e-11 
YBR088C PCNA-DAmP YOR236W DFR1 0.1779 3.01e-03 
      
PCNA-WT      
YBR088C PCNA-WT YDL111C RRP42 -0.3575 3.17e-09 
YBR088C PCNA-WT YGR195W SKI6 -0.3298 3.66e-06 
YBR088C PCNA-WT YDL148C NOP14 -0.2688 9.93e-05 
YBR088C PCNA-WT YDR156W RPA14 -0.2205 6.14e-03 
YBR088C PCNA-WT YHR101C BIG1 -0.1945 3.74e-02 
YBR088C PCNA-WT YML103C NUP188 -0.1879 4.00e-02 
YBR088C PCNA-WT YIL115C NUP159 -0.1813 2.44e-02 
YBR088C PCNA-WT YHR178W STB5 -0.181 1.92e-02 
YBR088C PCNA-WT YGR081C SLX9 -0.1664 1.55e-02 
YBR088C PCNA-WT YGR002C SWC4 -0.1638 1.40e-01 
YBR088C PCNA-WT YPL057C SUR1 -0.1545 3.17e-02 
YBR088C PCNA-WT YLR197W NOP56 -0.1515 1.45e-01 
YBR088C PCNA-WT YLR459W GAB1 -0.1493 3.75e-02 
YBR088C PCNA-WT YGL044C RNA15 -0.1451 2.72e-02 
YBR088C PCNA-WT YDR083W RRP8 -0.1446 3.86e-02 
 127 
 
Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-WT YIL046W MET30 -0.1444 3.49e-02 
YBR088C PCNA-WT YLR218C COA4 -0.1419 6.93e-02 
YBR088C PCNA-WT YDR280W RRP45 -0.1409 6.86e-02 
YBR088C PCNA-WT YNL064C YDJ1 -0.1379 2.16e-02 
YBR088C PCNA-WT YGR140W CBF2 -0.1301 6.00e-02 
YBR088C PCNA-WT YDR201W SPC19 -0.1268 1.05e-01 
YBR088C PCNA-WT YER161C SPT2 -0.1266 6.14e-02 
YBR088C PCNA-WT YOL102C TPT1 -0.1238 1.12e-01 
YBR088C PCNA-WT YHR118C ORC6 -0.1228 1.14e-01 
YBR088C PCNA-WT YDL084W SUB2 -0.1226 1.10e-01 
YBR088C PCNA-WT YJR042W NUP85 -0.1209 9.54e-02 
YBR088C PCNA-WT YJR017C ESS1 -0.1202 6.06e-02 
YBR088C PCNA-WT YML069W POB3 -0.1192 7.13e-02 
YBR088C PCNA-WT YAL011W SWC3 -0.1184 1.03e-01 
YBR088C PCNA-WT YJL050W MTR4 -0.1182 5.40e-02 
YBR088C PCNA-WT YLR276C DBP9 -0.1175 1.05e-01 
YBR088C PCNA-WT YGR172C YIP1 -0.1168 9.16e-02 
YBR088C PCNA-WT YDR331W GPI8 -0.116 9.44e-02 
YBR088C PCNA-WT YER092W IES5 -0.1152 5.07e-02 
YBR088C PCNA-WT YKL089W MIF2 -0.1152 1.01e-01 
YBR088C PCNA-WT YGR094W VAS1 -0.113 1.29e-01 
YBR088C PCNA-WT YPL169C MEX67 -0.1104 9.30e-02 
YBR088C PCNA-WT YDR189W SLY1 -0.1095 9.31e-02 
YBR088C PCNA-WT YDR331W GPI8 -0.1092 5.80e-02 
YBR088C PCNA-WT YJR141W YJR141W -0.1072 9.40e-02 
YBR088C PCNA-WT YOL021C DIS3 -0.1051 1.46e-01 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-WT YFL008W SMC1 -0.1048 1.21e-01 
YBR088C PCNA-WT YHR069C RRP4 -0.1044 1.22e-01 
YBR088C PCNA-WT YFR004W RPN11 -0.1043 1.55e-01 
YBR088C PCNA-WT YLR452C SST2 -0.1031 1.94e-01 
YBR088C PCNA-WT YDR460W TFB3 -0.1018 1.67e-01 
YBR088C PCNA-WT YFL009W CDC4 -0.1012 1.04e-01 
YBR088C PCNA-WT YMR272C SCS7 -0.1008 2.49e-01 
YBR088C PCNA-WT YKL145W RPT1 -0.0972 9.64e-02 
YBR088C PCNA-WT YDR170C SEC7 -0.0954 7.35e-02 
YBR088C PCNA-WT YFL034C-B MOB2 -0.0938 2.00e-01 
YBR088C PCNA-WT YGR113W DAM1 -0.0924 1.56e-01 
YBR088C PCNA-WT YPR060C ARO7 -0.0922 9.69e-02 
YBR088C PCNA-WT YML069W POB3 -0.0903 3.18e-02 
YBR088C PCNA-WT YNL136W EAF7 -0.0902 1.29e-01 
YBR088C PCNA-WT YHR036W BRL1 0.0906 6.40e-02 
YBR088C PCNA-WT YHR058C MED6 0.0907 9.47e-02 
YBR088C PCNA-WT YOL034W SMC5 0.0911 9.92e-02 
YBR088C PCNA-WT YDR081C PDC2 0.0914 1.77e-01 
YBR088C PCNA-WT YER125W RSP5 0.0917 8.08e-02 
YBR088C PCNA-WT YDR361C BCP1 0.0918 2.16e-02 
YBR088C PCNA-WT YPR034W ARP7 0.0924 2.07e-01 
YBR088C PCNA-WT YOR020C HSP10 0.0961 1.45e-01 
YBR088C PCNA-WT YER094C PUP3 0.0965 2.78e-02 
YBR088C PCNA-WT YKL208W CBT1 0.0972 9.18e-02 
YBR088C PCNA-WT YMR033W ARP9 0.0974 1.16e-01 
YBR088C PCNA-WT YML049C RSE1 0.0988 7.81e-02 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-WT YFL039C ACT1 0.1025 1.47e-01 
YBR088C PCNA-WT YMR043W MCM1 0.1042 2.40e-01 
YBR088C PCNA-WT YPR086W SUA7 0.1045 1.15e-01 
YBR088C PCNA-WT YFL039C ACT1 0.1053 9.75e-02 
YBR088C PCNA-WT YDL105W NSE4 0.1057 8.83e-02 
YBR088C PCNA-WT YNR026C SEC12 0.1086 3.49e-02 
YBR088C PCNA-WT YDR145W TAF12 0.1094 1.36e-01 
YBR088C PCNA-WT YDR145W TAF12 0.1105 1.06e-01 
YBR088C PCNA-WT YNL002C RLP7 0.115 7.31e-02 
YBR088C PCNA-WT YOR074C CDC21 0.1157 1.44e-01 
YBR088C PCNA-WT YOR181W LAS17 0.1157 6.32e-02 
YBR088C PCNA-WT YDL030W PRP9 0.1159 7.94e-02 
YBR088C PCNA-WT YOR174W MED4 0.1192 5.39e-02 
YBR088C PCNA-WT YDL165W CDC36 0.12 6.52e-02 
YBR088C PCNA-WT YDR212W TCP1 0.1202 1.77e-02 
YBR088C PCNA-WT YGL247W BRR6 0.1227 5.76e-02 
YBR088C PCNA-WT YGL066W SGF73 0.1339 8.92e-02 
YBR088C PCNA-WT YDL143W CCT4 0.138 1.52e-01 
YBR088C PCNA-WT YOR236W DFR1 0.1383 5.06e-02 
YBR088C PCNA-WT YLR078C BOS1 0.1427 8.27e-02 
YBR088C PCNA-WT YMR005W TAF4 0.1489 8.28e-02 
YBR088C PCNA-WT YFL039C ACT1 0.1503 5.46e-02 
YBR088C PCNA-WT YPR103W PRE2 0.162 3.56e-02 
YBR088C PCNA-WT YPL043W NOP4 0.1674 1.78e-01 
YBR088C PCNA-WT YPR103W PRE2 0.1875 2.49e-02 
YBR088C PCNA-WT YNR003C RPC34 0.1949 2.28e-02 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-WT YDR311W TFB1 0.2307 1.08e-02 
YBR088C PCNA-WT YDR088C SLU7 0.2387 1.38e-02 
      
PCNA-K164R Cl.1      
YBR088C PCNA-K164R Cl.1 YML028W TSA1 -0.3623 7.30e-15 
YBR088C PCNA-K164R Cl.1 YML032C RAD52 -0.3205 1.49e-06 
YBR088C PCNA-K164R Cl.1 YGL163C RAD54 -0.2627 5.20e-05 
YBR088C PCNA-K164R Cl.1 YAR007C RFA1 -0.2359 3.68e-06 
YBR088C PCNA-K164R Cl.1 YJR093C FIP1 -0.2258 8.57e-04 
YBR088C PCNA-K164R Cl.1 YMR112C MED11 -0.1887 2.80e-03 
YBR088C PCNA-K164R Cl.1 YKL145W RPT1 -0.1781 1.06e-02 
YBR088C PCNA-K164R Cl.1 YFR052W RPN12 -0.1588 6.03e-04 
YBR088C PCNA-K164R Cl.1 YER157W COG3 -0.1581 1.24e-02 
YBR088C PCNA-K164R Cl.1 YNR043W MVD1 -0.1565 1.09e-02 
YBR088C PCNA-K164R Cl.1 YFR028C CDC14 -0.148 9.46e-02 
YBR088C PCNA-K164R Cl.1 YPL055C LGE1 -0.1417 2.29e-02 
YBR088C PCNA-K164R Cl.1 YLR197W NOP56 -0.1411 1.87e-01 
YBR088C PCNA-K164R Cl.1 YDL105W NSE4 -0.1402 2.20e-02 
YBR088C PCNA-K164R Cl.1 YIR011C STS1 -0.1358 4.25e-02 
YBR088C PCNA-K164R Cl.1 YDR460W TFB3 -0.1314 1.09e-01 
YBR088C PCNA-K164R Cl.1 YMR043W MCM1 -0.1234 2.30e-01 
YBR088C PCNA-K164R Cl.1 YOL094C RFC4 -0.122 2.04e-05 
YBR088C PCNA-K164R Cl.1 YKL045W PRI2 -0.1211 7.83e-02 
YBR088C PCNA-K164R Cl.1 YHR058C MED6 -0.1182 3.25e-02 
YBR088C PCNA-K164R Cl.1 YMR076C PDS5 -0.1179 3.91e-02 
YBR088C PCNA-K164R Cl.1 YDR288W NSE3 -0.1172 7.17e-02 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.1 YPR135W CTF4 -0.1168 4.47e-03 
YBR088C PCNA-K164R Cl.1 YGL066W SGF73 -0.116 5.90e-02 
YBR088C PCNA-K164R Cl.1 YDL105W NSE4 -0.1156 4.29e-02 
YBR088C PCNA-K164R Cl.1 YNL102W POL1 -0.1138 7.83e-02 
YBR088C PCNA-K164R Cl.1 YGL112C TAF6 -0.1123 1.06e-01 
YBR088C PCNA-K164R Cl.1 YJR068W RFC2 -0.1119 1.12e-02 
YBR088C PCNA-K164R Cl.1 YDL102W POL3 -0.1104 8.96e-03 
YBR088C PCNA-K164R Cl.1 YLR007W NSE1 -0.1102 3.40e-02 
YBR088C PCNA-K164R Cl.1 YOR249C APC5 -0.1087 1.38e-01 
YBR088C PCNA-K164R Cl.1 YLR086W SMC4 -0.1082 9.78e-02 
YBR088C PCNA-K164R Cl.1 YGR092W DBF2 -0.1038 8.45e-02 
YBR088C PCNA-K164R Cl.1 YFR004W RPN11 -0.1025 5.95e-02 
YBR088C PCNA-K164R Cl.1 YOL081W IRA2 -0.0993 1.27e-01 
YBR088C PCNA-K164R Cl.1 YOR254C SEC63 -0.0988 7.06e-02 
YBR088C PCNA-K164R Cl.1 YJL074C SMC3 -0.0957 1.59e-01 
YBR088C PCNA-K164R Cl.1 YFL034C-B MOB2 -0.0951 1.90e-01 
YBR088C PCNA-K164R Cl.1 YOR259C RPT4 -0.0949 2.13e-02 
YBR088C PCNA-K164R Cl.1 YMR263W SAP30 -0.0933 4.16e-02 
YBR088C PCNA-K164R Cl.1 YPR086W SUA7 -0.0906 4.70e-02 
YBR088C PCNA-K164R Cl.1 YOR204W DED1 0.09 8.11e-02 
YBR088C PCNA-K164R Cl.1 YGL045W RIM8 0.0925 3.92e-02 
YBR088C PCNA-K164R Cl.1 YJR057W CDC8 0.0926 9.06e-02 
YBR088C PCNA-K164R Cl.1 YML069W POB3 0.1027 4.19e-02 
YBR088C PCNA-K164R Cl.1 YLL050C COF1 0.1086 1.29e-01 
YBR088C PCNA-K164R Cl.1 YMR117C SPC24 0.1166 7.05e-02 
YBR088C PCNA-K164R Cl.1 YNR003C RPC34 0.1427 5.61e-02 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
      
PCNA-K164R Cl. 2      
YBR088C PCNA-K164R Cl.2 YML028W TSA1 -0.4585 3.45e-14 
YBR088C PCNA-K164R Cl.2 YML032C RAD52 -0.2344 6.49e-17 
YBR088C PCNA-K164R Cl.2 YPL055C LGE1 -0.2238 2.61e-03 
YBR088C PCNA-K164R Cl.2 YAR007C RFA1 -0.2095 6.48e-04 
YBR088C PCNA-K164R Cl.2 YGL163C RAD54 -0.1928 1.74e-05 
YBR088C PCNA-K164R Cl.2 YFL034C-B MOB2 -0.1806 8.62e-02 
YBR088C PCNA-K164R Cl.2 YNR043W MVD1 -0.1781 7.76e-03 
YBR088C PCNA-K164R Cl.2 YIR011C STS1 -0.1367 2.72e-02 
YBR088C PCNA-K164R Cl.2 YHR058C MED6 -0.135 1.08e-02 
YBR088C PCNA-K164R Cl.2 YJR093C FIP1 -0.1235 2.90e-02 
YBR088C PCNA-K164R Cl.2 YIL040W APQ12 -0.1217 1.06e-01 
YBR088C PCNA-K164R Cl.2 YER157W COG3 -0.1202 1.93e-02 
YBR088C PCNA-K164R Cl.2 YNL138W SRV2 -0.1068 1.88e-01 
YBR088C PCNA-K164R Cl.2 YDL045C FAD1 -0.1019 1.07e-01 
YBR088C PCNA-K164R Cl.2 YDR512C EMI1 -0.098 1.45e-01 
YBR088C PCNA-K164R Cl.2 YPR168W NUT2 0.1042 8.19e-02 
YBR088C PCNA-K164R Cl.2 YML069W POB3 0.1359 3.14e-02 
YBR088C PCNA-K164R Cl.2 YMR043W MCM1 0.1525 1.43e-01 
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Table 3.2 
Table 3.2. SGA Screen of PCNA-K164R Cl. 1 and PCNA-K164R Cl. 2 against full genome array.  Genetic interactions 
were scored as described in [Baryshnikova et al. 2010]. Only genetic interactions with epsilon scores ε<-0.09 or ε> 0.09 are 
included. 
Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
PCNA-K164R Cl. 1      
YBR088C PCNA-K164R Cl.1 YJR011C YJR011C -0.3077 6.46e-03 
YBR088C PCNA-K164R Cl.1 YER095W RAD51 -0.2747 5.39e-46 
YBR088C PCNA-K164R Cl.1 YDR004W RAD57 -0.2692 1.55e-08 
YBR088C PCNA-K164R Cl.1 YAR029W YAR029W -0.2662 3.32e-03 
YBR088C PCNA-K164R Cl.1 YDR076W RAD55 -0.2634 5.56e-07 
YBR088C PCNA-K164R Cl.1 YML028W TSA1 -0.2481 7.51e-11 
YBR088C PCNA-K164R Cl.1 YGL163C RAD54 -0.2476 2.76e-09 
YBR088C PCNA-K164R Cl.1 YER173W RAD24 -0.2282 8.71e-55 
YBR088C PCNA-K164R Cl.1 YHL033C RPL8A -0.2262 2.18e-02 
YBR088C PCNA-K164R Cl.1 YOR368W RAD17 -0.2147 2.79e-
145 
YBR088C PCNA-K164R Cl.1 YOR144C ELG1 -0.2074 8.23e-18 
YBR088C PCNA-K164R Cl.1 YPL213W LEA1 -0.1924 9.79e-02 
YBR088C PCNA-K164R Cl.1 YHR046C INM1 -0.1921 1.25e-01 
YBR088C PCNA-K164R Cl.1 YLR028C ADE16 -0.1876 9.60e-02 
YBR088C PCNA-K164R Cl.1 YPL194W DDC1 -0.1871 2.11e-05 
YBR088C PCNA-K164R Cl.1 YDR359C EAF1 -0.1636 3.48e-04 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.1 YER166W DNF1 -0.1636 1.53e-01 
YBR088C PCNA-K164R Cl.1 YML032C RAD52 -0.1571 4.95e-07 
YBR088C PCNA-K164R Cl.1 YMR198W CIK1 -0.1511 0.00e+00 
YBR088C PCNA-K164R Cl.1 YOR311C DGK1 -0.1507 2.34e-01 
YBR088C PCNA-K164R Cl.1 YPL022W RAD1 -0.1484 1.83e-01 
YBR088C PCNA-K164R Cl.1 YGL007W BRP1 -0.1435 1.14e-12 
YBR088C PCNA-K164R Cl.1 YGL212W VAM7 -0.1391 5.33e-04 
YBR088C PCNA-K164R Cl.1 YIL035C CKA1 -0.1373 7.94e-02 
YBR088C PCNA-K164R Cl.1 YLR131C ACE2 -0.1367 2.14e-02 
YBR088C PCNA-K164R Cl.1 YLL023C POM33 -0.1342 2.56e-01 
YBR088C PCNA-K164R Cl.1 YLR448W RPL6B -0.132 7.74e-02 
YBR088C PCNA-K164R Cl.1 YML020W YML020W -0.1253 6.69e-03 
YBR088C PCNA-K164R Cl.1 YML007W YAP1 -0.12 7.58e-03 
YBR088C PCNA-K164R Cl.1 YJL117W PHO86 -0.1187 1.04e-01 
YBR088C PCNA-K164R Cl.1 YIR002C MPH1 -0.1174 9.41e-03 
YBR088C PCNA-K164R Cl.1 YOR033C EXO1 -0.1108 1.94e-02 
YBR088C PCNA-K164R Cl.1 YOL067C RTG1 -0.1105 9.15e-04 
YBR088C PCNA-K164R Cl.1 YOR334W MRS2 -0.1095 8.74e-02 
YBR088C PCNA-K164R Cl.1 YDR279W RNH202 -0.1083 6.31e-02 
YBR088C PCNA-K164R Cl.1 YDL062W YDL062W -0.106 2.11e-02 
YBR088C PCNA-K164R Cl.1 YPR045C THP3 -0.1034 1.60e-02 
YBR088C PCNA-K164R Cl.1 YJR074W MOG1 -0.103 1.92e-02 
YBR088C PCNA-K164R Cl.1 YPL226W NEW1 -0.1023 2.03e-01 
YBR088C PCNA-K164R Cl.1 YDL136W RPL35B -0.0995 5.14e-02 
YBR088C PCNA-K164R Cl.1 YGR146C ECL1 -0.0993 9.23e-08 
YBR088C PCNA-K164R Cl.1 YGL066W SGF73 -0.0972 1.08e-01 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.1 YDR217C RAD9 -0.0957 5.13e-02 
YBR088C PCNA-K164R Cl.1 YLR404W FLD1 -0.0941 2.12e-01 
YBR088C PCNA-K164R Cl.1 YPR043W RPL43A -0.0928 7.97e-02 
YBR088C PCNA-K164R Cl.1 YKL114C APN1 -0.0926 3.50e-05 
YBR088C PCNA-K164R Cl.1 YGL180W ATG1 -0.0923 1.71e-01 
YBR088C PCNA-K164R Cl.1 YNL091W NST1 -0.092 1.98e-02 
YBR088C PCNA-K164R Cl.1 YPL069C BTS1 -0.0913 8.58e-29 
YBR088C PCNA-K164R Cl.1 YKL087C CYT2 -0.09 1.18e-01 
YBR088C PCNA-K164R Cl.1 YDR453C TSA2 0.0909 4.53e-02 
YBR088C PCNA-K164R Cl.1 YDR445C YDR445C 0.0925 4.03e-02 
YBR088C PCNA-K164R Cl.1 YOR084W LPX1 0.094 8.84e-02 
YBR088C PCNA-K164R Cl.1 YFR023W PES4 0.0955 3.21e-07 
YBR088C PCNA-K164R Cl.1 YJL133W MRS3 0.0957 9.85e-06 
YBR088C PCNA-K164R Cl.1 YDL077C VAM6 0.0963 5.43e-02 
YBR088C PCNA-K164R Cl.1 YER097W YER097W 0.0975 9.89e-03 
YBR088C PCNA-K164R Cl.1 YPL140C MKK2 0.0993 3.04e-02 
YBR088C PCNA-K164R Cl.1 YER087C-A YER087C-A 0.0997 8.22e-02 
YBR088C PCNA-K164R Cl.1 YFL015C YFL015C 0.1048 1.42e-36 
YBR088C PCNA-K164R Cl.1 YGR097W ASK10 0.1075 1.55e-01 
YBR088C PCNA-K164R Cl.1 YER088C DOT6 0.1088 3.37e-02 
YBR088C PCNA-K164R Cl.1 YGR049W SCM4 0.1099 4.38e-02 
YBR088C PCNA-K164R Cl.1 YPL174C NIP100 0.1111 1.84e-03 
YBR088C PCNA-K164R Cl.1 YDR446W ECM11 0.1123 1.96e-02 
YBR088C PCNA-K164R Cl.1 YJR054W YJR054W 0.1129 7.21e-08 
YBR088C PCNA-K164R Cl.1 YFR011C AIM13 0.1154 3.46e-02 
YBR088C PCNA-K164R Cl.1 YFL019C YFL019C 0.1263 5.20e-08 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.1 YER179W DMC1 0.1382 3.56e-03 
YBR088C PCNA-K164R Cl.1 YLR206W ENT2 0.1385 1.45e-03 
YBR088C PCNA-K164R Cl.1 YDR046C BAP3 0.1606 3.47e-06 
YBR088C PCNA-K164R Cl.1 YDR258C HSP78 0.1618 1.50e-12 
      
PCNA-K164R Cl. 2      
YBR088C PCNA-K164R Cl.2 YGL163C RAD54 -0.4341 1.61e-27 
YBR088C PCNA-K164R Cl.2 YER095W RAD51 -0.3619 3.19e-19 
YBR088C PCNA-K164R Cl.2 YGR050C YGR050C -0.284 8.56e-02 
YBR088C PCNA-K164R Cl.2 YPL194W DDC1 -0.2793 4.41e-11 
YBR088C PCNA-K164R Cl.2 YML032C RAD52 -0.2685 1.31e-08 
YBR088C PCNA-K164R Cl.2 YOR368W RAD17 -0.2527 4.97e-08 
YBR088C PCNA-K164R Cl.2 YER173W RAD24 -0.2377 5.76e-81 
YBR088C PCNA-K164R Cl.2 YDR076W RAD55 -0.2196 1.36e-46 
YBR088C PCNA-K164R Cl.2 YPL055C LGE1 -0.2086 1.04e-34 
YBR088C PCNA-K164R Cl.2 YML020W YML020W -0.18 6.03e-07 
YBR088C PCNA-K164R Cl.2 YDR004W RAD57 -0.1691 1.75e-05 
YBR088C PCNA-K164R Cl.2 YIL146C ATG32 -0.1686 1.77e-03 
YBR088C PCNA-K164R Cl.2 YML028W TSA1 -0.1668 3.09e-03 
YBR088C PCNA-K164R Cl.2 YIR002C MPH1 -0.1613 2.44e-05 
YBR088C PCNA-K164R Cl.2 YDR274C YDR274C -0.1603 7.36e-49 
YBR088C PCNA-K164R Cl.2 YAL015C NTG1 -0.1576 9.89e-03 
YBR088C PCNA-K164R Cl.2 YLR278C YLR278C -0.1555 1.42e-02 
YBR088C PCNA-K164R Cl.2 YLR089C ALT1 -0.1507 5.92e-09 
YBR088C PCNA-K164R Cl.2 YHL020C OPI1 -0.1506 1.26e-02 
YBR088C PCNA-K164R Cl.2 YOR182C RPS30B -0.1471 4.92e-02 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.2 YDR123C INO2 -0.1459 3.98e-02 
YBR088C PCNA-K164R Cl.2 YPR151C SUE1 -0.1454 2.64e-32 
YBR088C PCNA-K164R Cl.2 YMR039C SUB1 -0.1441 2.83e-03 
YBR088C PCNA-K164R Cl.2 YMR123W PKR1 -0.1411 7.13e-03 
YBR088C PCNA-K164R Cl.2 YGL244W RTF1 -0.1374 1.61e-02 
YBR088C PCNA-K164R Cl.2 YPL001W HAT1 -0.1358 2.53e-07 
YBR088C PCNA-K164R Cl.2 YDR217C RAD9 -0.132 6.09e-03 
YBR088C PCNA-K164R Cl.2 YJR146W YJR146W -0.1307 1.60e-05 
YBR088C PCNA-K164R Cl.2 YPR141C KAR3 -0.1296 8.35e-02 
YBR088C PCNA-K164R Cl.2 YML095C RAD10 -0.1295 6.30e-02 
YBR088C PCNA-K164R Cl.2 YDL192W ARF1 -0.1279 2.60e-02 
YBR088C PCNA-K164R Cl.2 YMR157C AIM36 -0.1277 1.13e-03 
YBR088C PCNA-K164R Cl.2 YJR119C JHD2 -0.1234 1.65e-07 
YBR088C PCNA-K164R Cl.2 YDR402C DIT2 -0.118 5.12e-03 
YBR088C PCNA-K164R Cl.2 YKR099W BAS1 -0.1152 1.96e-09 
YBR088C PCNA-K164R Cl.2 YMR307W GAS1 -0.1148 7.44e-21 
YBR088C PCNA-K164R Cl.2 YJR054W YJR054W -0.1123 8.71e-02 
YBR088C PCNA-K164R Cl.2 YNL097C PHO23 -0.1111 1.61e-03 
YBR088C PCNA-K164R Cl.2 YIL035C CKA1 -0.1102 4.36e-02 
YBR088C PCNA-K164R Cl.2 YLL059C YLL059C -0.1089 5.00e-02 
YBR088C PCNA-K164R Cl.2 YDL180W YDL180W -0.108 7.49e-07 
YBR088C PCNA-K164R Cl.2 YMR174C PAI3 -0.1041 3.38e-02 
YBR088C PCNA-K164R Cl.2 YPL178W CBC2 -0.104 1.74e-01 
YBR088C PCNA-K164R Cl.2 YGL256W ADH4 -0.102 1.85e-03 
YBR088C PCNA-K164R Cl.2 YJR139C HOM6 -0.1012 1.17e-01 
YBR088C PCNA-K164R Cl.2 YKL006W RPL14A -0.1 6.90e-03 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.2 YMR182C RGM1 -0.0995 1.81e-06 
YBR088C PCNA-K164R Cl.2 YPR135W CTF4 -0.0995 4.26e-02 
YBR088C PCNA-K164R Cl.2 YPL174C NIP100 -0.0993 2.32e-03 
YBR088C PCNA-K164R Cl.2 YDL082W RPL13A -0.0982 8.26e-07 
YBR088C PCNA-K164R Cl.2 YIR020W-B YOR198C -0.0982 5.04e-03 
YBR088C PCNA-K164R Cl.2 YDR149C YDR149C -0.0973 2.29e-02 
YBR088C PCNA-K164R Cl.2 YLR434C YLR434C -0.0969 6.11e-03 
YBR088C PCNA-K164R Cl.2 YKL114C APN1 -0.0936 2.55e-02 
YBR088C PCNA-K164R Cl.2 YPR045C THP3 -0.0924 8.29e-02 
YBR088C PCNA-K164R Cl.2 YJL116C NCA3 -0.0902 2.24e-02 
YBR088C PCNA-K164R Cl.2 YKR082W NUP133 0.09 1.26e-04 
YBR088C PCNA-K164R Cl.2 YNL032W SIW14 0.0921 1.20e-01 
YBR088C PCNA-K164R Cl.2 YGL259W YPS5 0.0929 5.46e-03 
YBR088C PCNA-K164R Cl.2 YLR395C COX8 0.0946 6.19e-02 
YBR088C PCNA-K164R Cl.2 YJL098W SAP185 0.0969 1.24e-03 
YBR088C PCNA-K164R Cl.2 YNL136W EAF7 0.0981 3.62e-02 
YBR088C PCNA-K164R Cl.2 YDR080W VPS41 0.099 1.03e-01 
YBR088C PCNA-K164R Cl.2 YDR024W FYV1 0.1008 1.12e-01 
YBR088C PCNA-K164R Cl.2 YNL082W PMS1 0.1012 2.10e-01 
YBR088C PCNA-K164R Cl.2 YDR392W SPT3 0.1016 1.86e-01 
YBR088C PCNA-K164R Cl.2 YGL257C MNT2 0.103 9.31e-04 
YBR088C PCNA-K164R Cl.2 YJL036W SNX4 0.1041 1.11e-03 
YBR088C PCNA-K164R Cl.2 YML081C-A ATP18 0.1045 1.91e-01 
YBR088C PCNA-K164R Cl.2 YGL195W GCN1 0.1053 9.94e-02 
YBR088C PCNA-K164R Cl.2 YJR077C MIR1 0.1094 8.47e-02 
YBR088C PCNA-K164R Cl.2 YOR083W WHI5 0.1103 2.03e-01 
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Query systematic 
name 
Query standard 
name 
Array systematic 
name 
Array standard 
name 
Epsilon 
score 
p-value 
YBR088C PCNA-K164R Cl.2 YOR078W BUD21 0.1224 6.82e-02 
YBR088C PCNA-K164R Cl.2 YOR311C DGK1 0.1314 1.03e-01 
YBR088C PCNA-K164R Cl.2 YDR162C NBP2 0.1371 3.84e-03 
YBR088C PCNA-K164R Cl.2 YGR270W YTA7 0.1373 3.54e-07 
YBR088C PCNA-K164R Cl.2 YJR053W BFA1 0.1435 1.33e-05 
YBR088C PCNA-K164R Cl.2 YHL033C RPL8A 0.1453 1.71e-01 
YBR088C PCNA-K164R Cl.2 YGR027C RPS25A 0.1527 5.09e-03 
YBR088C PCNA-K164R Cl.2 YJL188C BUD19 0.1529 5.24e-02 
YBR088C PCNA-K164R Cl.2 YKR043C SHB17 0.1555 8.38e-08 
YBR088C PCNA-K164R Cl.2 YNL085W MKT1 0.1592 1.35e-01 
YBR088C PCNA-K164R Cl.2 YML063W RPS1B 0.1706 1.76e-02 
YBR088C PCNA-K164R Cl.2 YML010C-B YDR033W 0.2185 0.00e+00 
YBR088C PCNA-K164R Cl.2 YPR044C OPI11 0.2298 1.84e-11 
YBR088C PCNA-K164R Cl.2 YMR233W TRI1 0.2616 1.06e-07 
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Table 3.3 
 
 
 
 
 
 
 
 
Table 3.3. Lagging strand replication mutants that correlate strongly with PCNA-DAmP and PCNA-K164R. PCC 
values for mutant alleles of lagging strand replication genes with TS array signatures that correlated strongly with PCNA-
DAmP, PCNA-K164R Cl. 1, and PCNA-K164R Cl.2. 
 
  
  PCNA-DAmP PCNA-WT PCNA-K164R Cl. 1 PCNA-K164R Cl. 2 
elg1Δ 0.551 -0.023 0.356 0.262 
pol3-1 0.511 -0.018 0.300 0.267 
rfc5-DAmP 0.494 0.041 0.296 0.190 
rad27Δ 0.416 -0.077 0.325 0.268 
pol31-PH 0.362 -0.058 0.375 0.269 
pol1-2 0.300 0.045 0.170 0.147 
rad5Δ 0.215 -0.029 0.287 0.288 
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Table 3.4. 
Table 3.4. Full results of gene ontology analysis of FG array. 
GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
BIOLOGICAL PROCESS     
leading strand elongation  5 of 36 (13.9%)  0.08 61.54 5.52e-09 
DNA strand elongation involved in DNA 
replication 
 6 of 36 (16.7%)  0.22 27.69 4.19e-08 
DNA strand elongation  6 of 36 (16.7%)  0.23 26.59 5.48e-08 
DNA replication, removal of RNA primer  4 of 36 (11.1%)  0.06 63.30 1.92e-07 
mismatch repair  5 of 36 (13.9%)  0.15 32.58 2.57e-07 
DNA replication  9 of 36 (25.0%)  1.04 8.67 4.94e-07 
DNA replication, Okazaki fragment 
processing 
 4 of 36 (11.1%)  0.08 49.23 6.83e-07 
postreplication repair  5 of 36 (13.9%)  0.21 24.08 1.35e-06 
lagging strand elongation  4 of 36 (11.1%)  0.12 34.09 3.78e-06 
base-excision repair  4 of 36 (11.1%)  0.12 34.09 3.78e-06 
DNA repair 10 of 36 
(27.8%) 
 1.78 5.62 5.68e-06 
DNA-dependent DNA replication  7 of 36 (19.4%)  0.75 9.34 6.72e-06 
RNA-dependent DNA replication  4 of 36 (11.1%)  0.15 26.07 1.23e-05 
response to DNA damage stimulus 10 of 36 
(27.8%) 
 2.07 4.84 2.17e-05 
cellular response to stress 13 of 36 
(36.1%) 
 3.84 3.39 4.41e-05 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
DNA metabolic process 11 of 36 
(30.6%) 
 3.10 3.55 0.000136 
response to stress 14 of 36 
(38.9%) 
 4.98 2.81 0.000162 
DNA biosynthetic process  3 of 36 (8.3%)  0.14 22.16 0.000285 
double-strand break repair  5 of 36 (13.9%)  0.66 7.59 0.000434 
cellular response to stimulus 14 of 36 
(38.9%) 
 5.89 2.38 0.000951 
response to stimulus 16 of 36 
(44.4%) 
 7.49 2.14 0.00115 
error-prone translesion synthesis  2 of 36 (5.6%)  0.09 22.16 0.00341 
nucleotide-excision repair  3 of 36 (8.3%)  0.34 8.75 0.00459 
regulation of biological quality  8 of 36 (22.2%)  2.74 2.92 0.00467 
translesion synthesis  2 of 36 (5.6%)  0.11 18.46 0.00494 
sister chromatid cohesion  3 of 36 (8.3%)  0.37 8.11 0.00569 
RNA catabolic process  4 of 36 (11.1%)  0.74 5.40 0.00593 
homeostatic process  6 of 36 (16.7%)  1.72 3.50 0.00636 
intracellular accumulation of glycerol  1 of 36 (2.8%)  0.01 110.78 0.00903 
cellular magnesium ion homeostasis  1 of 36 (2.8%)  0.01 110.78 0.00903 
magnesium ion homeostasis  1 of 36 (2.8%)  0.01 110.78 0.00903 
base-excision repair, base-free sugar-
phosphate removal 
 1 of 36 (2.8%)  0.01 110.78 0.00903 
peptide pheromone export  1 of 36 (2.8%)  0.01 110.78 0.00903 
peptide hormone secretion  1 of 36 (2.8%)  0.01 110.78 0.00903 
peptide secretion  1 of 36 (2.8%)  0.01 110.78 0.00903 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
hormone secretion  1 of 36 (2.8%)  0.01 110.78 0.00903 
hormone transport  1 of 36 (2.8%)  0.01 110.78 0.00903 
signal release  1 of 36 (2.8%)  0.01 110.78 0.00903 
regulation of hormone levels  1 of 36 (2.8%)  0.01 110.78 0.00903 
generation of a signal involved in cell-cell 
signaling 
 1 of 36 (2.8%)  0.01 110.78 0.00903 
cell-cell signaling  1 of 36 (2.8%)  0.01 110.78 0.00903 
base-excision repair, gap-filling  1 of 36 (2.8%)  0.01 110.78 0.00903 
glycerol-3-phosphate catabolic process  1 of 36 (2.8%)  0.02 55.39 0.018 
mitochondrial respiratory chain complex II 
assembly 
 1 of 36 (2.8%)  0.02 55.39 0.018 
respiratory chain complex II assembly  1 of 36 (2.8%)  0.02 55.39 0.018 
mitochondrial respiratory chain complex II 
biogenesis 
 1 of 36 (2.8%)  0.02 55.39 0.018 
gene conversion at mating-type locus, DNA 
repair synthesis 
 1 of 36 (2.8%)  0.02 55.39 0.018 
cellular response to water deprivation  1 of 36 (2.8%)  0.02 55.39 0.018 
response to water deprivation  1 of 36 (2.8%)  0.02 55.39 0.018 
DNA replication proofreading  1 of 36 (2.8%)  0.02 55.39 0.018 
nucleotide-excision repair, DNA gap filling  1 of 36 (2.8%)  0.02 55.39 0.018 
glycerol-3-phosphate metabolic process  1 of 36 (2.8%)  0.03 36.93 0.0268 
response to singlet oxygen  1 of 36 (2.8%)  0.03 36.93 0.0268 
free ubiquitin chain polymerization  1 of 36 (2.8%)  0.03 36.93 0.0268 
negative regulation of ubiquitin-protein ligase 
activity involved in mitotic cell cycle 
 1 of 36 (2.8%)  0.03 36.93 0.0268 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
cellular macromolecule catabolic process  6 of 36 (16.7%)  2.41 2.49 0.0303 
nucleobase-containing compound catabolic 
process 
 5 of 36 (13.9%)  1.79 2.80 0.0309 
cellular response to abiotic stimulus  2 of 36 (5.6%)  0.30 6.71 0.0351 
DNA synthesis involved in DNA repair  1 of 36 (2.8%)  0.04 27.69 0.0356 
regulation of ubiquitin homeostasis  1 of 36 (2.8%)  0.04 27.69 0.0356 
ubiquitin homeostasis  1 of 36 (2.8%)  0.04 27.69 0.0356 
cellular response to water stimulus  1 of 36 (2.8%)  0.04 27.69 0.0356 
response to water stimulus  1 of 36 (2.8%)  0.04 27.69 0.0356 
negative regulation of ubiquitin-protein ligase 
activity 
 1 of 36 (2.8%)  0.04 27.69 0.0356 
negative regulation of protein ubiquitination  1 of 36 (2.8%)  0.04 27.69 0.0356 
negative regulation of ligase activity  1 of 36 (2.8%)  0.04 27.69 0.0356 
exocyst assembly  1 of 36 (2.8%)  0.04 27.69 0.0356 
aromatic compound catabolic process  5 of 36 (13.9%)  1.90 2.64 0.0384 
macromolecule catabolic process  6 of 36 (16.7%)  2.56 2.34 0.0393 
cellular macromolecule biosynthetic process 14 of 36 
(38.9%) 
 8.87 1.58 0.0407 
macromolecule biosynthetic process 14 of 36 
(38.9%) 
 8.92 1.57 0.0423 
cellular nitrogen compound catabolic process  5 of 36 (13.9%)  1.95 2.56 0.0426 
protein ubiquitination  3 of 36 (8.3%)  0.79 3.82 0.0427 
double-strand break repair via homologous 
recombination 
 2 of 36 (5.6%)  0.33 5.99 0.0433 
heterocycle catabolic process  5 of 36 (13.9%)  1.96 2.55 0.0433 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
phosphorelay signal transduction system  1 of 36 (2.8%)  0.05 22.16 0.0443 
regulation of transcription from RNA 
polymerase II promoter in response to 
oxidative stress 
 1 of 36 (2.8%)  0.05 22.16 0.0443 
regulation of ubiquitin-protein ligase activity 
involved in mitotic cell cycle 
 1 of 36 (2.8%)  0.05 22.16 0.0443 
exocyst localization  1 of 36 (2.8%)  0.05 22.16 0.0443 
organic cyclic compound catabolic process  5 of 36 (13.9%)  1.99 2.52 0.0455 
nucleic acid metabolic process 15 of 36 
(41.7%) 
 9.91 1.51 0.0466 
response to oxygen-containing compound  2 of 36 (5.6%)  0.35 5.68 0.0476 
catabolic process 10 of 36 
(27.8%) 
 5.71 1.75 0.0485 
secretion  2 of 36 (5.6%)  0.36 5.54 0.0499 
secretion by cell  2 of 36 (5.6%)  0.36 5.54 0.0499 
     
DEPLETED     
gene expression 4 of 36 (11.1%)  9.82 0.41 0.0168 
single-organism metabolic process 3 of 36 (8.3%)  8.02 0.37 0.0261 
protein metabolic process 4 of 36 (11.1%)  9.13 0.44 0.0303 
RNA processing 0 of 36 (0.0%)  3.20 0.00 0.0347 
cellular protein metabolic process 4 of 36 (11.1%)  8.68 0.46 0.0432 
     
MOLECULAR FUNCTION     
exonuclease activity  5 of 36 (13.9%)  0.23 21.30 2.58e-06 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
single-stranded DNA specific 3'-5' 
exodeoxyribonuclease activity 
 3 of 36 (8.3%)  0.04 83.08 2.69e-06 
single-stranded DNA specific 
exodeoxyribonuclease activity 
 3 of 36 (8.3%)  0.04 83.08 2.69e-06 
DNA-directed DNA polymerase activity  4 of 36 (11.1%)  0.14 29.54 7.12e-06 
DNA polymerase activity  4 of 36 (11.1%)  0.14 29.54 7.12e-06 
3'-5'-exodeoxyribonuclease activity  3 of 36 (8.3%)  0.05 55.39 1.33e-05 
exodeoxyribonuclease activity, producing 5'-
phosphomonoesters 
 3 of 36 (8.3%)  0.06 47.48 2.31e-05 
exodeoxyribonuclease activity  3 of 36 (8.3%)  0.07 41.54 3.67e-05 
nucleotidyltransferase activity  5 of 36 (13.9%)  0.45 11.08 7.11e-05 
deoxyribonuclease activity  4 of 36 (11.1%)  0.23 17.04 7.26e-05 
DNA binding 11 of 36 
(30.6%) 
 3.42 3.22 0.000332 
nuclease activity  5 of 36 (13.9%)  0.62 8.03 0.000333 
3'-5' exonuclease activity  3 of 36 (8.3%)  0.14 20.77 0.000349 
exonuclease activity, active with either ribo- 
or deoxyribonucleic acids and producing 5'-
phosphomonoesters 
 3 of 36 (8.3%)  0.14 20.77 0.000349 
DNA clamp loader activity  2 of 36 (5.6%)  0.04 55.39 0.00047 
protein-DNA loading ATPase activity  2 of 36 (5.6%)  0.04 55.39 0.00047 
5'-3' exonuclease activity  2 of 36 (5.6%)  0.05 44.31 0.000779 
DNA-dependent ATPase activity  3 of 36 (8.3%)  0.42 7.22 0.00786 
deoxycytidyl transferase activity  1 of 36 (2.8%)  0.01 110.78 0.00903 
ubiquitin-protein ligase inhibitor activity  1 of 36 (2.8%)  0.01 110.78 0.00903 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
ligase inhibitor activity  1 of 36 (2.8%)  0.01 110.78 0.00903 
endopeptidase activator activity  1 of 36 (2.8%)  0.01 110.78 0.00903 
hydrolase activity, acting on ester bonds  6 of 36 (16.7%)  1.87 3.21 0.00958 
nucleic acid binding 12 of 36 
(33.3%) 
 6.26 1.92 0.0151 
damaged DNA binding  2 of 36 (5.6%)  0.20 10.07 0.0163 
glycerol-3-phosphate dehydrogenase [NAD+] 
activity 
 1 of 36 (2.8%)  0.02 55.39 0.018 
lysophospholipase activity  1 of 36 (2.8%)  0.02 55.39 0.018 
peptidase activator activity  1 of 36 (2.8%)  0.02 55.39 0.018 
GTP-Rho binding  1 of 36 (2.8%)  0.02 55.39 0.018 
hydrolase activity 11 of 36 
(30.6%) 
 5.89 1.87 0.0247 
magnesium ion transmembrane transporter 
activity 
 1 of 36 (2.8%)  0.03 36.93 0.0268 
peptide-transporting ATPase activity  1 of 36 (2.8%)  0.03 36.93 0.0268 
four-way junction helicase activity  1 of 36 (2.8%)  0.03 36.93 0.0268 
Y-form DNA binding  1 of 36 (2.8%)  0.03 36.93 0.0268 
ATPase activity, coupled  4 of 36 (11.1%)  1.16 3.43 0.0276 
phosphorelay response regulator activity  1 of 36 (2.8%)  0.04 27.69 0.0356 
ubiquitin-protein ligase regulator activity  1 of 36 (2.8%)  0.04 27.69 0.0356 
ligase regulator activity  1 of 36 (2.8%)  0.04 27.69 0.0356 
endopeptidase regulator activity  1 of 36 (2.8%)  0.04 27.69 0.0356 
Rho GTPase binding  1 of 36 (2.8%)  0.04 27.69 0.0356 
5'-flap endonuclease activity  1 of 36 (2.8%)  0.05 22.16 0.0443 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
flap endonuclease activity  1 of 36 (2.8%)  0.05 22.16 0.0443 
sterol binding  1 of 36 (2.8%)  0.05 22.16 0.0443 
steroid binding  1 of 36 (2.8%)  0.05 22.16 0.0443 
four-way junction DNA binding  1 of 36 (2.8%)  0.05 22.16 0.0443 
phospholipase activity  1 of 36 (2.8%)  0.05 22.16 0.0443 
peptidase regulator activity  1 of 36 (2.8%)  0.05 22.16 0.0443 
     
CELLULAR COMPONENT     
delta DNA polymerase complex  3 of 36 (8.3%)  0.03 110.78 6.76e-07 
replication fork  6 of 36 (16.7%)  0.37 16.21 1.25e-06 
Elg1 RFC-like complex  3 of 36 (8.3%)  0.04 83.08 2.69e-06 
DNA polymerase complex  3 of 36 (8.3%)  0.07 41.54 3.67e-05 
chromosomal part 10 of 36 
(27.8%) 
 2.34 4.28 6.31e-05 
chromosome 10 of 36 
(27.8%) 
 2.56 3.90 0.000138 
nuclear replisome  3 of 36 (8.3%)  0.13 23.74 0.00023 
replisome  3 of 36 (8.3%)  0.13 23.74 0.00023 
DNA replication factor C complex  2 of 36 (5.6%)  0.03 73.85 0.000236 
Rad17 RFC-like complex  2 of 36 (5.6%)  0.04 55.39 0.00047 
protein-DNA complex  4 of 36 (11.1%)  0.40 10.07 0.000587 
Ctf18 RFC-like complex  2 of 36 (5.6%)  0.05 36.93 0.00116 
nuclear replication fork  3 of 36 (8.3%)  0.32 9.50 0.00363 
nuclear chromosome part  6 of 36 (16.7%)  1.80 3.34 0.00795 
nuclear chromosome  6 of 36 (16.7%)  1.98 3.04 0.0125 
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GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
extracellular region  3 of 36 (8.3%)  0.55 5.45 0.017 
fungal-type cell wall  3 of 36 (8.3%)  0.57 5.28 0.0185 
cell wall  3 of 36 (8.3%)  0.60 5.04 0.0209 
external encapsulating structure  3 of 36 (8.3%)  0.60 5.04 0.0209 
glycerol-3-phosphate dehydrogenase 
complex 
 1 of 36 (2.8%)  0.03 36.93 0.0268 
mating projection tip  3 of 36 (8.3%)  0.70 4.32 0.0313 
cell projection part  3 of 36 (8.3%)  0.72 4.15 0.0345 
chromosome, telomeric region  2 of 36 (5.6%)  0.30 6.71 0.0351 
proteasome core complex, beta-subunit 
complex 
 1 of 36 (2.8%)  0.04 27.69 0.0356 
mating projection  3 of 36 (8.3%)  0.79 3.82 0.0427 
cell projection  3 of 36 (8.3%)  0.79 3.82 0.0427 
nucleus 19 of 36 
(52.8%) 
13.53 1.40 0.0447 
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Table 3.5 
Table 3.5. Full results of gene ontology analysis of SGA screen against TS array. 
GO Term Set Expected Fold 
Enrichment 
1 Sided Fisher (p-
value) 
BIOLOGICAL     
DNA repair 23 of 29 (79.3%)  2.04 11.27 1.89e-22 
response to DNA damage stimulus 23 of 29 (79.3%)  2.29 10.05 3.09e-21 
DNA metabolic process 24 of 29 (82.8%)  3.45 6.96 1.57e-18 
cellular response to stress 23 of 29 (79.3%)  3.54 6.49 9.76e-17 
DNA recombination 16 of 29 (55.2%)  1.17 13.66 5.31e-16 
double-strand break repair 14 of 29 (48.3%)  0.84 16.65 3.47e-15 
response to stress 23 of 29 (79.3%)  4.13 5.56 3.48e-15 
DNA-dependent DNA replication 15 of 29 (51.7%)  1.13 13.27 9.88e-15 
cellular response to stimulus 23 of 29 (79.3%)  4.85 4.74 1.33e-13 
cell cycle phase 20 of 29 (69.0%)  3.31 6.05 2.6e-13 
DNA replication 15 of 29 (51.7%)  1.41 10.67 3.04e-13 
recombinational repair 11 of 29 (37.9%)  0.52 21.00 3.85e-13 
cell cycle process 21 of 29 (72.4%)  4.12 5.10 1.25e-12 
double-strand break repair via homologous 
recombination 
10 of 29 (34.5%)  0.45 21.99 3.34e-12 
response to stimulus 23 of 29 (79.3%)  5.71 4.03 5.04e-12 
cell cycle 21 of 29 (72.4%)  4.81 4.37 2.88e-11 
base-excision repair  7 of 29 (24.1%)  0.17 42.32 3.29e-11 
M phase 16 of 29 (55.2%)  2.76 5.80 5.59e-10 
non-recombinational repair  7 of 29 (24.1%)  0.26 26.73 1.96e-09 
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DNA strand elongation involved in DNA replication  8 of 29 (27.6%)  0.43 18.72 2.93e-09 
DNA strand elongation  8 of 29 (27.6%)  0.43 18.72 2.93e-09 
cellular process involved in reproduction 13 of 29 (44.8%)  2.14 6.08 2.79e-08 
single organism reproductive process 13 of 29 (44.8%)  2.14 6.08 2.79e-08 
reproductive process 13 of 29 (44.8%)  2.14 6.08 2.79e-08 
lagging strand elongation  6 of 29 (20.7%)  0.22 27.21 2.89e-08 
chromosome segregation 11 of 29 (37.9%)  1.39 7.90 3.05e-08 
meiosis I  8 of 29 (27.6%)  0.58 13.82 3.97e-08 
sister chromatid cohesion  8 of 29 (27.6%)  0.59 13.50 4.83e-08 
meiosis 10 of 29 (34.5%)  1.25 7.97 1.42e-07 
M phase of meiotic cell cycle 10 of 29 (34.5%)  1.25 7.97 1.42e-07 
meiotic cell cycle 10 of 29 (34.5%)  1.27 7.89 1.58e-07 
double-strand break repair via break-induced 
replication 
 6 of 29 (20.7%)  0.29 20.73 1.87e-07 
reproduction 13 of 29 (44.8%)  2.51 5.18 1.98e-07 
mitotic sister chromatid cohesion  7 of 29 (24.1%)  0.48 14.51 2.26e-07 
double-strand break repair via nonhomologous 
end joining 
 5 of 29 (17.2%)  0.18 27.90 4.14e-07 
sister chromatid segregation  8 of 29 (27.6%)  0.80 10.01 5.58e-07 
nucleic acid metabolic process 24 of 29 (82.8%) 10.97 2.19 7.82e-07 
mitotic cell cycle 13 of 29 (44.8%)  2.88 4.51 1.03e-06 
cellular macromolecule metabolic process 27 of 29 (93.1%) 15.38 1.76 3.14e-06 
telomere maintenance  6 of 29 (20.7%)  0.45 13.19 3.41e-06 
anatomical structure homeostasis  6 of 29 (20.7%)  0.45 13.19 3.41e-06 
maintenance of fidelity involved in DNA-
dependent DNA replication 
 4 of 29 (13.8%)  0.12 32.25 3.5e-06 
chromosome organization 13 of 29 (44.8%)  3.23 4.03 3.83e-06 
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telomere organization  6 of 29 (20.7%)  0.47 12.80 4.1e-06 
macromolecule metabolic process 27 of 29 (93.1%) 15.70 1.72 5.25e-06 
mitotic sister chromatid segregation  7 of 29 (24.1%)  0.76 9.23 5.66e-06 
DNA replication initiation  6 of 29 (20.7%)  0.52 11.46 8.1e-06 
mismatch repair  4 of 29 (13.8%)  0.15 26.38 9e-06 
nucleobase-containing compound metabolic 
process 
24 of 29 (82.8%) 12.34 1.95 9.39e-06 
leading strand elongation  4 of 29 (13.8%)  0.17 24.18 1.34e-05 
cellular aromatic compound metabolic process 24 of 29 (82.8%) 12.57 1.91 1.39e-05 
heterocycle metabolic process 24 of 29 (82.8%) 12.63 1.90 1.52e-05 
interphase of mitotic cell cycle  7 of 29 (24.1%)  0.91 7.69 1.96e-05 
interphase  7 of 29 (24.1%)  0.92 7.58 2.17e-05 
cellular nitrogen compound metabolic process 24 of 29 (82.8%) 12.90 1.86 2.38e-05 
organic cyclic compound metabolic process 24 of 29 (82.8%) 12.91 1.86 2.43e-05 
postreplication repair  4 of 29 (13.8%)  0.19 20.73 2.65e-05 
mitosis  9 of 29 (31.0%)  1.76 5.10 3.06e-05 
regulation of DNA metabolic process  6 of 29 (20.7%)  0.66 9.07 3.27e-05 
nuclear division  9 of 29 (31.0%)  1.79 5.02 3.47e-05 
homeostatic process  7 of 29 (24.1%)  0.99 7.05 3.5e-05 
regulation of cell cycle  8 of 29 (27.6%)  1.39 5.75 3.97e-05 
organelle fission  9 of 29 (31.0%)  1.83 4.91 4.17e-05 
DNA replication checkpoint  3 of 29 (10.3%)  0.08 36.28 4.58e-05 
negative regulation of G2/M transition of mitotic 
cell cycle 
 3 of 29 (10.3%)  0.08 36.28 4.58e-05 
nitrogen compound metabolic process 24 of 29 (82.8%) 13.48 1.78 5.84e-05 
single-organism cellular process 28 of 29 (96.6%) 18.87 1.48 5.88e-05 
regulation of cell cycle process  7 of 29 (24.1%)  1.08 6.51 5.94e-05 
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M phase of mitotic cell cycle  9 of 29 (31.0%)  1.92 4.70 5.95e-05 
negative regulation of DNA metabolic process  4 of 29 (13.8%)  0.23 17.07 6.13e-05 
G2/M transition of mitotic cell cycle  5 of 29 (17.2%)  0.45 10.99 6.3e-05 
organic substance metabolic process 28 of 29 (96.6%) 18.97 1.48 6.74e-05 
mitotic recombination  4 of 29 (13.8%)  0.25 16.12 7.81e-05 
negative regulation of mitotic cell cycle  3 of 29 (10.3%)  0.10 31.09 7.95e-05 
DNA replication, removal of RNA primer  3 of 29 (10.3%)  0.10 31.09 7.95e-05 
DNA catabolic process  3 of 29 (10.3%)  0.10 31.09 7.95e-05 
single-organism process 28 of 29 (96.6%) 19.10 1.47 8.16e-05 
meiotic chromosome segregation  4 of 29 (13.8%)  0.26 15.27 9.79e-05 
cellular metabolic process 28 of 29 (96.6%) 19.32 1.45 0.000111 
maintenance of DNA repeat elements  3 of 29 (10.3%)  0.11 27.21 0.000126 
meiotic DNA double-strand break formation  3 of 29 (10.3%)  0.11 27.21 0.000126 
DNA biosynthetic process  3 of 29 (10.3%)  0.11 27.21 0.000126 
regulation of mitotic cell cycle  6 of 29 (20.7%)  0.84 7.14 0.000131 
replication fork protection  2 of 29 (6.9%)  0.03 72.55 0.000184 
regulation of endodeoxyribonuclease activity  2 of 29 (6.9%)  0.03 72.55 0.000184 
regulation of deoxyribonuclease activity  2 of 29 (6.9%)  0.03 72.55 0.000184 
regulation of nuclease activity  2 of 29 (6.9%)  0.03 72.55 0.000184 
gene conversion at mating-type locus, DNA repair 
synthesis 
 2 of 29 (6.9%)  0.03 72.55 0.000184 
cell cycle checkpoint  5 of 29 (17.2%)  0.57 8.85 0.000184 
regulation of cell cycle arrest  5 of 29 (17.2%)  0.57 8.85 0.000184 
DNA replication, Okazaki fragment processing  3 of 29 (10.3%)  0.12 24.18 0.000187 
cell cycle arrest  5 of 29 (17.2%)  0.58 8.64 0.000207 
negative regulation of cell cycle  5 of 29 (17.2%)  0.59 8.44 0.000232 
metabolic process 28 of 29 (96.6%) 19.97 1.40 0.000264 
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DNA geometric change  3 of 29 (10.3%)  0.14 21.77 0.000265 
primary metabolic process 27 of 29 (93.1%) 18.50 1.46 0.000299 
nucleic acid phosphodiester bond hydrolysis  7 of 29 (24.1%)  1.42 4.93 0.000352 
regulation of G2/M transition of mitotic cell cycle  3 of 29 (10.3%)  0.15 19.79 0.000361 
DNA conformation change  5 of 29 (17.2%)  0.68 7.40 0.000434 
mating type switching  3 of 29 (10.3%)  0.17 18.14 0.000477 
biological regulation 18 of 29 (62.1%)  9.01 2.00 0.000517 
S phase of mitotic cell cycle  3 of 29 (10.3%)  0.18 16.74 0.000614 
mating type determination  3 of 29 (10.3%)  0.18 16.74 0.000614 
sex determination  3 of 29 (10.3%)  0.18 16.74 0.000614 
cell fate commitment  3 of 29 (10.3%)  0.18 16.74 0.000614 
cellular macromolecule biosynthetic process 17 of 29 (58.6%)  8.35 2.04 0.000705 
macromolecule biosynthetic process 17 of 29 (58.6%)  8.38 2.03 0.000736 
regulation of DNA recombination  3 of 29 (10.3%)  0.19 15.55 0.000774 
RNA-dependent DNA replication  3 of 29 (10.3%)  0.21 14.51 0.000959 
DNA topological change  2 of 29 (6.9%)  0.06 36.28 0.00108 
resolution of meiotic recombination intermediates  2 of 29 (6.9%)  0.06 36.28 0.00108 
meiotic chromosome separation  2 of 29 (6.9%)  0.06 36.28 0.00108 
negative regulation of DNA-dependent DNA 
replication 
 2 of 29 (6.9%)  0.06 36.28 0.00108 
double-strand break repair via synthesis-
dependent strand annealing 
 2 of 29 (6.9%)  0.06 36.28 0.00108 
DNA synthesis involved in DNA repair  2 of 29 (6.9%)  0.06 36.28 0.00108 
gene conversion at mating-type locus  2 of 29 (6.9%)  0.06 36.28 0.00108 
S phase  3 of 29 (10.3%)  0.22 13.60 0.00117 
regulation of interphase of mitotic cell cycle  3 of 29 (10.3%)  0.22 13.60 0.00117 
negative regulation of cellular process  9 of 29 (31.0%)  2.87 3.14 0.0013 
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negative regulation of biological process  9 of 29 (31.0%)  2.88 3.12 0.00135 
regulation of cellular process 16 of 29 (55.2%)  8.06 1.98 0.00162 
cell differentiation  5 of 29 (17.2%)  0.91 5.50 0.00173 
heteroduplex formation  2 of 29 (6.9%)  0.07 29.02 0.00179 
meiotic DNA double-strand break processing  2 of 29 (6.9%)  0.07 29.02 0.00179 
DNA double-strand break processing  2 of 29 (6.9%)  0.07 29.02 0.00179 
DNA catabolic process, exonucleolytic  2 of 29 (6.9%)  0.07 29.02 0.00179 
DNA integrity checkpoint  3 of 29 (10.3%)  0.26 11.46 0.00197 
regulation of biological quality  7 of 29 (24.1%)  1.89 3.71 0.00198 
regulation of biological process 16 of 29 (55.2%)  8.31 1.93 0.0023 
cellular component organization 19 of 29 (65.5%) 11.07 1.72 0.00245 
chromosome separation  2 of 29 (6.9%)  0.08 24.18 0.00266 
double-strand break repair via single-strand 
annealing 
 2 of 29 (6.9%)  0.08 24.18 0.00266 
gene conversion  2 of 29 (6.9%)  0.08 24.18 0.00266 
negative regulation of DNA recombination  2 of 29 (6.9%)  0.08 24.18 0.00266 
developmental process  6 of 29 (20.7%)  1.49 4.03 0.00287 
cellular biosynthetic process 18 of 29 (62.1%) 10.46 1.72 0.00369 
positive regulation of cell cycle process  2 of 29 (6.9%)  0.10 20.73 0.00369 
telomere maintenance via recombination  2 of 29 (6.9%)  0.10 20.73 0.00369 
reproductive process in single-celled organism  4 of 29 (13.8%)  0.68 5.92 0.00402 
cellular developmental process  5 of 29 (17.2%)  1.10 4.53 0.00406 
organic substance biosynthetic process 18 of 29 (62.1%) 10.61 1.70 0.00442 
regulation of macromolecule metabolic process 12 of 29 (41.4%)  5.57 2.16 0.00465 
regulation of DNA replication  3 of 29 (10.3%)  0.36 8.37 0.00495 
biosynthetic process 18 of 29 (62.1%) 10.72 1.68 0.00502 
regulation of catalytic activity  4 of 29 (13.8%)  0.73 5.48 0.00535 
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nucleotide-excision repair  3 of 29 (10.3%)  0.37 8.06 0.00552 
negative regulation of cell cycle process  3 of 29 (10.3%)  0.37 8.06 0.00552 
DNA duplex unwinding  2 of 29 (6.9%)  0.12 16.12 0.00622 
negative regulation of DNA replication  2 of 29 (6.9%)  0.12 16.12 0.00622 
developmental process involved in reproduction  4 of 29 (13.8%)  0.79 5.09 0.00694 
regulation of cellular metabolic process 12 of 29 (41.4%)  5.84 2.05 0.00701 
regulation of primary metabolic process 12 of 29 (41.4%)  5.87 2.04 0.00729 
chromatin silencing at silent mating-type cassette  3 of 29 (10.3%)  0.41 7.26 0.00745 
negative regulation of nucleobase-containing 
compound metabolic process 
 6 of 29 (20.7%)  1.83 3.27 0.00809 
organelle organization 15 of 29 (51.7%)  8.45 1.78 0.00834 
negative regulation of nitrogen compound 
metabolic process 
 6 of 29 (20.7%)  1.85 3.25 0.00838 
regulation of molecular function  4 of 29 (13.8%)  0.84 4.76 0.00883 
regulation of metabolic process 12 of 29 (41.4%)  6.05 1.98 0.00935 
negative regulation of macromolecule metabolic 
process 
 6 of 29 (20.7%)  1.97 3.04 0.0114 
activation of mitotic anaphase-promoting complex 
activity 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of ubiquitin-protein ligase 
activity involved in mitotic cell cycle 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
activation of anaphase-promoting complex activity  1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of ubiquitin-protein ligase 
activity 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of protein ubiquitination  1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of ligase activity  1 of 29 (3.4%)  0.01 72.55 0.0138 
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activation of anaphase-promoting complex activity 
involved in meiotic cell cycle 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of ubiquitin-protein ligase 
activity involved in meiotic cell cycle 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
regulation of ubiquitin-protein ligase activity 
involved in meiotic cell cycle 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
meiotic anaphase I  1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of endodeoxyribonuclease 
activity 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of deoxyribonuclease activity  1 of 29 (3.4%)  0.01 72.55 0.0138 
positive regulation of nuclease activity  1 of 29 (3.4%)  0.01 72.55 0.0138 
cell shape checkpoint  1 of 29 (3.4%)  0.01 72.55 0.0138 
base-excision repair, base-free sugar-phosphate 
removal 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
replication fork arrest  1 of 29 (3.4%)  0.01 72.55 0.0138 
negative regulation of endodeoxyribonuclease 
activity 
 1 of 29 (3.4%)  0.01 72.55 0.0138 
negative regulation of deoxyribonuclease activity  1 of 29 (3.4%)  0.01 72.55 0.0138 
negative regulation of nuclease activity  1 of 29 (3.4%)  0.01 72.55 0.0138 
negative regulation of metabolic process  6 of 29 (20.7%)  2.11 2.85 0.0157 
negative regulation of cellular metabolic process  6 of 29 (20.7%)  2.11 2.85 0.0157 
nucleobase-containing compound catabolic 
process 
 5 of 29 (17.2%)  1.56 3.21 0.0172 
cellular macromolecule catabolic process  6 of 29 (20.7%)  2.16 2.77 0.0177 
aromatic compound catabolic process  5 of 29 (17.2%)  1.57 3.18 0.0179 
regulation of nucleobase-containing compound 
metabolic process 
10 of 29 (34.5%)  4.98 2.01 0.018 
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regulation of nitrogen compound metabolic 
process 
10 of 29 (34.5%)  4.99 2.00 0.0183 
cellular nitrogen compound catabolic process  5 of 29 (17.2%)  1.59 3.15 0.0185 
cellular process 29 of 29 (100.0%) 25.32 1.15 0.019 
heterocycle catabolic process  5 of 29 (17.2%)  1.60 3.13 0.0191 
organic cyclic compound catabolic process  5 of 29 (17.2%)  1.60 3.13 0.0191 
reproduction of a single-celled organism  4 of 29 (13.8%)  1.06 3.77 0.0197 
macromolecule catabolic process  6 of 29 (20.7%)  2.23 2.69 0.0204 
regulation of DNA-dependent DNA replication  2 of 29 (6.9%)  0.23 8.54 0.022 
replicative cell aging  2 of 29 (6.9%)  0.26 7.64 0.0271 
meiotic mismatch repair  1 of 29 (3.4%)  0.03 36.28 0.0274 
DNA replication proofreading  1 of 29 (3.4%)  0.03 36.28 0.0274 
base-excision repair, gap-filling  1 of 29 (3.4%)  0.03 36.28 0.0274 
nucleotide-excision repair, DNA gap filling  1 of 29 (3.4%)  0.03 36.28 0.0274 
positive regulation of proteasomal ubiquitin-
dependent protein catabolic process 
 1 of 29 (3.4%)  0.03 36.28 0.0274 
positive regulation of mitotic metaphase/anaphase 
transition 
 1 of 29 (3.4%)  0.03 36.28 0.0274 
regulation of proteasomal ubiquitin-dependent 
protein catabolic process 
 1 of 29 (3.4%)  0.03 36.28 0.0274 
positive regulation of proteasomal protein 
catabolic process 
 1 of 29 (3.4%)  0.03 36.28 0.0274 
regulation of proteasomal protein catabolic 
process 
 1 of 29 (3.4%)  0.03 36.28 0.0274 
positive regulation of proteolysis  1 of 29 (3.4%)  0.03 36.28 0.0274 
positive regulation of mitosis  1 of 29 (3.4%)  0.03 36.28 0.0274 
positive regulation of nuclear division  1 of 29 (3.4%)  0.03 36.28 0.0274 
 159 
 
regulation of ubiquitin-protein ligase activity 
involved in mitotic cell cycle 
 1 of 29 (3.4%)  0.03 36.28 0.0274 
regulation of ubiquitin-protein ligase activity  1 of 29 (3.4%)  0.03 36.28 0.0274 
regulation of ligase activity  1 of 29 (3.4%)  0.03 36.28 0.0274 
cyclin catabolic process  1 of 29 (3.4%)  0.03 36.28 0.0274 
septin checkpoint  1 of 29 (3.4%)  0.03 36.28 0.0274 
cytokinesis checkpoint  1 of 29 (3.4%)  0.03 36.28 0.0274 
regulation of cell cycle cytokinesis  1 of 29 (3.4%)  0.03 36.28 0.0274 
free ubiquitin chain polymerization  1 of 29 (3.4%)  0.03 36.28 0.0274 
regulation of ubiquitin homeostasis  1 of 29 (3.4%)  0.03 36.28 0.0274 
ubiquitin homeostasis  1 of 29 (3.4%)  0.03 36.28 0.0274 
donor selection  1 of 29 (3.4%)  0.03 36.28 0.0274 
cellular component organization or biogenesis 19 of 29 (65.5%) 13.44 1.41 0.0287 
chromatin silencing at telomere  3 of 29 (10.3%)  0.69 4.35 0.0299 
RNA catabolic process  3 of 29 (10.3%)  0.72 4.19 0.0331 
reciprocal meiotic recombination  2 of 29 (6.9%)  0.30 6.60 0.0357 
reciprocal DNA recombination  2 of 29 (6.9%)  0.30 6.60 0.0357 
single-organism developmental process  4 of 29 (13.8%)  1.30 3.09 0.0377 
DNA recombinase assembly  1 of 29 (3.4%)  0.04 24.18 0.0408 
meiotic DNA recombinase assembly  1 of 29 (3.4%)  0.04 24.18 0.0408 
positive regulation of cellular catabolic process  1 of 29 (3.4%)  0.04 24.18 0.0408 
anaphase  1 of 29 (3.4%)  0.04 24.18 0.0408 
regulation of transcription during meiosis  1 of 29 (3.4%)  0.04 24.18 0.0408 
premeiotic DNA replication  1 of 29 (3.4%)  0.04 24.18 0.0408 
DNA replication, synthesis of RNA primer  1 of 29 (3.4%)  0.04 24.18 0.0408 
negative regulation of hydrolase activity  1 of 29 (3.4%)  0.04 24.18 0.0408 
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Table 3.6 
Table 3.6. Leading and lagging strand replication gene lists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Leading Strand Lagging Strand  
POL2 POL1 
DPB3 POL12 
MCM2 PRI1 
MCM3 PRI2 
MCM4 MCM10 
MCM5 CTF4 
MCM6 POL3 
MCM7 POL31 
 POL32 
  RAD27 
  DNA2 
  CDC9 
  ELG1 
  POL30 
  RFC1 
  RFC2 
  RFC3 
  RFC4 
  RFC5 
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Table 3.7 
 
Table 3.7. Yeast strains used in Chapter 3 
Strain Name Relevant Genotype Source 
EFS20 MATα, ade5-1, lys2-A12, trp1-289, his7-2, leu2-3,112, ura3-52, 
bar1 
[Tran et al. 
1997] 
AByb1724 rad27::kanMX This study 
AByb1733 pol30::POL30 (LEU2) This study 
AByb1735 pol30::pol30-K164R (LEU2) This study 
AByb1809 rad27::kanMX, pol30::POL30 (LEU2) This study 
AByb1810 rad27::kanMX, pol30::pol30-K164R (LEU2) This study 
AByb2049 rad5::TRP1 This study 
AByb2051 rad27::kanMX, rad5::TRP1 This study 
AByb2053 rad18::TRP1 This study 
AByb2055 rad27::kanMX, rad18::TRP1 This study 
AByb2062 leu2::His-POL30 (LEU2), pol30::TRP1 This study 
AByb2083 rev3::LEU2 This study 
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Strain Name Relevant Genotype Source 
AByb2085 rad27::kanMX, rev3::LEU2 This study 
AByb2086 rev3::LEU2, rad5::TRP1 This study 
AByb2087 rad27::kanMX, rev3::LEU2, rad5::TRP1 This study 
AByb2169 leu2::His-POL30 (LEU2), pol30::TRP1, rad27::URA3 This study 
AByb2171 leu2::His-pol30-K164R (LEU2), pol30::TRP1, rad27::URA3 This study 
AByb2192 elg1::TRP1, pol30::pol30-K164R (LEU2) This study 
AByb2193 siz1::TRP1 This study 
AByb2200 elg1::TRP1 This study 
AByb2213 leu2::His-pol30-K164R (LEU2), pol30::TRP1, elg1::URA3 This study 
AByb2233 leu2::His-POL30 (LEU2), pol30::TRP1, elg1::URA3 This study 
AByb2242 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::URA3, pRS424gal-
EV (TRP1) 
This study 
AByb2243 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::URA3, pBL336 
(TRP1) 
This study 
AByb2244 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::URA3, pBL336-01 
(TRP1) 
This study 
AByb2252 leu2::His-POL30 (LEU2), pol30::URA3, pRS424gal-EV (TRP1) This study 
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Strain Name Relevant Genotype Source 
AByb2253 leu2::His-POL30 (LEU2), pol30::URA3, pBL336 (TRP1) This study 
AByb2254 leu2::His-POL30 (LEU2), pol30::URA3, pBL336-01 (TRP1) This study 
AByb2277 leu2::His-POL30 (LEU2), pol30::TRP1, pJS227 (URA3) This study 
AByb2278 leu2::His-POL30 (LEU2), pol30::TRP1, gal-DNA2 (URA3) This study 
AByb2281 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::TRP1, pJS227 
(URA3) 
This study 
AByb2282 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::TRP1, gal-DNA2 
(URA3) 
This study 
AByb2299 leu2::His-POL30 (LEU2), pol30::TRP1, pRS316 (URA3) This study 
AByb2300 leu2::His-POL30 (LEU2), pol30::TRP1, gal-EXO1 (URA3) This study 
AByb2301 leu2::His-pol30-K164R (LEU2), pol30::TRP1, pRS316 (URA3) This study 
AByb2303 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::TRP1, pRS316 
(URA3) 
This study 
AByb2304 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::TRP1, gal-EXO1 
(URA3) 
This study 
AByb2410 rad27::kanMX, siz1::TRP1 This study 
AByb2412 leu2::His-POL30 (LEU2), pol30::TRP1, gal-exo1-D173A (URA3) This study 
AByb2414 rad27::kanMX, leu2::His-POL30 (LEU2), pol30::TRP1, gal-exo1-
D173A (URA3) 
This study 
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Strain Name Relevant Genotype Source 
SSL204 MATα, ade2, his3Δ200, trp1, leu2, ura3-52 Becker et al. 
2014 
ABy2430 leu2::His-POL30 (LEU2), pol30::TRP1, pRS316 (URA3) This Study 
ABy2432 leu2::His-POL30 (LEU2), pol30::TRP1, gal-EXO1 (URA3) This Study 
ABy2434 pol1-1, leu2::His-POL30 (LEU2), pol30::TRP1, pRS316 (URA3) This Study 
ABy2436 pol1-1, leu2::His-POL30 (LEU2), pol30::TRP1, gal-EXO1 (URA3) This Study 
ABy2438 pol1-1, leu2::His-pol30-K164R (LEU2), pol30::TRP1, pRS316 
(URA3) 
This Study 
ABy2440 pol1-1, leu2::His-pol30-K164R (LEU2), pol30::TRP1, gal-EXO1 
(URA3) 
This Study 
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CHAPTER 4   
Flap endonuclease overexpression is a potent driver of genome 
instability and mutation  
 
(The work in this chapter is in preparation for publication as Becker, J.R., Gallo, 
D., Nguyen, H.D., Thu, Y.M., Croissant, T., Leung, W., Brown, G.W., and 
Bielinsky, A.K. (2016)) 
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INTRODUCTION 
 Complete replication of the genome before cell division is a fundamental 
requirement for the multigenerational viability of all organisms. As a result of the 
necessity to complete this process repeatedly and successfully, evolution has 
provided a highly conserved set of replication factors, which carry out a 
magnificently coordinated array of activities. In the event of difficulty or error, a 
network of repair and checkpoint pathways has arisen to facilitate the completion 
of replication with a minimum of inherited mutations. The high level of conservation 
in these replication-, repair- and checkpoint pathways has allowed us to utilize 
relatively simpler model organisms such as S. cerevisiae to better understand how 
these processes are carried out in more complex metazoan systems. As such, in 
this study we started with an observation that has been made repeatedly in human 
cancer samples of increased expression of the replication factor flap endonuclease 
1 (FEN1) and attempted to understand, beginning in S. cerevisiae, the effect that 
this has on DNA replication and genome stability.  
 FEN1 and its yeast homolog radiation sensitive 27 (RAD27) have a 
conserved function in DNA replication to process 5’ flaps which are generated at 
the junction of Okazaki fragments on the lagging strand [Ayyagari et al. 2003, Jin 
et al. 2003]. Synthesis of the lagging strand is carried out primarily by polymerase 
(pol-) δ in conjunction with the homotrimeric replication clamp and processivity 
factor proliferating cell nuclear antigen (PCNA). Synthesis continues until the 
polymerase collides with the 5’ end of the previous Okazaki fragment and 
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displaces it into a 5’ flap [Burgers 2009]. PCNA then coordinates the processing of 
this flap in a manner that is dependent on a conserved interaction between the 
PCNA interacting peptide (PIP) box of Rad27/FEN1 and the interdomain connector 
loop of PCNA [Gary et al. 1999, Chapados et al. 2004, Tsutakawa et al. 2011].  
Flap cleavage results in a ligatable nick, which is sealed by DNA ligase I, 
completing Okazaki fragment maturation [Burgers 2009]. In addition to its well 
described function in DNA replication, Rad27/FEN1 has also been implicated in 5’-
deoxyribophosphate removal at abasic sites during base excision repair (BER) 
[Memisoglu and Samson 2000]. 
Deletion mutants of RAD27 in yeast are viable but exhibit temperature 
sensitive growth, increased mutation rate, hyper-recombination, repeat tract 
instability and DNA damage sensitivity [Reagan et al. 1995, Tishkoff et al. 1997, 
Freudenreich et al. 1998, Becker et al. 2015]. FEN1 is essential in mammalian 
cells and has furthermore been found to be haploinsufficient in a mouse model 
where deletion of one copy leads to rapid cancer formation [Kucherlapati et al. 
2002]. Mutant forms of FEN1 with reduced nuclease activity have been mapped in 
a variety of human cancer samples and at least one such allele leads to cancer 
formation in mice [Zheng et al. 2007, Larsen et al. 2008]. In addition to these loss 
of function mutations, FEN1 overexpression has been observed in a wide variety 
of cancer types including gastric, prostate, testis, brain, lung, breast, ovarian, and 
prostate and is a marker for poor prognosis in breast cancer [Kim et al. 2005, Lam 
et al. 2006, Singh et al. 2008, Nikolova et al. 2009, Abdel-Fatah et al. 2014, Zhang 
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et al. 2014]. Despite the prevalence of overexpression in cancer, remarkably little 
is understood as to the effect of FEN1 overabundance on DNA replication, cell 
cycle progression or genome stability. We hypothesized that overexpression of an 
enzyme capable of cleaving DNA strands that also interacts with PCNA and plays 
a crucial function in DNA replication could lead to negative effects on genome 
stability through the deregulation of any of these functions. 
In addition to its coordinating role in unperturbed replication, PCNA is also 
subject to a number of post-translational modifications which endow it with the 
ability to coordinate cellular responses to replication stress [Ulrich 2009]. 
Ubiquitination of PCNA at the residue of lysine (K)164 by Rad6-Rad18 is an 
evolutionarily conserved response to replication stress triggered by persistent 
regions of replication protein A (RPA) coated single stranded (ss) DNA [Hoege et 
al. 2002, Davies et al. 2008]. This modification can activate two potential 
postreplicative repair (PRR) pathways dependent on the length of the ubiquitin 
chain [Hoege et al. 2002]. Mono-ubiquitin facilitates a switch from the processive 
replicative polymerases to specialized translesion polymerases that are able to 
tolerate replication over damaged DNA, albeit with an increased rate of nucleotide 
misincorporation [Prakash et al. 2005]. Alternatively, poly-ubiquitination facilitates 
an error-free template switching pathway of PRR capable of bypassing damage 
sites and filling in ssDNA gaps [Branzei 2011]. The mechanistic details of this 
pathway are not yet well understood.  K164 is also a conserved target for 
attachment of a small ubiquitin-like modifier (SUMO). Unlike ubiquitination, this 
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modification occurs during unperturbed S phase and serves to inhibit illegitimate 
recombination between nascent sister chromatids by recruiting the helicase/anti-
recombinase suppressor of rad six 2 (Srs2) [Papouli et al. 2005, Pfander et al. 
2005]. Srs2 is thought to inhibit recombination at replication forks by disrupting the 
formation of Rad51 nucleoprotein filaments [Krejci et al. 2003, Veaute et al. 2003]. 
Conversely, recent studies have pointed to a pro-recombination role for Srs2 that 
is independent of its interaction with PCNA [Miura et al. 2013, Kolesar et al. 2016]. 
 In the present study we have used an inducible overexpression system to 
modulate RAD27 expression levels. Our findings indicate that overexpression 
causes marked impairment of DNA replication leading to delayed S phase 
progression and accumulation of DNA damage in a manner that is dependent on 
its interaction with PCNA. Unexpectedly, overexpression also dramatically 
increases DNA damage sensitivity that is linked to an inability to transfer ubiquitin 
onto PCNA. Instead, PCNA is heavily sumoylated and SUMO dependent pathways 
– including those targeting PCNA – promote viability under these conditions. 
Finally, we demonstrate that transient overexpression of FEN1 in human cell 
culture leads to an elevation of markers for genome instability. We conclude that 
overexpression of flap endonuclease is a potent driver of genome instability and 
mutation, both enabling characteristics of cancer, and that this widespread 
phenomenon has the potential to be an active contributor to cancer formation and 
evolution. 
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RESULTS 
RAD27 overexpression promotes genome instability  
Overexpression of the Rad27 homolog FEN1 has been observed in a 
variety of different cancers originating from varying tissue types. We therefore 
hypothesized that it may impact a fundamental enabling characteristic of cancer, 
such as genome instability [Kim et al. 2005, Lam et al. 2006, Singh et al. 2008, 
Nikolova et al. 2009, Abdel-Fatah et al. 2014, Zhang et al. 2014]. While 
overexpression may reflect an increased demand for FEN1 as a replication factor 
in rapidly dividing cells, overabundance of a PCNA-binding enzyme with DNA 
processing activity could also promote genome instability by disrupting normal 
replication kinetics.  
To investigate this possibility, we utilized a galactose inducible 
overexpression system in S. cerevisiae, which allowed us to rapidly and effectively 
overexpress RAD27 and track the effect on cell cycle progression and genome 
maintenance. Asynchronous cultures with a plasmid-borne, galactose-inducible 
copy of RAD27 (gal-RAD27) or an empty control vector (gal-EV) were grown to log 
phase before addition of galactose. Upon galactose addition, we observed 
increased accumulation of cells in G1 in all cultures (Figures 4.1A and B). 
Importantly, only upon RAD27 overexpression did we observe a significant 
accumulation of cells in S phase, indicating difficulty in the completion of replication 
(Figures 4.1A and B). Overexpression of RAD27 was rapidly observable and 
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coincided with increased phosphorylation of histone H2A at serine (S)129, a 
mitosis entry checkpoint 1 (Mec1) target and marker for DNA damage (Figure 
4.1C) [Downs et al. 2000]. We also observed increased phosphorylation of the 
checkpoint kinase Rad53, further indicating replication stress or DNA damage 
(Figure 4.1C) [Osborn and Elledge 2003]. Whereas a baseline level of 
hyperphosphorylated Rad53 was present in both gal-EV and gal-RAD27 
containing cultures, we noted that only RAD27 overexpressing cultures exhibited 
a progressive shift of the fast migrating unphosphorylated form to a slower 
migrating phosphorylated form (Figure 4.1C). The persistent hyperphosphorylated 
form (marked by an asterisk in Figure 4.1C) may result from growth in medium 
containing the sub-optimal carbon sources galactose and raffinose leading to 
metabolic stress and increased to difficulty making the G1 to S phase transition 
[Barford and Hall 1976]. Taken together, these observations suggested that 
replication stress and DNA damage resulting from RAD27 overexpression was 
interfering with the normal replication program.  
In agreement with the presence of increased DNA damage, we also 
observed reduced viability upon deletion of the homologous recombination (HR) 
gene RAD52 (Figure 4.1D). In contrast, there was no such requirement for the non-
homologous end joining (NHEJ) factor DNL4. If anything, growth was moderately 
more robust in dnl4Δ mutants (Figure 4.1D). We concluded that RAD27 
overexpression leads to replication stress and eventually double-strand breaks 
(DSB) that require HR but not NHEJ for efficient repair. Interestingly, a recent study 
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found that coincident overexpression of FEN1 and the HR factor RAD54B in lung 
adenocarcinomas was predictive of poor patient survival, suggesting that the 
dynamic between flap endonuclease overexpression and HR may be evolutionarily 
conserved [Hwang et al. 2015].  
 
PCNA ubiquitination is impaired in RAD27 overexpressing cultures 
The accumulation of RAD27 overexpressing cells in S phase, increased 
phosphorylation of H2A-S129, and activation of Rad53 led us to further investigate 
the relationship between flap endonuclease overexpression and replication stress.  
To this end, we examined ubiquitination of PCNA as a marker of replication stress 
that indicates the presence of ssDNA gaps [Davies et al. 2008]. We purified His6-
tagged PCNA (His6-PCNA) from RAD27 overexpressing cells and probed its 
ubiquitination and sumoylation status by western blot (Figure 4.2A). Treatment with 
UV light, which is known to induce PCNA ubiquitination was included as a positive 
control. Unexpectedly, RAD27 overexpression did not trigger PCNA ubiquitination, 
and it drastically reduced the level of ubiquitination in response to UV light (Figure 
4.2A). In contrast, PCNA sumoylation was vastly enhanced when RAD27 was 
overexpressed (Figure 4.2A). This was likely due to an increase of cells in S phase 
during which PCNA is sumoylated to recruit Srs2 and inhibit illegitimate 
recombination between sister chromatids [Papouli et al. 2005, Pfander et al. 2005]. 
We also measured a higher rate of mutation at the CAN1 locus in RAD27 
overexpressing cells compared to wild-type (Figure 4.2B). As expected, this was 
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independent of PCNA-K164, consistent with the observation that PCNA was not 
ubiquitinated (Figure 4.2A). Thus, mutagenesis was operating outside of 
ubiquitination-dependent translesion synthesis (TLS) (Figure 4.2B).  
We considered the possibility that overexpression of RAD27 may decrease 
ubiquitination by occluding PCNA binding surfaces and sterically hindering access 
for the Rad6-Rad18 ubiquitination complex. However, overexpression of a 
dominant negative nuclease dead allele identified as rad27-n (D179A) led to robust 
ubiquitination in the absence of UV, arguing against this model (Figure 4.2C) [Gary 
et al. 1999]. Interestingly, in rad27-n overexpressing cells we observed 
ubiquitination of PCNA at K164 as well as at an alternate site, which we mapped 
to K242 (Figure 4.2C). Whereas a K164R mutation moderately reduced cell 
viability, K242 was dispensable for growth (Figure 4.3). In contrast to cells 
overexpressing wild-type RAD27, the mutation rate in rad27-n expressing cells 
was significantly increased in a manner that was dependent on both K164 and 
K242 (Figure 4.2D). These findings support that TLS was primarily responsible for 
the increase in the mutation rate and that K242 is sufficient, but not necessary, to 
facilitate TLS under these conditions.  
We next considered the possibility that ubiquitination of PCNA may have 
simply been delayed in RAD27 overexpressing cells due to reduced replication 
fork progression. However, ubiquitination rapidly reached its maximum level 15 
min after UV treatment in the presence or absence of RAD27 overexpression, 
albeit this level was much lower in the former cell poplulation (Figure 4.2E). From 
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these observations we concluded that high abundance of flap endonuclease 
interferes with the ubiquitination of PCNA, but that this phenomenon is not due to 
steric hindrance.  
 
Sumoylation promotes viability in RAD27 overexpressing cells 
 Although overexpression of RAD27 did not lead to PCNA ubiquitination and 
in fact suppressed ubiquitination in response to UV treatment, we tested for a 
genetic interaction with a PCNA-K164R mutation, which resulted in a very mild but 
reproducible growth defect (Figure 4.4A). In contrast, the deletion of PRR pathway 
components REV3 and RAD5 had no effect on viability (Figure 4.4A). To 
investigate whether the observed genetic interaction between the pol30-K164R 
allele and RAD27 overexpression was due to the loss of sumoylation at this 
residue, we induced flap endonuclease in siz1Δ mutants deficient for the E3 SUMO 
ligase, which targets PCNA at K164 [Pfander et al. 2005]. Interestingly, the loss of 
SIZ1 had a more severe effect on viability than the pol30-K164R mutation alone, 
suggesting that additional targets of Siz1 are necessary to fully counteract the 
genotoxic effects of RAD27 overexpression (Figure 4.4B). We also observed a 
significant reduction in viability in strains carrying a catalytically inactive allele of 
the E3 SUMO ligase MMS21 (mms21-CH) (Figure 4.4B). Deletion of siz2Δ had no 
impact on viability. Together, these findings indicate that sumoylation by Siz1 and 
Mms21 is enhancing growth under conditions of RAD27 overexpression. 
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 Sumoylation of PCNA at K164 is thought to primarily act to recruit the 
helicase/anti-recombinase Srs2 which suppresses illegitimate HR between 
nascent sister chromatids at the replication fork [Papouli et al. 2005, Pfander et al. 
2005].  Deletion of SRS2 resulted in a very mild growth defect, similar to that 
observed in K164R mutants (Figure 4.4C). Combination of the two alleles revealed 
an additive effect in reducing viability, indicating that PCNA-K164 and Srs2 have 
independent functions under these conditions (Figure 4.4C). This, in turn, is 
consistent with Srs2 having a pro-recombination role that is independent of its 
interaction with PCNA and promotes cell viability [Miura et al. 2013, Kolesar et al. 
2016]. It may be that Srs2 is required at replication forks in RAD27 overexpressing 
cells to inhibit illegitimate recombination, but facilitates HR at DSB sites. pol30-
K164R siz1Δ mutants on the other hand behaved similarly to siz1Δ mutants, 
further supporting the notion that Siz1 dependent sumoylation, including that of 
PCNA at K164, is promoting the viability of RAD27 overexpressing cells (Figure 
4.4C).   
 We next sought to determine whether the pol30-K164R, siz1Δ, mms21-CH, 
or rad52Δ alleles, which decreased the viability of RAD27 overexpressing cells, 
also led to increased DNA damage sensitivity. Consistent with previous reports, 
pol30-K164R, mms21-CH, and rad52Δ mutants all exhibited enhanced sensitivity 
to DNA damage even in the absence of RAD27 overexpression (Figure 4.5A and 
B) [Stelter and Ulrich 2003, Sacher et al. 2006, Cremona et al. 2012]. Remarkably 
however, when combined with RAD27 overexpression, the sensitivity to the UV 
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mimic 4-nitroquinoline 1-oxide (4-NQO), alkylating drug methyl methanesulfonate 
(MMS), or replication inhibitor hydroxyurea (HU) was dramatically enhanced 
(Figure 4.5A-4.5C). RAD27 overexpression alone was sufficient to acutely 
sensitize cells to 4-NQO, MMS and HU at concentrations that had a minimal effect 
on the control (gal-EV) strain. This sensitivity was not further enhanced by SIZ1 
mutation (Figure 4.5A-4.5C). These results suggested that elevated levels of 
Rad27 simulate DNA repair or DNA damage tolerance pathway deficiencies.  This 
is compounded by our finding that RAD27 overexpression impeded normal 
ubiquitination of PCNA and this may provide a mechanistic explanation for the 
observed sensitivity to DNA damaging agents. 
 
PCNA is the primary target for sumoylation 
 Our finding that siz1Δ mutants overexpressing RAD27 had a reduction in 
viability greater than that resulting from the loss of K164 sumoylation alone led us 
to conclude that additional Siz1 targets might be contributing to the growth of these 
cells. Western blot analysis of whole cell extracts of cells overexpressing RAD27 
showed an increase in SUMO-conjugates relative to controls (Figure 4.6A). A side-
by-side comparison of the same blot developed with a PCNA specific antibody 
revealed a banding pattern highly similar to the pattern of sumoylated proteins, 
suggesting that PCNA is the primary target for increased sumoylation under these 
conditions (Figure 4.6A). In addition, we isolated His8-tagged SUMO-conjugates 
by cobalt affinity purification to identify sumoylated species by liquid 
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chromatography coupled tandem mass spectrometry (MS) (Figure 4.6B). PCNA 
was the most abundant sumoylated protein in our purification (Figure 4.6C). We 
also identified increased sumoylation of the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) isozyme triose-phosphate dehydrogenase 1 (Tdh1). 
Tdh1 protein levels have been reported to increase under conditions of replication 
stress although both the biological significance of this increase and the function of 
Tdh1 sumoylation remain unclear [Tkach et al. 2012]. However, considering the 
role of Tdh1 in sugar metabolism and the change of sugar conditions in the growth 
medium necessary to induce RAD27 overexpression, it would be difficult to 
conclude that these changes are exclusively a result of genome instability. 
Furthermore, both Tdh1 and Rad27 were abundant in a control with untagged 
SUMO, arguing that they may have contaminated the His8-SUMO preparation due 
to high overall abundance (Figure 4.6C). Taken together, these data indicate that 
the primary target for sumoylation as measured by abundance under conditions of 
RAD27 overexpression is PCNA.  
 
Genome instability in RAD27 overexpressing cells is dependent on its 
interaction with PCNA  
 We demonstrated that overexpression of RAD27 is a source of replication 
stress, genome instability, and mutation. To better understand the underlying 
mechanism, we considered two potential models: 1) RAD27 overexpression leads 
to spurious or unregulated processing of replication intermediates causing DNA 
 178 
 
breakage, or 2) genome instability is simply a side-effect of having an over-
abundance of a PCNA interacting protein interfering with the kinetics of replication 
as it pertains to PCNA binding.  
To test these hypotheses, we generated a variant of the overexpression 
construct carrying a rad27-FFAA allele in which two crucial phenylalanine residues 
(F346, F347) located in the PIP box of Rad27 were mutated to alanine, ablating its 
interaction with PCNA [Gary et al. 1999]. Remarkably, we found that 
overexpression of this PCNA binding mutant did not result in any observable 
increase in phosphorylation of H2A-S129 or Rad53 over that observed in an empty 
vector control (Figure 4.7A). Additionally, the severe S-phase delay observed in 
RAD27 overexpressing cells was absent when overexpressing rad27-FFAA 
(Figure 4.7B and C). Expression of this mutant in combination with pol30-K164R, 
siz1Δ, mms21-CH, or rad52Δ, which all displayed negative genetic interactions 
with RAD27 overexpression, did not result in growth inhibition (Figure 4.7D and E). 
In fact, the rad27-FFAA mutation rescued the proliferation defect and the other 
observed genome instability phenotypes inherent to RAD27 overexpression 
(Figure 4.7D and E). These results suggested that RAD27 overexpression 
interfered with normal progression of active replication forks, likely by blocking 
binding sites on PCNA. However, this experiment did not allow us to distinguish 
whether Rad27 simply acted as a spatial block or caused DNA damage by 
spurious or unregulated DNA processing. 
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 To address whether the over-abundance of a PCNA interacting protein 
alone is sufficient to explain the phenotype of RAD27 overexpressing cells, we 
generated a fusion protein composed of the full sequence of GFP with the C-
terminal 48 amino acids of Rad27 fused to its C-terminus (GFP-PIP) (Figure 4.8A). 
This fragment of Rad27 contains the PIP motif and nuclear localization sequence 
(NLS) but none of the catalytic domains. While overexpression of GFP-PIP led to 
a mild accumulation of cells in S phase, this phenotype was not ameliorated when 
the PIP motif contained the inactivating FFAA mutation (Figure 4.8B and C). 
Furthermore, GFP-PIP expressing cells were not sensitive to 4-NQO at the 
concentrations examined and only mildly sensitive to MMS or HU treatment (Figure 
4.9 A-C). This partial phenotype supports the contention that the impact of RAD27 
overexpression on genome stability is at least partially unique to Rad27 and not 
entirely generalizable to all PCNA interacting peptides. 
 
Overexpression of FEN1 in 293T cells causes genome instability 
 Overexpression of flap endonuclease in yeast impaired DNA replication and 
promoted genome instability. To investigate whether the same held true for 
overexpression of the human Rad27 homolog FEN1, we transiently transfected 
293T cells with a vector encoding FLAG-tagged FEN1 under control of a CMV 
promoter. Transient overexpression of FLAG-FEN1 led to a temporary increase in 
the phosphorylation of RPA32-S4/S8, an ATM target and marker for DSB 
processing, which subsided at the 48 h timepoint (Figure 4.10A) [Sartori et al. 
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2007, Liu et al. 2012]. It is possible that reduced RPA phosphorylation at 48 h was 
reflective of Rad51 displacing RPA for repair by HR. Levels of γH2AX, a marker 
for DSB formation were also increased at 24 and 48 h timepoints [Rogakou et al. 
1998]. These findings are indicative of DNA damage induction upon FLAG-FEN1 
expression. However, in contrast to our findings in yeast, we did not observe any 
significant reorganization of the cell cycle distribution of these cultures as 
measured by DNA content (Figure 4.10B).  
 A hypomorphic E160D mutation in the catalytic domain of FEN1 primarily 
causes lung tumors in mice [Zheng et al. 2007]. We wondered whether 
overexpression of FEN1 would similarly affect lung tissue. Relative expression 
levels of FEN1 mRNA in matched normal and tumor tissues from lung 
adenocarcinoma patients as measured by RNAseq were obtained from The 
Cancer Genome Atlas (TCGA). In accordance with what has been previously 
reported, we found overexpression of FEN1 to be prevalent in the vast majority of 
tumor samples (Figure 4.10C) [Sato et al. 2003, Nikolova et al. 2009, Yang et al. 
2009]. The median level of overexpression was ~5-fold with individual samples 
and ranged as high as 10-fold over normal tissue. It is possible that disrupting the 
balance of flap processing by mutation or overexpression of FEN1 manifests with 
particular penetrance in lung tissue. The mechanism underlying any lung-specific 
effect remains unclear.  
Altogether, it appears that increased expression of flap endonuclease has 
a conserved effect between yeast and human cell systems marked by a significant 
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increase in genome instability. When taken into consideration with the high 
prevalence of FEN1 overexpression in a wide variety of cancers we believe that 
this phenomenon is likely not a passenger effect, but may be a direct contributor 
to, and driver of genome instability and mutation (Figure 4.10C).  
 
DISCUSSION 
 Here, we have demonstrated that overexpression of the FEN1 homolog 
Rad27 in yeast impairs DNA replication in a manner that is dependent on its 
interaction with PCNA and leads to the accumulation of DNA damage and 
mutations. Overexpression of FEN1 has been observed in cancers derived from a 
variety of tissue types at levels approaching 50-fold greater than matched normal 
tissues in some cases [Nikolova et al. 2009]. With this in mind, we modeled FEN1 
overexpression using the strong GAL1/10 promoter to enforce overexpression of 
RAD27 at a high level. This promoter has the dual advantages of inducible control 
and expression at sufficiently high levels to model what has been observed in 
human cancers. 
 
Sumoylation suppresses the effects of RAD27 overexpression 
 Work over the past two decades has vastly increased our understanding of 
the complex networks of posttranslational modifications that are mobilized in 
response to replication stress and DNA damage [Cremona et al. 2012, Jackson 
and Durocher 2013]. Among these, the ubiquitination of PCNA at the conserved 
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residue K164 plays a crucial role in coordinating PRR pathways [Hoege et al. 
2002]. Because the appearance of this modification is a sensitive marker for 
replication stress, we were surprised that RAD27 overexpression not only failed to 
elicit this response, but suppressed it following UV treatment. This was particularly 
puzzling given the preponderance of other replication stress markers.  
 The observation that sumoylation, but not ubiquitination, of PCNA at K164 
enhanced the viability of RAD27 overexpressing cells prompted us to investigate 
the role of the three yeast SUMO ligases under these conditions. Genetic 
interaction studies with mutant alleles of SIZ1, SIZ2 and MMS21 revealed a 
significant decrease in viability in combination with siz1Δ and mms21-CH, but not 
siz2Δ, suggestive of broader applications for sumoylation beyond the attachment 
to PCNA. Although our analysis of the SUMO proteome in RAD27 overexpressing 
cells identified PCNA as the most abundant target, it is possible that additional 
Siz1 and Mms21 targets of importance remain unidentified due to lower relative 
abundance. More sensitive and quantitative techniques will be necessary to 
identify these targets. It is also possible that multiple targets of low individual 
importance have an additive effect on viability. Additional studies will be necessary 
to fully understand the role of SUMO in mediating Rad27-induced replication 
stress. 
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Interaction with PCNA mediates RAD27 overexpression effects   
 Our finding that mutation of the RAD27 PIP box in rad27-FFAA mutants 
abrogates the negative impacts of RAD27 overexpression suggests two possible 
mechanisms by which expression of the wild-type enzyme imperils genome 
stability. First, it could be interpreted that overabundance of Rad27 as a PCNA 
interacting protein disrupts the kinetics of replication by impeding the ability of other 
PCNA binding replication factors to be appropriately localized. Such a model has 
been proposed to explain the detrimental effects of DNA ligase I overexpression 
on genome stability and is also thought to be one of the mechanisms by which p21 
regulates DNA replication [Waga et al. 1994, Subramanian et al. 2005]. If this 
model were to withstand examination, it would stand to reason that overexpression 
of any PCNA binding protein would have a similar effect on replication and that 
there is nothing intrinsic to RAD27 that causes the observed phenotypes. 
However, overexpression of a GFP-Rad27 fusion protein (GFP-PIP) which retains 
the PIP box and NLS of RAD27 but none of the nucleolytic domains failed to fully 
reproduce the results of expressing full-length RAD27, arguing that this model 
does not completely explain our observations. 
Instead, we favor a second model in which the effect of RAD27 
overexpression is at least partially due to its catalytic activity. Unfortunately, we 
were not able to directly test this model as a catalytically dead mutant of RAD27 
(rad27-n) displays a dominant negative phenotype [Gary et al. 1999]. This is 
thought to be the result of substrate binding by the catalytically dead enzyme which 
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is then unable to complete its catalytic cycle [Gary et al. 1999]. The enzyme 
substrate complex then acts as an impediment to processing by alternative 
enzymes, severely disrupting Okazaki fragment processing and inhibiting the 
completion of DNA replication. It is, however, telling that a mutation in the PIP box 
of Rad27-n alleviates the dominant negative phenotype of the mutant [Gary et al. 
1999]. This demonstrates that the PIP box mutation not only abrogates the 
Rad27:PCNA physical interaction, but it also must impair substrate binding and 
processing in vivo [Li et al. 1995]. Furthermore, the observation that 
overexpression of catalytically inert GFP-PIP fusion protein does not completely 
reproduce overexpression of full length Rad27, let us conclude that the phenotypes 
we observed are not entirely a generalizable effect of any PIP box containing 
protein, but are at least partially unique to RAD27.  
The fact that all observed growth and genome instability phenotypes upon 
RAD27 overexpression are completely dependent on the interaction between 
Rad27 and PCNA and result in a severe S phase delay argues that the effect is 
linked to replication. We can speculate that due to the well described role of Rad27 
in Okazaki fragment processing, disruption of this process is a likely side-effect of 
overexpression. It is possible that too much flap endonuclease present during 
Okazaki fragment processing interferes with RNA primer removal, fill-in DNA 
synthesis and eventual ligation, leading to unligated nicks [Ayyagari et al. 2003, 
Jin et al. 2003, Garg et al. 2004]. If left unrepaired, these nicks would form DSB 
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during the next round of replication, explaining the observed dependence on HR 
of RAD27 overexpressing cells.  
 
RAD27 overexpression causes DNA damage sensitivity 
 One of the more striking phenotypes that we observed upon Rad27 
overexpression was an acute sensitivity to DNA damage. High abundance of flap 
endonuclease rendered multiple strains uniformly sensitive to both 4-NQO and 
MMS treatment at concentrations that failed to impact the growth of control cells 
that harbored an empty vector. Considering that Rad27 is involved in BER, which 
is the primary pathway for removal of MMS-induced lesions, it is somewhat 
counterintuitive that overexpression would sensitize cells to this type of damage 
[Memisoglu and Samson 2000, Ma et al. 2008]. Nevertheless, we propose two 
reasons for why this is the case. First, we have thoroughly demonstrated that 
RAD27 overexpression leads to genome instability and impaired replication. It may 
be that given the amount of replication stress already present in these cells, they 
are unable to tolerate additional damage and easily succumb to drug treatment. 
Second, we observed that ubiquitination of PCNA in response to DNA damage 
was severely impaired (Figure 4.2). It has been well established that both 4-NQO 
and MMS treatment lead to an increased dependence on PRR for viability [Hoege 
et al. 2002, Stelter and Ulrich 2003]. It is therefore possible that the inability to 
ubiquitinate PCNA and activate PRR renders these cells highly sensitive to DNA 
damage. If this relationship between flap endonuclease overexpression and DNA 
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damage sensitivity is conserved in human cancer cells, it may offer an effective 
therapeutic target for cancers with high levels of FEN1. Because the mode of 
action for many clinical chemotherapeutics relies on causing damage to DNA or 
otherwise inducing replication stress, this would be a highly implementable 
strategy with a readily identifiable marker in FEN1. 
 
FEN1 overexpression and cancer 
  Overexpression of FEN1 in cancers from a wide variety of tissue types may 
suggest simply that dividing cancer cells require elevated levels of this replication 
factor to enable proliferation. However, our finding that overexpression of flap 
endonuclease in both yeast and human systems is a potent source of genome 
instability raises the possibility that overabundance of FEN1 presents an active 
mechanism to drive cancer evolution irrespective of tissue type. Based solely on 
the results presented in this study, it is impossible to determine whether FEN1 
overexpression is a driving factor in carcinogenesis, a promoter of cancer 
progression, or a combination of the two. Nonetheless, inhibition of FEN1 has 
already been investigated as a potential chemotherapeutic strategy with promising 
results, although none of these studies have analyzed the effect of FEN1 inhibitors 
specifically in cancers with elevated expression levels [McManus et al. 2009, 
McWhirter et al. 2013, van Pel et al. 2013]. Such studies will be necessary to 
determine whether some cancers become “addicted” to overexpression and 
whether this is exploitable as a therapeutic strategy. 
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 In summary, we report that overexpression of flap endonuclease 
impairs DNA replication leading to S phase delay, DNA damage and mutation in a 
manner that is dependent on its interaction with PCNA. Furthermore, 
overabundance of Rad27 impairs ubiquitination of PCNA in response to DNA 
damaging agents and renders these cells acutely sensitive to DNA damage. Our 
findings provide evidence that this common occurrence in cancer cells may not be 
simply a passenger effect but must be considered as a driver of genome instability. 
 
 
MATERIALS AND METHODS 
Yeast Strains and culture conditions 
All yeast strains with the exception of those used for MS analysis were 
derived from E133 wild-type cells (Table 4.1) [Tran et al. 1997]. Strains used for 
MS were derived from W303-1a [Thomas and Rothstein 1989]. Cultures carrying 
plasmid-borne galactose inducible constructs were grown in synthetic medium 
lacking uracil and containing 2% raffinose as a sugar source. Induction of gene 
expression was accomplished by adding galactose to a final concentration of 2% 
once cultures had reached an OD600 of ~0.600.  All genetic knockouts were 
generated by PCR mediated gene disruption [Lorenz et al. 1995]. The mms21-CH 
allele was introduced via a two-fragment PCR method that has been described 
previously [Nguyen et al. 2013]. Briefly, one fragment containing mms21-CH was 
generated from genomic DNA using a 5’ primer upstream of the mms21-CH locus 
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and a downstream 3’ primer with a region complementary to the 5’ end of a second 
PCR fragment containing a LEU2 marker. Equal molar ratios of the two fragments 
were mixed, denatured at 95°C for 5 min and allowed to anneal at room 
temperature for 30 min before being transformed into competent yeast cells.  
 
Plasmids 
 Overexpression of RAD27, rad27-n, and rad27-FFAA was under control of 
an inducible GAL1-10 promoter in a YEp195SPGAL plasmid backbone[Clark et al. 
1999]. These constructs were obtained from D. Gordenin and have been described 
[Gary et al. 1999]. His6-PCNA strains were constructed using Yip128-P30-POL30 
(a gift from H.D. Ulrich, IMB Mainz). This construct was linearized with AflII and 
integrated at the genomic LEU2 locus. Expression was analyzed by western blot 
to ensure similar protein levels to endogenous untagged PCNA. Endogenous 
POL30 was then knocked out via PCR mediated gene disruption.   
 The GFP-PIP construct was generated by PCR amplification of GFP using 
5’_GFP_SalI (5’-TATATGTCGACATGAGTAAAGGAGAAGAACTTTTCAC-3’) and 
3’_GFP_PIP_1 (5’-
CTTGGAAGAACCCATCTAACCTACCCTGAATGCCAGATTTTTTGTATAGTTCA
TCCATGC-3’), followed by sequential overlapping PCR extensions at the 3’ end 
using 3’_GFP_PIP_2 (5’-
TTCGCCGCAGCAGCCAGCTGTTCCTTTGTCTTAGGCACCACTTGGAAGAAC
CCATCTAAC-3’), 3’_GFP_PIP_3 (5’-
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ATTCTTATTTTTGTTCAATTTTTTATTTTCTTGTGCTCTTTTCGCCGCAGCAGC
CAGCT-3’), 3’_GFP_PIP_4 (5’-
TCATCTTCTTCCCTTTGTGACTTTATTCTTATTTTTGTTCAATTTTTTATTTTC-
3’), and 3’_GFP_PIP_NotI (5’-
TATATGCGGCCGCTCATCTTCTTCCCTTTGTGACTTTAT-3’). The resulting 
fragment was composed of GFP in its entirety with the terminal 144 nucleotides of 
RAD27 fused to the 3’ end. This fragment was then digested with SalI and NotI 
restriction enzymes before ligation into a YEp195SPGAL backbone. Expression 
was confirmed by the visualization of GFP fluorescence after the addition of 
galactose to cultures carrying the GFP-PIP construct. The GFP-PIP-FFAA variant 
was generated by site directed mutagenesis with a previously published primer set 
[Gary et al. 1999].  
Strains with a PCNA-K164R mutation were generated by transformation of 
a single PCR fragment amplified from pCH1654 (a gift from L. Prakash, UTMB) or 
derivatives with additional lysine mutations introduced using the QuikChange 
Lightning Site-Directed Mutagenesis kit (Agilent). The resulting fragment was 
composed of the PCNA coding sequence and a LEU2 marker flanked by homology 
arms targeting it for integration at the endogenous PCNA locus. Integration and 
incorporation of the mutant allele were confirmed by PCR and sequencing. 
3xFLAG-FEN1 was transiently overexpressed in 293T cells from a pShuttle-
3xFLAG-FEN1 vector under the control of a CMV promoter (S. Stewart, 
Washington U).  
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His6-PCNA and His8-SUMO purification 
 Purification of His6-PCNA was performed as previously described [Becker 
et al. 2014, Becker et al. 2015]. Briefly, cultures were grown to OD600 ~0.600 in 
medium containing 2% raffinose. Galactose was then added to a final 
concentration of 2% to induce RAD27 overexpression. In experiments with UV 
treatment, induction was carried out for 2 h before treatment with 100 J/m2 of 254 
nm light using a UV crosslinker (CL-1000, UVP). After collection, cell pellets were 
stored at -80°C overnight before processing. The pellets were then subjected to 
lysis under denaturing conditions and protein extracts were prepared in 8 M urea 
buffer. His6-PCNA was bound to Ni-NTA conjugated agarose overnight at room 
temperature before washing with buffers of decreasing pH to successively 
increase stringency. Bound His6-PCNA was eluted with EDTA-containing buffer 
and the eluates were fractionated by SDS-PAGE for western blot analysis with 
antibodies raised against PCNA, ubiquitin and SUMO. His8-SUMO was also 
purified under denaturing conditions from cultures that were grown to OD600 ~0.600 
in medium containing 2% raffinose. Galactose was added to a final concentration 
of 2% to induce RAD27 overexpression in cells with tagged or untagged SUMO. 
Cultures were harvested after 3 h for His8-SUMO pulldown with TALON metal 
affinity beads (Clonetech). Purification was carried out as described in Thu, et al. 
and submitted for MS [Thu et al. 2016]. 
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Protein extraction and western blotting 
 Protein extracts were isolated by lysing cells under denaturing conditions, 
precipitating protein with trichloracetic acid, and resuspending the precipitated 
protein pellet in SDS loading buffer [Ricke and Bielinsky 2006]. Extracts were 
fractionated by SDS-PAGE, transferred to a PVDF membrane and analyzed by 
western blot with the following antibodies as indicated in each figure; anti-FEN1 
(ab2619, Abcam) at a 1:1000 dilution in 5% blocking solution overnight, anti-Rad53 
(a gift from JFX Diffley, LRI) at a 1:1000 dilution in 5% blocking solution for 1 h, 
anti-phospho-S129 H2A (ab15083, Abcam) at a 1:500 dilution in blocking solution 
overnight, anti-tubulin (MMS-407R, Covance) at a 1:5000 dilution in 5% blocking 
solution overnight, anti-PCNA (a gift from B. Stillman, CSHL) at a 1:4000 dilution 
in TBST for 2 h, anti-ubiquitin (P4D1, Covance) at a 1:1000 dilution in 5% blocking 
solution overnight, anti-SUMO (a gift from X. Zhao, MSKCC) at a 1:3000 dilution 
in TBST for 1 h, anti-phospho-S4/8 RPA32 (A300-245A, Bethyl Laboratories) at a 
1:2000 dilution in 5% blocking solution overnight, and anti-γH2AX (A300-081A, 
Bethyl Laboratories) at a 1:2000 dilution in 5% blocking solution overnight. The 
anti-FEN1 antibody was raised against human FEN1 and only cross-reacted with 
yeast Rad27 sufficiently to visualize by western blot when Rad27 was 
overexpressed.  
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Mutation rate estimation 
 Mutation rates were estimated using the forward rate of mutations at the 
CAN1 locus that conferred resistance to canavanine. Individual colonies were 
inoculated in medium lacking uracil and containing 2% raffinose as well as 2% 
galactose. Under these conditions the cultures required 8 days of growth at 25°C 
to reach saturation. Saturated cultures were washed and appropriate dilutions 
were plated on medium lacking arginine and containing canavanine (60 mg/L) or 
on rich medium to obtain a viable cell count. Mutation rates were calculated using 
Drake’s formula and significance was determined using the Mann-Whitney U test 
[Mann and Whitney 1947, Drake 1991, Foster 2006]. Determinations were made 
from at least 16 independent cultures for each strain. 
 
Cell cycle analysis 
 DNA content in yeast cells was measured by flow cytometry using a BD 
Accuri C6 flow cytometer and Sytox Green (Invitrogen) DNA dye. Measurement of 
DNA content in 293T cells was carried out using the same machine with propidium 
iodide (Sigma-Aldrich) as the DNA stain.  
 
Viability analysis 
The relative viability of yeast strains was examined in a “spotting” assay. 
We began by inoculating 10 ml cultures in medium lacking uracil and containing 
2% glucose as a sugar source. These cultures were grown to saturation for 4 days 
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at 25°C, harvested, washed with 10 ml water, and resuspended in 5 ml water.  The 
cells in the resulting suspension were quantified and 10-fold serial dilutions were 
then prepared in a 96 well plate from a starting cell count of 2x107. The spots were 
then plated using a multi-pronged plating instrument on medium lacking uracil and 
containing either 2% glucose or 2% galactose. Images were taken after 4 days 
growth at 25°C. Strains containing the mms21-CH allele had an inherent growth 
defect made direct comparison with other strains difficult to visualize. To account 
for this, 5-fold more cells (108) were used as the starting cell count for all mms21-
CH strains.  
 
Human cell culture 
 293T cells were cultured in Dulbecco’s modified eagle medium (DMEM). 
Transient transfection was carried out with Lipofectamine LTX (Thermo Fisher). In 
these experiments 10 μg of circular plasmid DNA was transfected into 293T cells 
at ~60% confluency on a 10 cm plate. Cells were harvested at 24 and 48 h for 
protein extraction and DNA content analysis by flow cytometry. For protein 
extraction cells were lysed in NETN (20 mM Tris-HCl at pH 8.0, 100 mM NaCl, 1 
mM EDTA, 0.5% Nonidet P-40 and protease inhibitors) for 10 min and then 
centrifuged at 16,000g for 10 min. Cleared lysates were collected, mixed with SDS 
loading buffer, and boiled before fractionation by SDS-PAGE and analysis by 
western blot. 
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Figure 4.1  
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Figure 4.1. RAD27 overexpression causes genome instability and impairs S 
phase progression. (A) Strains containing either gal-EV or gal-RAD27 expression 
vectors were grown to OD600 ~0.600 in synthetic medium lacking uracil and 
containing 2% raffinose as a sugar source. Galactose was then added to a final 
concentration of 2% and samples were collected at the indicated time points for 
analysis by western blot and flow cytometry. DNA content was measured by flow 
cytometry on a BD Accuri C6 flow cytometer. (B) Quantification of the cell cycle 
distribution of the profiles in panel B. Quantification was carried out using the BD 
Accuri C6 software. This result is representative of 3 independent experiments. 
(C) Samples from the same cultures described above were harvested at the 
indicated timepoints and protein extracts were prepared by TCA precipitation.  
Extracts were fractionated by SDS-PAGE for western blot analysis with anti-
Rad27, anti-Rad53, anti-phospho-S129 H2A, and anti-tubulin antibodies. The 
asterisk on the Rad53 blot marks the galactose-dependent effect. (D) 10-fold serial 
dilutions of the indicated strains were plated on medium lacking uracil and 
containing either 2% glucose to suppress gal-RAD27 or 2% galactose to induce 
RAD27 overexpression. Plates were incubated at 25°C for 4 days before imaging. 
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Figure 4.2   
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Figure 4.2. RAD27 overexpression inhibits PCNA ubiquitination. (A) Strains 
with either untagged PCNA, His6-PCNA, or His6-PCNA-K164R and all carrying gal-
RAD27 were grown to OD600~0.600 in medium lacking uracil. Overexpression of 
RAD27 was then induced where indicated by the addition of galactose to a final 
concentration of 2%. UV treatment was applied 2 h after addition of galactose and 
the cultures were harvested 1 h later. His6-PCNA was purified under denaturing 
conditions and analyzed by western blot with antibodies against PCNA, ubiquitin, 
and SUMO. (B) The mutation rate at the CAN1 locus was measured in the 
indicated strains after growth to saturation in galactose containing medium. Each 
bar represents the median of at least 16 independent determinations. Error bars 
indicate standard error. Significance was determined by the Mann-Whitney U-test. 
(C) The indicated strains were grown to OD600~0.600 in complete medium with 2% 
raffinose before addition of galactose to a final concentration of 2%. Cells were 
harvested after 3 h and His6-PCNA was purified under denaturing conditions 
before analysis by western blot with antibodies against PCNA, ubiquitin, and 
SUMO. (D) The mutation rate at the CAN1 locus was measured as in (B). (E) A 
strain with His6-PCNA and carrying gal-RAD27 was grown to OD600~0.600 in 
medium lacking uracil and containing 2% raffinose. The culture was then split in 
half with one half receiving an additional 2% raffinose and the other having 
galactose added to a final concentration of 2%. Both cultures were treated with 
100 J/m2 UV after 2 h. Samples were analyzed as in (A).   
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Figure 4.3  
 
 
 
 
 
 
 
  
Figure 4.3. rad27-n overexpressing cells rely on error-free PRR for viability. 
5-fold serial dilutions of the indicated strains were plated on medium lacking uracil 
and containing either 2% glucose to suppress overexpression or 2% galactose to 
induce rad27-n overexpression. Plates were incubated at 25°C for 4 days before 
imaging. 
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Figure 4.4  
 
 
 
 
  
Figure 4.4. Sumoylation promotes the viability of RAD27 overexpressing 
cells. (A-C) 10-fold serial dilutions of the indicated strains were plated on medium 
lacking uracil and containing either 2% glucose to suppress gal-RAD27 or 2% 
galactose to induce RAD27 overexpression. Plates were incubated at 25°C for 4 
days before imaging. 
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Figure 4.5  
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Figure 4.5. Sumoylation promotes the viability of RAD27 overexpressing 
cells. (A-C) 10-fold serial dilutions of the indicated strains were plated on medium 
lacking uracil and containing either 2% glucose to suppress gal-RAD27 or 2% 
galactose to induce RAD27 overexpression. Plates were incubated at 25°C for 4 
days before imaging. 
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Figure 4.6  
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Figure 4.5. PCNA is the most abundant sumoylation target. (A) Strains with 
either untagged SUMO or His8-SUMO and carrying gal-RAD27 were grown to 
OD600~0.600 in medium lacking uracil and containing 2% raffinose. The cultures 
were then each split in half with one half receiving an additional 2% raffinose and 
the other having galactose added to a final concentration of 2%. Samples were 
harvested after 3 h and whole cell protein extracts were made by TCA precipitation. 
Extracts were fractionated by SDS-PAGE and analyzed by western blot with 
antibodies against PCNA and SUMO. The blots in this image were run side-by-
side on the same gel. Corresponding bands between the SUMO and PCNA blots 
are marked with circles of the same color. (B) His8-SUMO was purified under 
denaturing conditions from the cultures described in (A), fractionated by SDS-
PAGE and analyzed by western blot with and anti-SUMO antibody. This 
purification was subsequently subjected to mass spectrometry analysis. (C) The 
most abundant proteins identified by mass spectrometry analysis under conditions 
of RAD27 overexpression. 
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Figure 4.7
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Figure 4.6. Rad27-PCNA interaction mediates the effects of RAD27 
overexpression. (A) Strains containing either gal-EV, gal-RAD27, or gal-rad27-
FFAA expression vectors were grown to OD600 ~0.600 in synthetic medium lacking 
uracil and containing 2% raffinose as a sugar source. Galactose was then added 
to a final concentration of 2% and samples were collected at the indicated time 
points for analysis by western blot and flow cytometry. Protein extracts were 
prepared by TCA precipitation and fractionated by SDS-PAGE for western blot 
analysis with anti-Rad27, anti-Rad53, anti-phospho-S129 H2A, and anti-tubulin 
antibodies. The asterisk on both Rad53 blots marks the galactose-dependent 
effect. (B) Samples from the same cultures described above were harvested at the 
indicated time points and DNA content was measured by flow cytometry on a BD 
Accuri C6 flow cytometer. (C) Quantification of the cell cycle distribution of the 
profiles in panel B. Quantification was carried out using the BD Accuri C6 software. 
(D and E) 10-fold serial dilutions of the indicated strains were plated on medium 
lacking uracil and containing either 2% glucose to suppress overexpression or 2% 
galactose to induce RAD27 or rad27-FFAA overexpression. Plates were incubated 
at 25°C for 4 days before imaging. 
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Figure 4.8  
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Figure 4.7. Overexpression of GFP-PIP does not fully replicate RAD27 
overexpression. (A) GFP-PIP was constructed by fusing the PIP motif and NLS 
of RAD27 to the C terminus of full length GFP. The variant in which the PIP box 
contains the inactivating FFAA mutation was generated by site directed 
mutagenesis. (B) Cells overexpressing either GFP, GFP-PIP, or GFP-PIP-FFAA 
were harvested at the indicated time points after galactose addition and DNA 
content was measured by flow cytometry on a BD Accuri C6 flow cytometer. (C) 
Quantification of the cell cycle distribution of the profiles in panel B. Quantification 
was carried out using the BD Accuri C6 software. 
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Figure 4.9 
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Figure 4.8. GFP-PIP overexpression confers mild DNA damage 
sensitivity. (A) 10-fold serial dilutions of the indicated strains were plated on 
medium lacking uracil and containing either 2% glucose to suppress gal-
RAD27 or 2% galactose to induce RAD27 overexpression. The medium 
contained either 0.05, 0.10 or 0.20 μg/ml 4-NQO as indicated. Plates were 
incubated at 25°C for 4 days before imaging. (B) 10-fold serial dilutions of the 
indicated strains were plated on medium lacking uracil and containing either 
2% glucose to suppress gene expression or 2% galactose to induce 
overexpression. The medium contained either 0.005%, 0.01% or 0.02% MMS 
as indicated. Plates were incubated at 25°C for 4 days before imaging. 
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Figure 4.10 
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Figure 4.9. FEN1 overexpression promotes genome instability. (A) 293T cells 
were either mock transfected or transiently transfected with FLAG-FEN1 under 
control of a CMV promoter and collected 24 or 48 h after transfection. Treatment 
with 10 J/m2 UV was included as a positive control for DNA damage. UV treated 
cultures were harvested 24 h after irradiation. Whole cell extracts were isolated 
and fractionated by SDS-PAGE for western blot analysis with anti-phospho-S4/8 
RPA32, anti-γH2AX, anti-FEN1, and anti-α-tubulin. (B) A portion of the cells 
collected from the experiment described in (A) were fixed in ethanol and DNA 
content was measured by flow cytometry on a BD Accuri C6 flow cytometer. (C) 
FEN1 reads per kilobase of transcript per million mapped reads (RPKM) from lung 
adecarcinoma and matched normal tissue were compared. Of the 162 RNASeq 
datasets available, these 50 were paired tumor/normal samples from 25 patients. 
Lines indicate mean values and bars represent standard deviations. Source: The 
Cancer Genome Atlas (TCGA): http://cancergenome.nih.gov/. 
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Table 4.1  
 
Table 4.1. Yeast Strains used in Chapter 4 
Strain Name Relevant Genotype Source 
 E133 derived strains  
EFS20 MATα, ade5-1, lys2-A12, trp1-289, his7-2, leu2-3,112, ura3-52, bar1 [Tran et al. 1997] 
AByb1541 pYEP195spgal-EV (URA3) This study 
AByb1542 pRG105A (URA3) This study 
AByb1543 pRG106A (URA3) This study 
AByb1800 pRG106A (URA3), pol30::pol30-K164R (LEU2) This study 
AByb2205 pRG106A (URA3), rad52::TRP1 This study 
AByb2216 pRG106A (URA3), dnl4::TRP1 This study 
AByb2108 pRG106A (URA3), leu2::His-POL30 (LEU2), pol30::TRP1 This study 
AByb2110 pRG106A (URA3), leu2::His-pol30-K164R (LEU2), pol30::TRP1 This study 
EFS3101 rad27::gal-rad27-D179A This study 
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Strain Name Relevant Genotype Source 
AByb1549 rad27::gal-RAD27, leu2::His-POL30 (LEU2), pol30::URA3 This study 
AByb1550 rad27::gal-rad27-D179A, leu2::His-POL30 (LEU2), pol30::URA3 This study 
AByb1554 rad27::gal-rad27-D179A, leu2::His-pol30-K164R (LEU2), pol30::URA3 This study 
AByb1805 rad27::gal-rad27-D179A, leu2::His-pol30-K242R (LEU2), pol30::URA3 This study 
AByb1806 rad27::gal-rad27-D179A, leu2::His-pol30-KK164/242RR (LEU2), pol30::URA3 This study 
 
AByb1795 pRG105A (URA3), pol30::POL30 (LEU2) This study 
AByb1797 pRG105A (URA3), pol30::pol30-K164R (LEU2) This study 
AByb1798 pRG106A (URA3), pol30::POL30 (LEU2) This study 
AByb1834 pRG105A (URA3), pol30::pol30-K242R (LEU2) This study 
AByb1836 pRG105A (URA3), pol30::pol30-KK164/242RR (LEU2) This study 
AByb1835 pRG106A (URA3), pol30::pol30-K242R (LEU2) This study 
AByb1837 pRG106A (URA3), pol30::pol30-KK164/242RR (LEU2) This study 
AByb2094 YEP195spgal-EV (URA3), rev3::LEU2 This study 
AByb2096 YEP195spgal-EV (URA3), rad5::TRP1 This study 
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Strain Name Relevant Genotype Source 
AByb2098 YEP195spgal-EV (URA3), rad5::TRP1, rev3::LEU2 This study 
AByb2100 pRG106A (URA3), rev3::LEU2 This study 
AByb2102 pRG106A (URA3), rad5::TRP1 This study 
AByb2104 pRG106A (URA3), rad5::TRP1, rev3::LEU2 This study 
AByb2469 pRG106A-FFAA (URA3) This study 
AByb2165 pRG106A (URA3), siz1::TRP1 This study 
AByb2289 pRG106A (URA3), mms21::mms21-CH (LEU2) This study 
AByb2471 pRG106A-FFAA (URA3), pol30::pol30-K164R (LEU2) This study 
AByb2477 pRG106A-FFAA (URA3), siz1::TRP1 This study 
AByb2483 pRG106A-FFAA (URA3), mms21::mms21-CH (LEU2) This study 
AByb2473 pRG106A-FFAA (URA3), rad52::TRP1 This study 
AByb2124 pRG105A (URA3), rev3::LEU2 This study 
AByb2057 pRG105A (URA3), rad5::TRP1 This study 
AByb2126 pRG105A (URA3), rad5::TRP1, rev3::LEU2 This study 
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Strain Name Relevant Genotype Source 
AByb2525 gal-GFP (URA3) This study 
AByb2518 gal-GFP-PIP (URA3) This study 
AByb2520 gal-GFP-PIP-FFAA (URA3) This study 
   
 W303-1a derived strains  
AByb2382 pRG106A (URA3), smt3::SMT3 (TRP1)  
AByb2384 pRG106A (URA3), smt3::His-SMT3 (TRP)   
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CHAPTER 5   
Discussion and Future Directions 
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 The work described in this dissertation is aimed at understanding the role 
of PCNA ubiquitination and PRR in the absence of DNA damage. A wealth of 
evidence gathered over the past 50 years has described the function of these 
pathways in the tolerance of chemical damage, which impairs the progress of DNA 
polymerases and prevents complete replication. Only more recently have we come 
to appreciate that PRR pathways are also operational in the absence of DNA 
damage. This was first identified in yeast strains carrying hypomorphic alleles of 
genes encoding the replication polymerases Pol-α, Pol-δ, and Pol-ε [Northam et 
al. 2006, Suzuki et al. 2009, Becker et al. 2014]. It is likely that the replication defect 
in these cells is very similar to DNA damage insofar as the activity of the 
polymerases is incapable of maintaining pace with DNA unwinding, causing 
ssDNA regions to be formed [Byun et al. 2005, Lopes et al. 2006, Suzuki et al. 
2009]. In chapter 3, I describe a role for PRR in mutants of genes unrelated to DNA 
synthesis, further widening the scope of conditions under which these pathways 
operate. The picture that is emerging is that PCNA ubiquitination and PRR act as 
general suppressors of replication stress under a variety of compromising 
conditions. 
The findings summarized in chapter 2 provide greater detail for the activity 
of PRR in mutants impaired for nascent DNA priming. This study identifies a 
requirement for PRR in Mcm10 mutants and establishes that the basis for this 
dependence is separable between Mcm10’s activity in priming/DNA synthesis and 
its role in origin activation [Becker et al. 2014]. These findings support the notion 
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that Mcm10 has functions beyond origin activation, which had hitherto been 
controversial in the field. To extend the analysis beyond obvious defects in the 
replication machinery that affect DNA synthesis, in chapter 3, I have taken a 
systematic approach to characterizing PRR in the absence of DNA damage 
through the use of a genome-wide genetic screen. Two particularly exciting 
conclusions were derived from this study. First, mutations that disrupt lagging 
strand replication exhibited a much greater requirement for PRR than those 
affecting leading strand synthesis. Second, I demonstrated that PRR acts to 
rescue DNA processing defects at the junction of Okazaki fragments in rad27Δ 
mutants [Becker et al. 2015]. This is to my knowledge the first example of PRR 
acting in response to disruption of a non-DNA synthesis related process of 
replication. Finally, in chapter 4 I have studied the effect of RAD27 overexpression 
on genome stability. Whereas overexpression markedly impairs replication and 
leads to the accumulation of DNA damage and mutations, I observed no 
dependence on PRR. In fact, PRR was largely suppressed under these conditions 
as measured by the level of PCNA ubiquitination. Instead, SUMO-dependent 
pathways, including those that target PCNA, were highly upregulated and played 
a critical role in supporting cell viability.  
Altogether this work has illuminated conditions that lead to a requirement 
for PRR, particularly on the lagging strand, and show that RAD27 overexpression 
is a potent driver of genome instability. These studies leave some old questions 
unanswered as well as raising several new ones. For the remainder of this chapter, 
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I will address outstanding questions resulting from this work that would provide 
interesting avenues for further research.  
 
1) How does SUMO improve the viability of RAD27 overexpressing cells? In 
chapter 4, I identified a genetic requirement for the SUMO E3 ligases Siz1 and 
Mms21 in cells that overexpress RAD27. Furthermore, I determined that PCNA-
K164 is not the only SUMO target of importance for Siz1 under these conditions 
(Figure 4.4). No specific targets of Mms21 were identified despite the fact that it 
has been previously reported to be activated in response to replication stress 
[Branzei et al. 2006]. Identification of Siz1 and Mms21 targets would provide 
valuable mechanistic insight into how these proteins counteract replication stress, 
particularly when RAD27 is overexpressed. 
In the experiment described in Figure 4.6, His8-tagged SUMO was purified 
under denaturing conditions in the presence or absence of RAD27 overexpression. 
Analysis by SDS-PAGE fractionation and anti-SUMO western blot revealed a 
noticeable change in the pattern of sumoylated proteins in cells overexpressing 
RAD27 (Figure 4.6A). A single pilot experiment was performed to identify these 
SUMO targets by mass spectrometry using spectral counts as a measure of 
abundance. PCNA was the only clear candidate identified in this analysis. 
However, as discussed in chapter 4, the minimal effect on viability of ablating 
PCNA-K164 sumoylation in comparison to deleting the SUMO ligases SIZ1 or 
MMS21 indicates that there are additional targets of importance (Figure 4.4). 
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Recent work in our laboratory has exploited the same purification strategy to 
isolate SUMO conjugates and quantified changes in their abundance between 
wild-type and mutant conditions [Thu et al. 2016]. Quantification was carried out 
using a novel label-free method known as DRIPPER [Thu et al. 2016, Van Riper 
et al. 2016]. Optimization of the His8-SUMO purification strategy with RAD27 
overexpression and utilization of this sensitive quantification method could 
potentially identify additional targets that were missed in the first analysis.  
It may also be that the relatively high amount of PCNA identified masks our 
ability to detect other target proteins. Performing the same experiment in a siz1Δ 
or PCNA-K164R mutant background that lacks sumoylated PCNA would be a 
strategy to increase our detection of non-PCNA targets. The siz1Δ background in 
particular would allow us to identify targets that are specific to Mms21 and assist 
in dissecting the divergent functions of these E3 SUMO ligases. The simplicity of 
the yeast system and the abundance of genetic tools at our disposal make it ideally 
suited for solving mechanistic questions such as this. Principles established in 
yeast can then be used in guiding similar investigations in the more complex 
human system.  
We already know that many cancers have elevated levels of genome 
instability and chronic replication stress [Gaillard et al. 2015]. How they are able to 
manage this stress over many rounds of replication is not entirely clear. A cursory 
review of MMS21 status in a variety of cancers available in the TCGA database 
reveals that its expression is frequently amplified in many cancer cell types (Figure 
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5.1). It is possible that this is reflective of an increased requirement for MMS21-
dependent sumoylation pathways. Unfortunately, this line of inquiry is woefully 
understudied at the moment. A better understanding for the targets of MMS21 
during stressed replication holds the potential to reveal mechanisms at work in 
cancer cells that are relied upon to manage rapid proliferation in the face of chronic 
replication stress. Such pathways would be attractive therapeutic targets for anti-
cancer treatment. Yeast research offers the opportunity to understand 
mechanistically how MMS21 amplification acts as a compensatory mechanism 
that enables the tolerance of chronic replication stress.  
 
2) What are the functions of non-K164 sites of PCNA ubiquitination? Since 
the original discovery of PCNA-K164 as a site of ubiquitin attachment at least two 
additional sites in yeast, K107 and K242, have been identified [Das-Bradoo et al. 
2010, Nguyen et al. 2013]. Alternate sites of ubiquitination have also been mapped 
in proteomic screens of human cells after UV irradiation or treatment with the 
spindle formation inhibitor colchicine [Xu et al. 2010, Povlsen et al. 2012, Elia et 
al. 2015]. The conventional dogma in the field has long stated that K164 is the sole 
site for ubiquitination. However, in light of these recent findings, it is becoming 
increasingly apparent that modification of PCNA by ubiquitin is not as exclusive to 
K164 as initially thought.  
Chapter 4 includes the first description of K242 as a site for ubiquitin 
attachment in yeast. This was observed in cells overexpressing the nuclease dead 
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allele of RAD27 known as rad27-n (Figure 4.2C). Interestingly, whereas K242 is 
not evolutionarily conserved, a nearby lysine residue (K240) is conserved in higher 
eukaryotes (Figure 5.2). These residues map to very similar positions on the PCNA 
trimer and could conceivably be functionally redundant (Figure 5.2). However, 
K240 has not yet been reported as a site of ubiquitination on human PCNA. 
Because substitution of K242 with arginine reduced the mutation rate of rad27-n 
expressing cells, we inferred that K242, like K164, is capable of facilitating 
mutagenic TLS. Given that ubiquitination at this site has never been previously 
observed and that no in vivo evidence has linked TLS to ubiquitination of a non-
K164 site, investigation of K242 modification and its regulation may be of 
importance in understanding the factors that govern PRR usage.  
 Determining the ubiquitin conjugating enzymes that target K242 will be 
crucial in understanding its relationship to PRR. Because I have already 
established detection tools for ubiquitination at this site via His6-PCNA purification 
and western blot analysis with anti-PCNA and anti-ubiquitin antibodies (Figure 
4.2C), I would begin by knocking out candidate ubiquitin conjugating enzymes and 
ubiquitin ligases. First, I would delete Rad6-Rad18 to immediately determine 
whether the same pathway that attaches ubiquitin to K164 regulates K242. If 
deletion of these enzymes were not to have any impact on K242 ubiquitination, the 
relative simplicity of yeast would make a systematic approach manageable. S. 
cerevisiae has twelve described E2 ubiquitin conjugating enzymes [Ye and Rape 
2009]. Three have no known nuclear functions and can be initially discounted. Of 
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the nine remaining E2 enzymes, eight could be deleted individually in rad27-n 
overexpressing mutants. One is known to be essential but its activity can be 
modulated through the use of a temperature sensitive allele [Goebl et al. 1988]. 
Candidate E2 enzyme(s) can be used to narrow the number of potential E3 
ubiquitin ligases based on their known E2 preferences [Ye and Rape 2009]. This 
information may give insight into how K242 ubiquitination is regulated based on 
what is already known about the enzymes that target it and may reveal co-
regulated pathways. Furthermore, identification of E2 and E3 enzymes would 
provide genetic tools to alter ubiquitination status that are independent of PCNA 
mutation. 
 In addition to K242, our laboratory has described K107 as an alternative site 
of PCNA ubiquitination in yeast [Das-Bradoo et al. 2010, Nguyen et al. 2013]. 
Similar to K242, targeting of this residue has only been observed under a specific 
genetic condition, namely, DNA ligase I deficiency. With the exception of K107, 
very little is known about the enzymatic pathways that underlie targeting of 
alternative residues or the downstream effectors impacted by such modifications. 
However, the fact that K242 and K107 are both targeted in response to very 
specific mutations may indicate that different sites are involved in the cellular 
response to specific replication defects [Das-Bradoo et al. 2010]. If K242 were 
targeted for ubiquitination in a Rad6-Rad18 independent manner it would further 
support the notion that different sites of PCNA ubiquitination are linked to different 
sources of replication stress. This suggests a model in which different sites of 
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ubiquitination act as a sort of “DNA damage code” that enables cells to distinguish 
between different replication stress intermediates and respond appropriately. 
 
3) Do RPA coated 5’ flaps directly recruit Rad6-Rad18? In Chapter 3, I provided 
genetic evidence that flap endonuclease (rad27Δ) deficient yeast cells accumulate 
long RPA-coated flaps, which act as a substrate for Rad6-Rad18 recruitment and 
subsequent PCNA ubiquitination (Figure 3.8D). This conclusion is predicated on 
the assumption that the rad27Δ mutants do not form ssDNA gaps, which are also 
a stimulus for PCNA ubiquitination. The foundation of our argument in this study 
was that overexpression of DNA2, which cleaves 5’ flaps after they have grown 
long enough to bind RPA, had no impact on the level of PCNA ubiquitination in 
rad27Δ mutants. In contrast, overexpression of EXO1, which cleaves short DNA 
flaps before they become long enough to bind RPA did alleviate PCNA 
ubiquitination. Together, these two pieces of evidence support a model in which 
long RPA-bound flaps present in rad27Δ are sufficient to recruit Rad6-Rad18 and 
ubiquitinate PCNA. However, we lack direct biochemical evidence that RPA-bound 
5’ flaps are a direct substrate for Rad6-Rad18 recruitment. We therefore cannot 
exclude the possibility that overexpression of EXO1, a close evolutionary relative 
of RAD27, more effectively rescues the rad27Δ mutant phenotype than DNA2 and 
compensates for any deficiency that leads to ssDNA gap formation [Orans et al. 
2011, Tsutakawa et al. 2011, Miętus et al. 2014]. Evidence of a more direct nature 
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will be necessary to confirm the model that long RPA-coated flaps stimulate PCNA 
ubiquitination. 
Previous in vitro work has shown that long flaps are capable of binding RPA 
and indeed a robust body of evidence suggests that this is necessary for flap 
processing by DNA2 [Bae and Seo 2000, Bae et al. 2001, Ayyagari et al. 2003]. 
Furthermore, genetic evidence has suggested that RPA-bound 5’ flaps are 
sufficient to propagate Mec1-Ddc2 binding and checkpoint activation [Budd et al. 
2011, Nguyen et al. 2013]. Although the theory that long RPA coated flaps 
participate in DNA damage response signaling has existed for at least 5 years, it 
has never been directly demonstrated. Confirmation that such flaps are key 
participants in checkpoint/PRR signaling would force us to reconsider the dynamic 
relationship between Okazaki fragment processing and the DNA damage 
response. This finding would also have implications for other processes such as 
BER which involve 5’ flap intermediates [Krokan and Bjørås 2013].  
To prove that RPA-bound 5’ flaps are sufficient to recruit Rad6-Rad18 to 
ubiquitinate PCNA, I would carry out a set of in vitro experiments using a biotin 
labelled 5’ flapped DNA substrate with purified PCNA, RPA, ubiquitin, and Rad6-
Rad18. Purification of the biotin-labelled DNA substrate from this mixture over 
streptavidin conjugated resin, fractionation by SDS-PAGE, and analysis by 
western blot with antibodies directed against components of the RPA complex will 
be necessary to demonstrate that RPA is binding the 5’ flap under defined reaction 
conditions. Western blot analysis for Rad6 and Rad18 that might co-purify with the 
 226 
 
biotin-DNA substrate in the presence or absence of RPA would determine whether 
RPA-bound flaps recruit this complex. A DNA substrate with a single-stranded gap 
would serve as a positive control, whereas a dsDNA fragment of equal length 
would act as a negative control. If the addition of RPA in the presence of a 5’ 
flapped DNA substrate significantly enhanced PCNA ubiquitination, I would 
conclude that Rad6-Rad18 ubiquitinated PCNA by directly binding RPA-coated 5’ 
flaps.  
Such an experimental system could also be adapted to assay the 
involvement of RPA-bound flaps in other DNA damage response transactions, 
including binding and activation of the kinase Mec1. Between BER and Okazaki 
fragment processing, the frequency with which 5’ flaps appear throughout the cell 
cycle suggests that their involvement in intracellular signaling could be a powerful 
regulatory element for DNA replication and cell cycle progression. 
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Figure 5.1 
Figure 5.1. MMS21 expression is frequently amplified in cancer. 
Illustrated are the genetic alterations of MMS21 associated with a variety of 
cancers.  This data is freely available from TCGA and was accessed via 
cBioportal for Cancer Genomics (http://www.cbioportal.org/). This figure was 
adapted from an image downloaded from cBioportal [Cerami et al. 2012, Gao 
et al. 2013]. 
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Figure 5.2 
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Figure 5.2. Yeast PCNA-K242 is positionally conserved in higher eukaryotes. 
An alignment between yeast PCNA and that of other eukaryotic organisms was 
generated using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) (top). 
Residues 240 and 242 are highlighted with red boxes. The space filling models of 
human and yeast PCNA (bottom) were obtained from the RCSB Protein Database 
(PDB) (http://www.rcsb.org/pdb/home/home.do) and modeled using the Chimera 
program (https://www.cgl.ucsf.edu/chimera/). In the human PCNA structure K240 
is highlighted in red and in the yeast structure K242 is highlighted [Krishna et al. 
1994, Gulbis et al. 1996]. 
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